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ABSTRACT

TRPA1 CHANNELS IN COCHLEAR SUPPORTING CELLS
REGULATE HEARING SENSITIVITY AFTER NOISE EXPOSURE
TRPA1 channels are sensors for noxious stimuli in a subset of nociceptive neurons.
TRPA1 channels are also expressed in cells of the mammalian inner ear, but their
function in this tissue remains unknown given that Trpa1–/– mice exhibit normal hearing,
balance and sensory mechanotransduction. Here we show that non-sensory (supporting)
cells of the hearing organ in the cochlea detect tissue damage via the activation of
TRPA1 channels and subsequently modulate cochlear amplification through active cellshape changes.
We found that cochlear supporting cells of wild type but not Trpa1–/– mice generate
inward currents and robust long-lasting Ca2+ responses after stimulation with TRPA1
agonists. These Ca2+ responses often propagated between different types of supporting
cells and were accompanied by prominent tissue displacements. The most prominent
shape changes were observed in pillar cells which here we show possess Ca2+-dependent
contractile machinery. Increased oxidative stress following acoustic overstimulation leads
to the generation of lipid peroxidation byproducts such as 4-hydroxynonenal (4-HNE)
that could directly activate TRPA1. Therefore, we exposed mice to mild noise and found
a longer-lasting inhibition of cochlear amplification in wild type than in Trpa1–/– mice.
Our results suggest that TRPA1-dependent changes in pillar cell shape can alter the
tissue geometry and affect cochlear amplification. We believe this novel mechanism of
cochlear regulation may protect or fine-tune the organ of Corti after noise exposure or
other cochlear injuries.

KEYWORDS: Transient receptor potential A1 channel, cochlear supporting cells,
reactive oxygen species, cochlear amplification, 4-hydroxynonenal

Alejandra Catalina Vélez-Ortega
Student’s Signature
December 10, 2014
Date

TRPA1 CHANNELS IN COCHLEAR SUPPORTING CELLS
REGULATE HEARING SENSITIVITY AFTER NOISE EXPOSURE

By
Alejandra Catalina Vélez-Ortega

Dr. Gregory I. Frolenkov
Director of Dissertation
Dr. Bret N. Smith
Director of Graduate Studies
December 10, 2014
Date

To my father,
whose creativity kept my curiosity from fading

(a curiosity that now fuels a career in research).

PREFACE AND ACKNOWLEDGEMENTS
Almost 10 years ago, in a course for advanced English writing, I was asked to write an
essay about the perfect career pattern for myself. I wrote about my passion for research
and my desire to return to school to obtain a graduate degree. Now that I see ‘the light at
the end of the PhD tunnel’, I am glad that I still feel the same level of passion and
curiosity I felt 10 years ago. This further confirms my desire to pursue a career in
research. Interestingly, back then I was absolutely convinced that “…it (was) not part of
my (career) scheme to create my own research group”. I did not feel I was creative
enough or that I had the critical thinking required to develop my own research ideas. So, I
went on and obtained a Master’s degree and subsequently joined a PhD program, all
while thinking that a career in academia was not the option for me.
I thank my advisor, Dr. Gregory I. Frolenkov, for his guidance throughout the
development and execution of this research project. At occasions, my curiosity led me off
track, but he always brought me back by providing a clear distinction between the main
experiments that were required to test our hypothesis vs. the additional experiments that
only provided extra support (or, as he called them, the ‘icing on the cake’). Gregory often
made me think like an independent investigator. For instance, he allowed me set up the
imaging/electrophysiological system that was used for most experiments presented here.
For about three months, I read countless manuals, made dozens of cable connections,
calibrated and tested individual components, and configured the system’s software.
Gregory knew that by allowing me to do this I would be able to easily troubleshoot
“technical problems” encountered during the experiments. Additionally, I knew the full
capabilities of the system and therefore was able to plan experiments to take full
advantage of them. This process indeed facilitated the standardization phase of new
experiments. But most importantly, as Gregory knew and eventually told me, those 3
iii

months provided a glimpse of what one day setting up my own laboratory could feel like.
And I must confess, this took some of the fear I had away. Together with this, our long
discussions over the results of experiments, grant proposals, publication strategies and
career options, allowed me to feel like a colleague more than a student. Nowadays, I
often think about my career options and I find myself contemplating a career in academia
and wanting to start my own laboratory. Therefore, I feel most grateful to Gregory for
boosting my own confidence and believing I have what it takes to become an independent
investigator.
I want to thank Dr. Timothy S. McClintock, Dr. Bradley K. Taylor, Dr. Kenneth S.
Campbell and Dr. Olivier Thibault for serving on my PhD committee. Their constructive
criticism in each of our meetings has truly improved the quality of this work. I also thank
Dr. Douglas A. Andres for agreeing to be the outside examiner for my dissertation
defense.
I also wish to express my gratitude to all members in the Frolenkov laboratory. When
I first joined the laboratory, the former members, Dr. Ruben S. Stepanyan, Dr. Artur A.
Indzhykulian and Dr. Mircea Anghelescu (a.k.a. ‘the boys’), provided training for several
techniques, a welcoming work environment, and even a ‘big brother’-like behavior since
they often walked me to my car when I would leave the laboratory in the late night. I feel
truly lucky to have met Ms. Stephanie E. Edelmann as well. Her kind heart and unselfish
nature mean the world to me. In addition, Stephanie provided significant help with the in
vivo experiments in this project. In addition to the people mentioned above, I also thank
Dr. Ghanshyam P. Sinha, Mr. Mike Grossheim, Ms. Diana Syam and Ms. Shadan Hadi
for their valuable comments during laboratory meetings.
Throughout this and other projects, I had the privilege to mentor several students: Ms.
Weisi Fu, Ms. Brianna D. Harfmann, Ms. Shaniya Maimaiti, Mr. Julián Vergara and Ms.
Kathryn M. Toner. I enjoyed the time they spent in the laboratory and I look forward to
continue training more students in the years ahead. I also had the pleasure to mentor Dr.
Channy Park. Her help was crucial for some of the experiments presented here.
I am extremely thankful to Dr. Francesc Martí, who gave me the opportunity to come
to Lexington, KY to work in his laboratory. Francesc played a crucial role in my decision

iv

to apply to a PhD program in the University of Kentucky. Francesc is also one of the
kindest people I have ever met and my time in his laboratory was incredibly enjoyable.
To my friends, far too many to mention individually (for which I am grateful for), I
am thankful for the words of encouragement throughout this PhD process, the laughter
shared over coffee dates, the long nights dancing, the expeditions and trips together, the
willingness to lend an ear and serve as my pressure release valves, the early morning
rides to the airport, the welcoming smile after a long work day, the delicious cakes,
cupcakes, desserts and little doughnuts, the tolerance and support during my craziness
over world-cup season, and the silly science-related jokes. All of you have made the past
few years quite an interesting ride.
I am grateful to have the support from my family, both the family related through
blood and the families through love and close friendships. My parents, brother and aunts
in Colombia and my world traveler sister have given me nothing but freedom and
encouragement after my decision to move to a different country to pursue a lifestyle of
long working hours. I thank my host parents here in Lexington for their unconditional
love and fun gatherings; and thank my in-laws in South Carolina for always welcoming
me with warm hugs and the biggest smiles every time I visit them.
Lastly, I would like to thank my sweet and loving husband, Phillip Chase Hawkins.
Chase brought a new meaning to music in my life. At times, Chase seems to know me
better than I know myself. Without him by my side, this process would have been infinite
times more stressful.

Copyright © A. Catalina Vélez-Ortega 2014
v

TABLE OF CONTENTS
Preface and acknowledgements ......................................................................................... iii
List of tables ..................................................................................................................... viii
List of figures .......................................................................................................................x
Chapter 1: An introduction to cochlear cell morphology and function........................1
1.1 Overview of mammalian hearing ...............................................................................1
1.2 The cochlea ................................................................................................................2
1.3 The cochlear sensory epithelium ................................................................................4
1.4 Cochlear sensory cells and mechano-electrical transduction .....................................5
1.4.1 Mechano-electrical transduction .........................................................................5
1.4.2 Outer hair cells and cochlear amplification........................................................7
1.4.3 Inner hair cells.....................................................................................................8
1.5 Cochlear innervation ..................................................................................................8
1.6 Cochlear supporting cells and fluid-filled compartments ........................................10
1.6.1 Inner sulcus cells and the Kolliker’s organ .......................................................11
1.6.2 Inner border and inner phalangeal cells ...........................................................11
1.6.3 Pillar cells..........................................................................................................12
1.6.4 Deiters’ cells ......................................................................................................12
1.6.5 Hensen’s and Claudius’ cells ............................................................................13
1.7 Purinergic signaling in cochlear supporting cells ....................................................14
1.7.1 Spontaneous release of ATP during postnatal development .............................14
1.7.2 Pathophysiological release of ATP ...................................................................15
1.7.3 Mechanism of propagation of ATP-induced Ca2+ waves in supporting cells ...15
1.8 Impact of noise exposure on hearing thresholds ......................................................16
1.9 Impact of noise exposure on the geometry of the organ of Corti .............................18
Chapter 2: A comprehensive review of literature on TRPA1 channels ......................20
2.1 The TRP channel family ..........................................................................................20
2.2 TRPA1: from gene to protein ...................................................................................21
2.2.1 The mouse Trpa1 gene .......................................................................................21
2.2.2 The rat TRPA1 gene ..........................................................................................21
2.2.3 The human TRPA1 gene ....................................................................................25
2.2.4 Tissue expression of TRPA1 ..............................................................................25
2.2.5 Channel assembly from TRPA1 subunits...........................................................26
2.2.6 Ankyrin repeats in the intracellular N-terminus of TRPA1 ...............................26
vi

2.2.7 The intracellular C-terminus and pore-forming regions of TRPA1 ..................28
2.3 TRPA1 agonists and the mechanisms of TRPA1 channel gating ............................28
2.3.1 Pungent compounds ...........................................................................................33
2.3.2 Airborne irritants...............................................................................................34
2.3.3 Byproducts of reactive oxygen and nitrogen tissue damage .............................34
2.3.4 Divalent cations .................................................................................................35
2.3.5 Noxious cold ......................................................................................................35
2.3.6 Pro- and anti-inflammatory agents ...................................................................36
2.3.8 Other TRPA1 agonists .......................................................................................37
2.3.9 Agonists able to inhibit TRPA1 channels ..........................................................39
2.4 TRPA1 in nociceptive neurons ................................................................................39
2.4.1 TRPA1 activation in nociceptive neurons .........................................................39
2.4.2 Functional interplay between TRPA1 and TRPV1 channels .............................42
2.5 Regulatory mechanisms of TRPA1 function ...........................................................42
2.5 TRPA1 as a hair cell MET channel candidate .........................................................44
2.6 Research hypothesis and scope of the dissertation...................................................45
Chapter 3: Materials and methods .................................................................................46
3.1 Mice..........................................................................................................................46
3.2 Cochlear explants .....................................................................................................47
3.2.1 Tissue dissection ................................................................................................47
3.2.2 Tissue culture of cochlear explants ...................................................................47
3.2.3 Freshly-isolated cochlear explants ....................................................................50
3.2.4 Identification of cochlear cell types...................................................................51
3.3 Immunohistochemistry .............................................................................................53
3.3.1 PLAP immunolabeling .......................................................................................53
3.3.2 Immunolabeling of 4-HNE-modified proteins ...................................................53
3.3.3 Imaging set up ...................................................................................................54
3.4 Drug delivery............................................................................................................54
3.4.1 Stock and working solutions of the drugs used..................................................54
3.4.2 Glass micro-pipettes ..........................................................................................56
3.4.3 Puff stimulation..................................................................................................56
3.5 FM1-43 labeling .......................................................................................................57
3.6 Ratiometric calcium imaging ...................................................................................58
3.6.1 Loading cells with the Ca2+ indicator ...............................................................58
3.6.2 Live cell imaging ...............................................................................................59
3.6.3 Image analysis ...................................................................................................59
3.6.4 Calculating free Ca2+ concentrations from F340/F380 ratios..............................60
3.7 Patch clamping recordings .......................................................................................61
3.8 Laser uncaging .........................................................................................................66
3.8.1 Set-up configuration ..........................................................................................66
3.8.2 Ca2+ uncaging in pillar cells ............................................................................66
3.9 Measurement of tissue displacements and cell contractions ....................................67
3.9.1 Imaging set-up and software .............................................................................67
3.9.2 Tissue displacement measurements ...................................................................67
3.9.3 Measuring cell diameters ..................................................................................68
vii

3.10 Auditory brainstem responses (ABR) ....................................................................69
3.10.1 Mouse anesthesia .............................................................................................69
3.10.2 ABR recordings................................................................................................69
3.10.3 Noise exposure .................................................................................................70
3.11 Distortion product otoacoustic emissions (DPOAE) .............................................70
3.12 Statistical analysis ..................................................................................................71
Chapter 4: Results............................................................................................................72
4.1 TRPA1 is widely expressed in the mammalian cochlea ..........................................72
4.2 Sensory and supporting cells within the cochlear epithelium express
functional TRPA1 channels ...........................................................................................74
4.3 TRPA1 activation evokes robust and long-lasting Ca2+ responses in
Hensen’s cells .................................................................................................................76
4.4 Responses to TRPA1 agonists in the Hensen’s cells are modulated by the
levels of intracellular Ca2+ levels ...................................................................................83
4.5 Cells of the Kolliker’s organ exhibit oscillating Ca2+ responses after TRPA1
agonist stimulation .........................................................................................................85
4.6 TRPA1-dependent Ca2+ responses in the Hensen’s cell can propagate to the
Kolliker’s organ..............................................................................................................88
4.7 In the presence of a gap junction blocker Claudius’ cells exhibit TRPA1mediated Ca2+ responses ................................................................................................93
4.8 Deiters’ cells express functional TRPA1 channels ..................................................96
4.9 TRPA1 stimulation induces tissue movement that seems to originate at
pillar and Deiter’s cells ..................................................................................................99
4.10 Cochlear pillar cells posses Ca2+-dependent contractile machinery ....................104
4.11 TRPA1 contributes to a long-lasting inhibition of cochlear amplification
after noise exposure......................................................................................................106
Chapter 5: Discussion of results, study limitations and future directions ................111
5.1 Propagation of TRPA1-mediated signals across the cochlear epithelium ............ 112
5.2 TRPA1 activation induces changes in the geometry of the cochlear epithelium .. 118
5.3 TRPA1-mediated inhibition of cochlear amplification ......................................... 123
5.4 Closing remarks..................................................................................................... 126
Appendix A ......................................................................................................................128
Appendix B ......................................................................................................................131
Appendix C ......................................................................................................................135
Appendix D ......................................................................................................................137
References ........................................................................................................................139


9ita .............................................................................................................160

Copyright © A. Catalina Vélez-Ortega 2014
viii

LIST OF TABLES
Table 2.1. Mammalian TRP channels ............................................................................... 22
Table 2.2. List of TRPA1 agonists.................................................................................... 29
Table 3.1. Imaging conditions used during ratiometric Ca2+ imaging .............................. 60

Copyright © A. Catalina Vélez-Ortega 2014
ix

LIST OF FIGURES
Figure 1.1. Overview of the human ear ...............................................................................2
Figure 1.2. Diagram showing the three fluid compartments found in the
mammalian cochlea .....................................................................................................3
Figure 1.3. Diagram of the adult mammalian cochlear epithelium .....................................4
Figure 1.4. Diagram of hair cell stereocilia deflections induced by basilar
membrane movements .................................................................................................5
Figure 1.5. View of the apical surface of the organ of Corti ...............................................6
Figure 1.6. Diagram of stereocilia deflection and MET gating ...........................................7
Figure 1.7. Diagram of OHC electromotility .......................................................................8
Figure 1.8. IHC and OHC innervation .................................................................................9
Figure 1.9. Diagram of the cochlear epithelium at an early postnatal age.........................11
Figure 1.10. Mechanism of propagation of ATP-induced Ca2+ waves in supporting
cells ............................................................................................................................16
Figure 1.11.Diagram of temporary vs. permanent shifts in hearing thresholds .................17
Figure 2.1. Diagram of a TRPA1 channel subunit.............................................................27
Figure 2.2. Pathways for TRPA1 activation after tissue damage ......................................41
Figure 3.1. Cochlear epithelium attached to a glass-bottom dish ......................................48
Figure 3.2. Cochlear explants cultured with outer supporting cells and stria
vascularis exhibited morphological abnormalities.....................................................49
Figure 3.3. Apoptotic cells are observed in the stria vascularis during culture .................50
Figure 3.4. Freshly-isolated cochlear tissue held in place by glass capillaries ..................51
Figure 3.5. Representative bright field images of a cochlear explant taken at two
different focal planes..................................................................................................52
Figure 3.6. Performance test of the 4-HNE antibody ........................................................55
Figure 3.7. System delay during puff stimulation..............................................................57
Figure 3.8. Puff stimulation area........................................................................................58
Figure 3.9. Calibration curves for the fura-2 dye...............................................................62
Figure 3.10. Supporting cells are electrochemically coupled via gap junctions ................63
Figure 3.11. CBX fails to block the diffusion of a fluorescent dye between
supporting cells ..........................................................................................................64
Figure 3.12. Electrophysiological characteristics of cochlear supporting cells .................65
Figure 3.13. Laser spot size ...............................................................................................66
Figure 3.14. Cell diameter measurements..........................................................................68
Figure 3.15. Representative ABR traces before and after noise exposure.........................70
Figure 4.1. TRPA1 is widely expressed in the cochlear epithelium. .................................73
Figure 4.2. IHCs, OHCs, Hensen’s and Kolliker’s organ cells express functional
TRPA1 channels ........................................................................................................75
x

Figure 4.3. TRPA1 agonists induce robust and long-lasting Ca2+ responses in wild
type Hensen’s cells ....................................................................................................77
Figure 4.4. Intracellular Ca2+ levels from Figure 4.3 without normalization to the
baseline ......................................................................................................................78
Figure 4.5. TRPA1 agonists induce robust Ca2+ responses in Hensen’s cells from
wild type but not Trpa1–/– mice..................................................................................79
Figure 4.6. Mustard oil induces Ca2+ responses in Hensen’s cells with similar
kinetics to 4-HNE and CA .........................................................................................80
Figure 4.7. Sensory hair cells fail to show Ca2+ responses even after stimulation
with a high concentration of a TRPA1 agonist ..........................................................81
Figure 4.8. Hensen’s cells from wild type and TRPA1-deficient mice exhibit
similar resting intracellular Ca2+ levels......................................................................83
Figure 4.9. Intracellular Ca2+ modulates responses to TRPA1 agonists ............................84
Figure 4.10. 4-HNE induces fast and short-lived Ca2+ responses in the cells of the
Kolliker’s organ .........................................................................................................86
Figure 4.11. Oscillating and sustained Ca2+ responses in cochlear supporting cells
might reflect different Ca2+ handling properties ........................................................87
Figure 4.12. Puff stimulation with TRPA1 agonists at the Hensen’s cell region
also triggers Ca2+ waves in the Kolliker’s organ .......................................................89
Figure 4.13. TRPA1-dependent activation of Hensen’s cells propagates to the
Kolliker’s organ and triggers Ca2+ waves that require extracellular ATP .................90
Figure 4.14. The ratiometric fura-2 Ca2+ indicator fails to load pillar and Deiters’
cells ............................................................................................................................92
Figure 4.15. Presence of FFA in the bath solution does not change the resting Ca2+
level in Hensen’s cells ...............................................................................................93
Figure 4.16. In the presence of FFA, 4-HNE induces Ca2+ responses in Claudius’
cells ............................................................................................................................95
Figure 4.17. TRPA1-mediated inward currents in Hensen’s and Deiters’s cells ..............97
Figure 4.18. Current-voltage relationship of TRPA1 activation in the presence of
a different gap junction blocker .................................................................................98
Figure 4.19. TRPA1 activation induces prominent tissue movement .............................100
Figure 4.20. Tissue displacements seem to originate by the contractions of pillar
and Deiters’ cells......................................................................................................102
Figure 4.21. ATP puff stimulation induces pillar cell contraction ..................................103
Figure 4.22. Outer pillar cells exhibit cell contractions after an increase in
intracellular Ca2+ ......................................................................................................105
Figure 4.23. Trpa1–/– mice exhibit normal hearing thresholds ........................................106
Figure 4.24. TRPA1 channels mediate a long-lasting inhibition of hearing
thresholds after noise exposure ................................................................................107
Figure 4.25 Faster recovery of ABR hearing thresholds in Trpa1–/– mice ......................108
Figure 4.26. The noise exposure used leads to permanent threshold shifts in the
high frequency range................................................................................................109
Figure 4.27. 4-HNE-modified proteins are increased in the cochlear epithelium 5
days after noise exposure .........................................................................................110
Figure 5.1. Diagram of Ca2+ responses and their propagation after TRPA1
stimulation in the cochlear epithelium .....................................................................117
xi

Figure 5.2. Tissue movement during bright field imaging leads to changes in pixel
intensity values.........................................................................................................120
Figure 5.3. Labeling of cell membranes in the cochlear epithelium for 3D imaging
reconstruction ...........................................................................................................121
Figure 5.4. Changes in pillar cell shape can alter the geometry of the organ of
Corti .........................................................................................................................123
Figure 5.5. TRPA1 activation after ATP release or 4-HNE production in the
cochlea modulates hearing thresholds .....................................................................125

Copyright © A. Catalina Vélez-Ortega 2014
xii

CHAPTER 1
An introduction to cochlear cell morphology and function
1.1 Overview of mammalian hearing
Air pressure sound waves that reach the pinna of the outer ear (a cartilaginous
structure that protrudes on the side of the head) are reflected into the ear canal and
toward the tympanic membrane (colloquially known as the ear drum) (Figure 1.1). When
the tympanic membrane vibrates, it causes the movement of the chain of three small
bones in the middle ear, known as ossicles. The ossicles are in charge of transmitting
vibrations from the tympanic membrane to the oval window at the base of the cochlea in
the inner ear. The oval window is significantly smaller than the tympanic membrane,
resulting in a necessary large increase in force –given that the sound pressure waves now
need to travel in a fluid-filled environment.
Sound waves reach the coiled cochlea and cause the vibration of the sensory
epithelium contained within. This sensory epithelium rests on the basilar membrane, a
membrane that gradually decreases in stiffness, but increases in size, from the base to the
apex of the cochlea [1, 2]. Sound-induced vibrations of the sensory epithelium initiate
traveling waves that resonate at specific regions of the basilar membrane depending on
their frequency, with high frequencies toward the base and low frequencies toward the
apex of the cochlea. And, as explained in greater detail in section 1.4, there are cells
within the cochlear sensory epithelium that can transduce such tonotopically-arranged
vibrations into neurotransmitter release and excitation of cochlear nerve afferent neurons.
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Figure 1.1†. Overview of the human ear
Modified from reference [3]. A, Diagram showing the main structures of the
external, middle and inner ear with sound vibrations traveling through the ear
canal. B, Cross-section of the cochlea (from a perpendicular plane positioned at
the red dashed line in A) through the cochlear modiolus.
1.2 The cochlea
The bony structure in the middle of the cochlea, known as the modiolus, has a conical
shape and it is filled with cell bodies and axons from cochlear nerve neurons. In a
cochlear cross section, the modiolus constitutes the medial part of the cochlea while the
outer shell localized to both sides is referred to as the lateral wall (Figure 1.1). The
outermost layer of the lateral wall is the otic capsule made up of bone. The basilar
membrane spans from the modiolus to the lateral wall, and its sites of insertion at each
end are known as the spiral limbus (medial) and spiral prominence (lateral) (Figure 1.2).
The spiral prominence spans the inner side of the otic capsule on the lateral wall. Several
types of sensory and supporting cells rest on the basilar membrane, and they will be
discussed in detail in sections 1.4 and 1.6.
A cross-section of the cochlea reveals the presence of three distinct compartments:
scala vestibuli, scala media and scala tympani (Figure 1.2).
†

All drawings and data figures in this dissertation are my original artwork and
experimental results, unless otherwise stated.
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Figure 1.2. Diagram showing the three fluid compartments found in the
mammalian cochlea
A small region in a cochlear partition (indicated by the red box in the inset) is
shown at greater magnification. The scalae vestibuli and tympani are rich in
Na+ while the scala media is filled with an unusual extracellular fluid high in
K+ and a high extracellular potential. Labels pointing to the positions of the
lateral wall and modiolus are shown as reference.
The scalae vestibuli and tympani contain perilymph, a Na+-rich solution similar to the
cerebrospinal fluid. In contrast, the scala media contains a K+-rich solution that has an
electric potential of about +80 to +120 mV (Figure 1.2) [1, 4]. The scalae media and
vestibuli are separated by a thin epithelial layer known as the Reissner’s membrane.
Similarly, the sensory and supporting cells located above the basilar membrane are
connected with tight junctions at their apical side and form a barrier known as the
reticular lamina, which keeps the endolymph in the scala media separate from the
perilymph in the scala tympani.
The stria vascularis, which rests on the spiral prominence and constitutes the inner
layer of the lateral wall (Figure 1.2), is a highly vascularized tissue that contains three
3

layers of specialized epithelial cells in charge of pumping K+ ions into the endolymph to
establish the positive extracellular potential.
1.3 The cochlear sensory epithelium
Several types of sensory and supporting cells compose the epithelium located over the
basilar membrane (Figure 1.3). The sensory hair cells and the supporting cells in close
proximity are known as the organ of Corti (Figure 1.2). A unique extracellular matrix
structure, the tectorial membrane, extends from the medial region of the cochlea and
covers the apical surface of the organ of Corti.
When sound vibrations cause the basilar membrane to move up and down, a shear
force is produced between the hair cells and the tectorial membrane (Figure 1.4). This
leads to the deflection of the mechanosensitive apparatus located on the surface of the
hair cells (see section 1.4.1 for more details) [5, 6].

Figure 1.3. Diagram of the adult mammalian cochlear epithelium
Redrawn from reference [3]. Colored labels indicate the different types of
sensory and supporting cells (black), extracellular membranes (red) and fluidfilled compartments (blue) present in the adult mammalian cochlear
epithelium.

4

1.4 Cochlear sensory cells and mechano-electrical transduction
There are two types of sensory cells in the mammalian cochlea: inner and outer hair
cells. They receive the name of hair cells due to the modified microvilli projections
present on their apical surface, which have been inaccurately named as stereocilia
(Figure 1.5). Hair cells are arranged in one row of inner hair cells (IHC) medially and
three to four rows of outer hair cells (OHC) laterally (Figures 1.3 and 1.5A).
The stereocilia in the tallest row of OHC (but not IHC) are directly connected to the
overlaying tectorial membrane and thus basilar membrane movements directly lead to
OHC stereocilia bundle deflections (see inset in Figure 1.4B). In contrast, IHC stereocilia
seem to get deflected by the fluid motion initiated with the basilar membrane vibrations.

Figure 1.4. Diagram of hair cell stereocilia deflections induced by basilar
membrane movements
A, Diagram of the organ of Corti at a resting position (i.e. without soundinduced basilar membrane vibrations). B, Sound stimulation leads to basilar
membrane vibrations toward and away from the scala vestibuli, but only the
phase of the upward movement is illustrated. The dashed line is placed as a
reference of the basilar membrane position at rest. Insets illustrate the OHC
bundle deflection that occurs during the basilar membrane movement.
1.4.1 Mechano-electrical transduction
Stereocilia bundles are highly organized actin-filled projections [7, 8]. IHC and OHC
stereocilia are usually arranged in three rows, ordered by height in a staircase-like manner
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(Figure 1.5B). Within a given bundle, stereocilia are connected by several types of links.
In particular, links that connect the top of a stereocilium to the side of a taller
stereocilium are known as tip links (Figure 1.5B inset). Tip links are formed by the
interaction of a dimer (or perhaps a trimer) of cadherin-23 molecules on the top, and a
dimer of protocadherin-15 molecules on the bottom (reviewed in [9]).

Figure 1.5. View of the apical surface of the organ of Corti
A, Scanning electron micrograph (SEM) showing the apical surface of a wild
type organ of Corti dissected at postnatal day 4. The stereocilia bundles of the
three rows of OHCs (top) and one row of IHCs (bottom) are visible. B, Higher
magnification SEM picture of an IHC stereocilia bundle from the explant shown
in A. Notice the staircase arrangement of the stereocilia rows and the presence of
tip links (inset) and side links.
Stereocilia are rigid structures due to a core made up of actin filaments arranged in a
paracristaline fashion [10]. Thus, bundle deflections do not bend stereocilia, but instead,
cause them to pivot at their base (taper region) (Figure 1.6) [11]. This leads to a force
build up at the tip link region and mechano-electrical transduction (MET) channel gating.
MET channels are located on the top of shorter stereocilia [12], but their molecular
identity is still under debate. Tip links are most likely unstretchable structures [13, 14],
and it is unknown whether they pull directly on the MET channels or on the membrane
nearby to induce their gating. Due to the negative intracellular potential of hair cells
(about -50mV) and the large positive extracellular potential in the endolymph, opening of
the non-selective cation MET channels produces a large K+ and Ca2+ inward current that
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leads to hair cell depolarization (Figure 1.6). Dedicated K+ channels (KCNQ4 type) on
the basolateral membrane mediate the efflux of the large amount of K+ ions that entered
through the MET channels [15, 16]. Next, these K+ ions are presumably reabsorbed from
the perilymph by neighboring supporting cells (see section 1.6).

Figure 1.6. Diagram of stereocilia deflection and MET gating
A, Staircase arrangement of hair cell stereocilia at a resting position, where
most MET channels are closed. B, Stereocilia bundle deflection leads to
tension buildup at the tip links and MET gating, allowing the influx of K+ and
Ca2+ ions and subsequent hair cell depolarization.
1.4.2 Outer hair cells and cochlear amplification
Changes in the membrane potential of OHCs induce cell shape changes, termed
electromotility, with depolarizations leading to cell contraction and repolarizations to cell
elongation (Figures 1.7A and 1.7B) [17-19]. These changes in cell shape are driven by
the protein prestin, which is expressed at a high density in the OHC plasma membrane
[20, 21]. Prestin molecules exhibit a piezoelectric behavior, since they undergo
conformational changes dependent on the membrane potential (reviewed in [22]).
Because such piezoelectric action results in the movement of charges in the plasma
membrane, changing the membrane potential of OHCs leads to apparent changes in
membrane capacitance with a characteristic non-linear relationship (Figure 1.7C).
Ultimately, the contractions and elongations of the OHCs, enhance the vibrations of the
basilar membrane and thus OHCs act as active amplifiers within the cochlea.
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1.4.3 Inner hair cells
IHCs have specialized structures, known as synaptic ribbons, where large quantities of
neurotransmitter-filled vesicles accumulate (Figure 1.8) (reviewed in [23]). Upon
stereocilia bundle deflection, IHCs depolarize and voltage-gated Ca2+ channels are
activated. The Ca2+ influx at the base of the IHCs triggers the release of vesicle contents
at the synapses with afferent cochlear nerve endings, with the major neurotransmitter
released most likely being glutamate (reviewed in [24]). IHCs are capable of releasing
contents from large quantities of vesicles [25] and, in addition, they can sustain vesicle
release at high frequencies and for long periods of time [26].

Figure 1.7. Diagram of OHC electromotility
A, Elongated OHC with the stereocilia bundle at a resting position. B, OHC
contraction after the deflection of its hair bundle. C, Typical changes in OHC
membrane capacitance (Cm) induced by changes in membrane potential (V).
The red squares indicate actual data points obtained from a young postnatal
OHC from a wild type mouse, while the black line corresponds to a double
Boltzmann fit. The results shown in C were obtained by Dr. Ruben Stepanyan,
a former member of the Frolenkov laboratory.
1.5 Cochlear innervation
In general, IHCs synapse with afferent neurons while OHCs receive efferent
innervation (for a comprehensive review, see [24]). There are two types of spiral
ganglion cells (SGC), the afferent fibers in the cochlear nerve. The majority of the SGCs
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(90 – 95%) are type I large bipolar neurons that innervate IHCs (Figure 1.8A). Each type
I SGC receives input from a single IHC, but each IHC synapses with nerve terminals
from several type I SGC neurons. The rest of the SGCs (5 – 10%) are the type II
pseudounipolar neurons. Each type II SGC neuron branches to innervate several OHCs
(Figure 1.8B), sometimes from all three OHC rows [27]. The function of the type II SGC
fibers has not been completely elucidated, but they are presumed to be activated in the
presence of harmful noise exposure [28].

Figure 1.8. IHC and OHC innervation
A, B, Diagrams illustrating the afferent (blue) and efferent (yellow)
innervation in IHCs (A) and OHCs (B). SGC, spiral ganglion cell; LOC, lateral
olivocochlear terminal; MOC, medial olivocochlear terminal.
Two types of efferent fibers leave the brain stem and reach the cochlea: the lateral
olivocochlear (LOC) and medial olivocochlear (MOC) fibers. LOC fibers innervate the
ipsilateral cochlea while the majority of MOC fibers innervate the contralateral cochlea.
LOC fibers form synapses with the terminals of the type I SGCs underneath the IHCs
(Figure 1.8A) and, since they contain both excitatory (e.g., acetylcholine) and inhibitory
(e.g., GABA) neurotransmitters, they presumably fine tune the sensitivity of the SGCs.
Each MOC fiber directly innervates several OHCs (Figure 1.8B). The main
neurotransmitter in MOC fibers is acetylcholine, which induces OHC hyperpolarization
and changes in OHC electromotility. LOC and MOC fibers might provide a feedback
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loop controlling hearing sensitivity and amplification to adapt to different sound levels or
to protect during noise exposure.
Branches from type II SGCs and efferent fibers can also form synapses with the
supporting cells near the OHCs (see sections 1.6.4 and 1.6.5 for more details) [27, 29-31].
The efferent fibers that contact supporting cells are believed to be of MOC origin, but this
has yet to be fully determined. Moreover, the functional role of the afferent and efferent
innervation of supporting cells remains largely unknown.
1.6 Cochlear supporting cells and fluid-filled compartments
There are several distinct types of supporting cells in the cochlea. They have been
named and/or classified based on their morphology and location in relation to the hair
cells (Figure 1.3). For more comprehensive reviews see [24, 32].
Supporting cells make up the complex architecture of the organ of Corti and provide
physical support for the hair cells. In addition, supporting cells play an important role
maintaining the ionic homeostasis of cochlear fluids. All supporting cells are
electrochemically connected via gap junctions, with permeability profiles that vary
generally between different cell types [33], most likely due to differences in connexin
composition of the gap junctions [34]. This gap junctional network allows for the fast
spread of small molecules between most supporting cells but limits the propagation of
larger molecules. Notably, supporting cells reabsorb the K+ ions that are released by hair
cells into the perilymph after sound stimulation. Presumably, this gap junctional network
allows the recycling of the K+ ions back into the stria vascularis (reviewed in [35, 36]).
Supporting cells also play an important role after hair cell death due to acoustic
overstimulation or ototoxic trauma. Supporting cells sense hair cell death via mechanisms
that involve the release of ATP to the extracellular space. This generates robust Ca2+
waves that can travel throughout the cochlear epithelium [37, 38], but their biological
significance still remains under study (see section 1.7 for more details). It is known,
however, that some supporting cells can act as macrophages to engulf dying hair cells
[39-42]. They can also help reseal the cochlear epithelium to maintain the barrier between
different cochlear fluids intact [43-45].
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1.6.1 Inner sulcus cells and the Kolliker’s organ
In the adult mammalian cochlea, the inner sulcus (located medially to the IHCs) is
covered by small cuboidal cells. Early in development, however, the inner sulcus is filled
with large columnar cells which are collectively known as the Kolliker’s organ and are in
direct contact with the tectorial membrane (Figure 1.9) [46]. The cells of the Kolliker’s
organ are known to spontaneously release ATP to the extracellular space, which is
believed to play an important role in the fine tuning of tonotopicity in cochlear neural
pathways (see section 1.7 for more details). The Kolliker’s organ gradually decreases in
size over the first couple of weeks during postnatal development [46, 47]. While most
cells of the Kolliker’s organ are presumed to undergo apoptosis, it is still unknown
whether some of them can transdifferentiate into the inner sulcus cells of the adult
cochlea.

Figure 1.9. Diagram of the cochlear epithelium at an early postnatal age
Cochlear supporting cells are still changing their morphology during early
postnatal days. At this developmental stage, the organ of Corti is still
collapsed, and no flui-filled spaces are evident yet. In addition, the inner
sulcus is filled by the Kolliker’s organ.
1.6.2 Inner border and inner phalangeal cells
A thin row of inner border cells is located between the inner sulcus cells (or the cells
of the Kolliker’s organ) and the IHCs. Inner border cells do not reach all the way to the
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reticular lamina and therefore are not in direct contact with the endolymph. A thin row of
inner phalangeal cells is present between the IHCs and the inner pillar cells. Inner
phalangeal cells provide support for the IHCs and extend small projections to the
reticular lamina between adjacent IHCs. Inner border and inner phalangeal cells form an
envelope around the base of IHCs, where nerve synapses are formed, and they express
high levels of channels and transporters required for the uptake of K+ ions and glutamate
after IHC stimulation [48-51].
1.6.3 Pillar cells
Two rows of pillar cells are located between the rows of IHCs and OHCs. In the adult
mammalian cochlea, inner and outer pillar cells separate at the base to create a triangular
perilymph-filled space known as the tunnel of Corti (compare diagrams of the adult vs.
early development cochleae in Figures 1.3 and 1.9, respectively) [52]. Pillar cells have a
particular morphology with three distinct regions in each cell (reviewed in [32]). The feet
of the pillar cells rest directly on the basilar membrane and are filled with actin filaments.
The middle regions, also known as pillar shafts, are densely packed with arrangements of
microtubules and actin filaments [53]. The head plates of inner and outer pillar cells are
tightly joined together by desmosomes and adherens junctions, with the heads of outer
pillar cells partially localized underneath those of inner pillar cells. In addition, each
outer pillar head plate surrounds one OHC. Interestingly, the microtubules in these cells
have 15 protofilaments (instead of the typical 13 protofilaments found in microtubules
from other cell types) [54]. Large amounts of intermediate filaments are found in the feet
of outer pillar cells, and lower amounts at the feet of inner pillar cells and head plates of
both [55].
1.6.4 Deiters’ cells
Three rows of Deiters’ cells, also known as outer phalangeal cells, are located
underneath of the OHCs and they extend small projections, termed phalangeal processes,
from their cell body to the reticular lamina. The top region in each Deiters’ cell body is
shaped like a cup and forms a place where the base of an OHC can rest. The phalangeal
process of a given Deiters’ cell does not attach to the OHC directly above it, but to a
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more apical (1 to 3 cells away) OHC instead. The cytoskeleton within the phalangeal
processes of Deiters’ cells resembles that of the pillar cell shafts because it contains
arrangements of microtubules and actin filaments, but it also contains large amounts of
intermediate filaments. These phalangeal processes have been shown to exhibit
mechanical changes in isolated Deiters’ cells upon stimulation with extracellular ATP
[56] or through the uncaging of cytosolic Ca2+ [57]. Large amounts of intermediate
filaments are also found at the top and bottom regions of the cell body [55].
OHC and Deiters’ cell bodies are surrounded by perilymph. In particular, the area
between the outer pillar cells and the first row of OHCs and Deiters’ cells is known as the
space of Nuel (Figure 1.3) [52]. Moreover, similarly to inner border and inner phalangeal
cells, Deiters’ cells express K+ channels and transporters needed for the recycling of K+
ions upon OHC stimulation [48-50]. Some Deiters’ cells have also been reported to form
synapses with thin branches from type II SGC fibers [27, 29, 30] and efferent fibers [31].
These synapses have been observed in the Deiters’ phallangeal processes as well as in the
cell bodies; and they seem to only be present in one half of the cochlear epithelium
(apical half in guinea pig and basal half in the cat) [27, 58, 59].
1.6.5 Hensen’s and Claudius’ cells
Two to three rows of Hensen’s cells are located laterally to the OHCs. The perilymphfilled space between the OHCs and the Hensen’s cells is known as the outer tunnel
(Figure 1.3) [52]. Hensen’s cells are large columnar cells notorious for the presence of
prominent lipid droplets in their cytoplasm [60]. These lipid droplets have been suggested
to modify the mechanical properties of the organ of Corti by changing its geometry or
increasing the load on the basilar membrane. In addition, Hensen’s cells may be able to
modulate anti-inflammatory responses by releasing the contents of these lipid droplets
into the endolymph [60] in response to certain stimuli (e.g., glucocorticoids) [61].
Similarly to Deiters’ cells, some Hensen’s cells are in contact with branches from type II
SGC fibers. And, there seems to be a direct correlation in Hensen’s cells between the
presence of lipid droplets and the incidence of innervation by type II SGC fibers [27, 30].
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Much less is known about the Claudius’ cells, the cuboidal cells that cover the outer
sulcus of the cochlea (i.e. the region from the Hensen’s cells to the spiral prominence) in
a monolayer fashion.
1.7 Purinergic signaling in cochlear supporting cells
Several types of P1 and P2 receptors are expressed in sensory and supporting cells of
the cochlear epithelium and in auditory nerve fibers; moreover, ATP has been shown to
be released to the cochlear fluids during the normal development of the cochlea and also
after noise exposure or tissue damage (reviewed in [62]). P1 receptors are coupled to Gproteins, and are activated by the binding of adenosine. There are two types of P2
receptors: metabotropic P2Y (G protein-coupled) and ionotropic P2X (ligand-gated ion
channels). There are several subtypes of P2Y receptors. They are activated by ATP, UTP,
ADP and/or UDP. Moreover, the potencies of each agonist vary between subtypes which
allow, to some extent, to identify the expression of P2Y subtypes using pharmacological
approaches. There are also several P2X isoforms that can form homomeric or
heteromeric channels –with three subunits forming one functional channel. These P2X
isoforms are mainly activated by ATP. For a comprehensive review of the pharmacology
of P2Y and P2X receptors see references [63, 64].
1.7.1 Spontaneous release of ATP during postnatal development
In rodents, it was shown that the cells of the Kolliker’s organ spontaneously release
ATP to the extracellular space, which induces Ca2+ responses that propagate between
supporting cells [65]. These Ca2+ responses in the Kolliker’s organ were accompanied by
changes in their cell shape, specifically, cell crenations that lead to an increase in the
extracellular space between adjacent cells [65, 66]. These cell crenations were largely
diminished by a Cl- channel inhibitor, suggesting that the extrusion of water might be the
underlying cause of such cell contractions. In addition, the spontaneous release of ATP
by the cells of the Kolliker’s organ can cause IHCs to depolarize and trigger action
potentials in the type I SGC fibers [65, 67]. These spontaneous Ca2+ waves peak (in
frequency and magnitude) around postnatal days 6 to 8 and they cease soon after the
onset of hearing (around postnatal day 12 in mice and rats). Importantly, they were
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shown to induce synchronous responses between neighboring IHCs (cell depolarization)
and SGCs (excitatory postsynaptic currents and action potentials). And, this correlation
between spontaneous Ca2+ waves and IHC/SGC responses was limited to areas encoding
similar frequencies [65, 67]. Therefore, this spontaneous activation of neighboring IHCs
and SGCs before the hearing onset is believed to provide important cues for the tonotopic
maturation of auditory neural pathways.
1.7.2 Pathophysiological release of ATP
ATP is also released into the cochlear fluids after noise exposure [68] or hair cell
damage [37, 38] and induces robust Ca2+ waves able to propagate throughout large areas
of the cochlear epithelium [38]. The Ca2+ responses in the supporting cells are known to
activate several members of the MAP kinase family [37, 69] that seem to favor cell
survival. In addition, the release of ATP after noise exposure might be able to trigger
action potentials in type II SGC fibers via the activation of P2X receptors [28]. Centrally,
these afferent signals could potentially trigger the activation of efferent fibers to modify
hearing sensitivity during noise exposure.
Hair cell damage also induces a fast-propagating Ca2+ wave along the rows of the
sensory hair cells. This wave seems to require the influx of Ca2+ from the extracellular
space via P2X channels [38], however, its functional role is still under examination.
1.7.3 Mechanism of propagation of ATP-induced Ca2+ waves in supporting cells
The expression of P2Y receptors provides supporting cells with high sensitivity to the
presence of extracellular ATP, and concentrations in the nanomolar range are able to
trigger Ca2+ waves that propagate rapidly from cell to cell [37]. When ATP binds P2Y
receptors in a supporting cell, it induces an IP3-dependent increase in intracellular Ca2+.
This response propagates to neighboring cells by (i) the diffusion of IP3 through gap
junctions, and (ii) the further release of ATP through connexin hemichannels (Figure
1.10) [34, 70]. However, it is currently unknown whether the ATP is released through the
apical or basolateral membranes. Nonetheless, the self-propagating nature of these ATPinduced Ca2+ waves allows them to travel both from supporting cells in the inner to the
outer sulcus and vice versa [34].
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Figure 1.10. Mechanism of propagation of ATP-induced Ca2+ waves in
supporting cells
ATP that is released to the extracellular fluid after tissue damage, or through
connexin hemichannels (i.e. one connexon formed by six connexin subunits),
binds P2Y metabotropic receptors on the plasma membrane of supporting
cells. IP3 is then generated via the activation of Phospholipase C (PLC) and
leads to the release of Ca2+ from intracellular stores. IP3 also diffuses to
neighboring cells through gap junctions and somehow induces the release of
more ATP, which ultimately leads to the propagation of Ca2+ waves from cell
to cell [34, 70].
1.8 Impact of noise exposure on hearing thresholds
Acoustic overstimulation typically leads to an increase in hearing thresholds that can
be temporary or permanent, depending on the magnitude and duration of the exposure.
Clinically, a permanent threshold shift (PTS) is diagnosed when hearing thresholds have
not recovered to baseline levels at least 2 weeks after the acoustic overstimulation (Figure
1.11). PTS is associated with extensive damage to the stereocilia bundles and/or
sensory/supporting cell death [71-73]. In addition, a decrease in the endocochlear
potential, usually recoverable, can occur after the exposure to loud sounds that lead to
PTS [72, 74, 75]. In contrast, temporary threshold shifts (TTS) can last from hours to
several days, but the hearing thresholds eventually recover to baseline levels (Figure
1.11).
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Figure 1.11.Diagram of temporary vs. permanent shifts in hearing thresholds
Acoustic overstimulation leads to an increase in hearing thresholds. This
increase is considered to be a temporary threshold shift (TTS) if it recovers
around two weeks after the cochlear overstimulation (blue trace). In contrast,
if the hearing thresholds continue to be elevated and do not recover, this
constitutes a permanent threshold shift (PTS) (black trace). The dashed line
indicates the hearing threshold before noise exposure, and the red arrow
indicates the time point when noise exposure occurred. dB SPL, decibel sound
pressure level.
Several histopathological findings that could explain the development of TTS have
been identified. For instance, the continuous release of neurotransmitters after IHC
overstimulation leads to the swelling of the type I SGC postsynaptic terminals and their
retraction away from the IHC basolateral membrane, presumably due to glutamatergic
excitotoxicity [76, 77]. In addition, a reduction in the number of presynaptic (IHC)
ribbons was also observed soon after the exposure to low noise [77]. Temporary changes
in the architecture of the organ of Corti, involving changes in supporting cell shape, have
been observed after acoustic overstimulation (see section 1.9). Because changes in the
shape of supporting cells can alter the overall tissue geometry (e.g., changing the angle
between the tectorial membrane and the OHC stereocilia bundles at the resting position),
it is no surprise that these changes can modify hearing sensitivity. Some changes in the
cell density and the balance of inhibitory and excitatory circuits in central auditory
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pathways have also been observed after noise exposure to a TTS-producing noise [78,
79]. These modifications in central auditory pathways represent a secondary level of
adaptation to the changes that occur in the periphery; however, they have the potential to
alter sound perception after acoustic trauma.
Even though hearing thresholds return to normal levels after a TTS, some of the
pathophysiological findings described above do not recover completely [71, 77]. And, in
fact, they might constitute a risk factor for the development of PTS after subsequent noise
exposures and/or eventually underlie the progression toward age-related hearing loss
[80]. However, the occurrence of TTS can also constitute a protective response to
minimize tissue damage during longer periods or stronger levels of acoustic
ovestimulation. For instance, mice lacking P2X2 channels are more susceptible to
develop PTS after exposure to loud noise [81]. Interestingly, when exposed to low noise,
these mice do not exhibit changes in hearing thresholds; not even to noise levels that
induce TTS in wild type mice. Although the exact role of P2X2 in TTS has not been
elucidated yet, it does imply the involvement of extracellular ATP. The TTS protective
effects have also been abundantly shown during sound conditioning experiments
(reviewed in [82]), where animals become resistant to noise that initially induced TTS.
The sound conditioning is achieved through long-term exposure to low sound levels, in
either a continuous or intermittent manner, and has been shown to prevent PTS after the
exposure to a loud and typically damaging noise. Even though the exact mechanisms are
largely unknown, there is evidence that these sound conditioning protocols might provide
protection by increasing the expression of antioxidants, heat-shock proteins, Ca2+ buffers
and neurotrophic factors [82].
1.9 Impact of noise exposure on the geometry of the organ of Corti
Several reports have shown a ‘contraction’ of the organ of Corti (i.e. a reduction in the
height of the tissue) after noise exposure in vivo (awake or anesthetized animals) [71, 73,
74, 83] or in vitro (temporal bone preparations) [84-86]. These changes in the tissue
architecture often involved (i) Hensen’s and Deiters’ cells getting closer to the basilar
membrane and the tunnel of Corti, (ii) a reduction in the space of Nuel and (iii) the
buckling of inner and/or outer pillar cells.
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Sound stimulation leads to the vibration of the basilar membrane and the elongation
and contraction of OHCs (section 1.4). Therefore, loud and/or prolonged noise exposure
can potentially involve damaging tissue vibrations and changes in the architecture of the
cochlear epithelium simply as a result of mechanical damage. However, it is plausible
that the modified tissue architecture observed after acoustic overstimulation is the result
of active changes in the shape of the supporting cells surrounding the sensory hair cells.
To date, Deiters’ cells are the only type of cochlear supporting cells reported to have
Ca2+-dependent contractile machinery (section 1.6.4). The cytoskeleton of pillar cells (in
particular of outer pillar cells) resembles that of Deiters’ cells and, therefore, they may
potentially contract upon an increase of cytosolic Ca2+.
Sound induced depolarizations of the hair cells create currents that are large enough to
be measured by an electrode placed near the round window of the cochlea. This
technique known as cochlear microphonics can be used to assess cochlear sensitivity
(reviewed in [87]). Interestingly, the supporting cell-driven changes in the organ of Corti
geometry after acoustic overstimulation seem to be reversible and often correlate with an
improvement in cochlear microphonics or with TTS [71, 73, 83, 85].
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CHAPTER 2
A comprehensive review of literature on TRPA1 channels
2.1 The TRP channel family
Based on their homology to the transient receptor potential (TRP) channels in
Drosophila, several genes have been grouped into the big TRP family of ion channels
[88]. TRP channels have been divided into seven groups according to their amino acid
sequence homology: ankyrin (TRPA), canonical (TRPC), melastatin (TRPM), mucolipin
(TRPML), NompC-like (TRPN), polycystin (TRPP) and vanilloid (TRPV). The TRPN
channel, however, has been found in the genomes of invertebrates (fly and worm [89])
and lower vertebrates (zebrafish [90] and frog [91]) but not in mammalian genomes [90].
TRP proteins have six transmembrane segments (S1 through S6), intracellular amino
(N) and carboxy (C) termini [92, 93], and four subunits assemble into homo- or
heterotetramers to form functional ion channels (reviewed in [94]). The pore region in
TRP channels seems to be comprised of the linker segment between the transmembrane
segments S5 and S6. While all TRP channels are permeable to cations, different channels
exhibit specific degrees of selectivity between mono- and divalent cations (reviewed in
[95]). The intracellular termini of TRP channels vary greatly between subfamilies, but in
general they allow the interaction of the channels with intracellular signaling molecules
and pathways. For instance, three members of the TRPM subfamily have protein kinase
activity in their C-termini [96] and TRP channels usually possess intracellular domains
such as ankyrin repeat, pleckstrin homology (PH)-like or EF-hand-like domains
(reviewed in [97]) that allow for protein-protein or protein-ligand interactions. TRP
channels can be activated by a wide variety of mechanical, thermal and chemical stimuli
(reviewed in [98]) and, together with their broad intracellular responses, constitute
powerful modulators of cell physiology.
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At present, 28 mammalian TRP channels have been identified and their role in human
pathophysiology is rapidly growing after the generation of specific TRP knockout mice
and the identification of disease-causing TRP mutations in humans (see Table 2.1 for
details). A quantitative analysis of mRNA expression of all 28 channels performed in
developing cochlear tissue (from embryonic to early postnatal stages) could not detect
mRNA of TRPC7 or TRPM8 at all, or TRPV5 in half the samples tested. However, this
study did revealed different degrees of expression for the remaining 25 TRP channels
[99]. But, given the scope of this dissertation project, the main focus of this review will
be on TRPA1 channels.
2.2 TRPA1: from gene to protein
TRPA1 is the only member of the mammalian TRPA subfamily. Given that the animal
model used in this dissertation project was the mouse, this review will focus largely on
mouse, rat (given its homology) and human (due to its translational relevance) TRPA1
channels.
2.2.1 The mouse Trpa1 gene
The mouse Trpa1 gene is located in chromosome 1, it contains 27 exons and two
TRPA1 splice variants have been identified [100]. While the full TRPA1 mRNA
transcript encodes a protein of 1,125 amino acid residues (UCSC ID: uc007ajc.1), the
splice variant encodes a protein 30 residues smaller that lacks exon 20 (UCSC ID:
uc033fid.1). The missing 30 residues are part of the transmembrane segment S2 and part
of the intracellular linker between S2 and S3.
2.2.2 The rat TRPA1 gene
The rat TRPA1 gene is in found in chromosome 5 and, like the mouse TRPA1 gene, it
has 27 exons and encodes a 1,125 amino acid protein (UCSC ID: RGD_1303284). No
TRPA1 mRNA splice variants have been reported in the rat [100]. Notably, the rat and
mouse proteins share over 96% identity (see Appendix B for the protein sequence
alignment).
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Table 2.1. Mammalian TRP channels
SubFamily

Members*

Mouse knockout phenotypes
Defective pain sensitivity to cold,

TRPA

TRPA1

mechanical stimuli, chemical

(ANKTM1)

irritants and bradykinin [101,
102]

Human
pathophysiology†
Debilitating episodes of
pain in the upper body
[103]

Increased body size and impaired
TRPC1

salivary gland fluid secretion
[104, 105]

TRPC2‡
TRPC3

Impaired pheromone-induced

‡

behaviors [106, 107]
Defective walking behavior [108]
Impaired regulation of blood

TRPC

TRPC4

vessel tone and permeability of
lung microvessels [109]

TRPC5
TRPC6
TRPC7

TRPM1

TRPM

TRPM2

TRPM3

Reduced anxiety-like behavior
[110]
Increased blood vessel tone and

Renal dysfunction

contractility [111]

[112, 113]

Resistance to pilocarpine-induced
seizures [114]
Loss of light-induced inward

Reduced central vision,

currents in retinal ON bipolar

nystagmus and eczema

cells [115-117]

[118-121]

Impaired chemokine production
by monocites [122]
Defective pain sensitivity to
inflammation and heat [124]
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Coding SNP associated
with bipolar disorder
[123]

Table 2.1. Mammalian TRP channels (continued)
Augmented degranulation and
TRPM4

histame release in mast cells

Conduction

[125], impaired dendritic cell

abnormalities in the

migration [126], and protection

heart [128-130]

against spinal cord injury [127].
Abolished sweet, umami and
TRPM5

bitter taste reception [131], and
defective insulin release [132,
133]

TRPM

Embryonic or early postnatal
TRPM6

death with neural tube defects
[134]

Hypomagnesemia and
hypocalcemia [135, 136]
Susceptibility for a

TRPM7

Embryonic lethal [137]

neurodegenerative
disorder [138]

TRPM8

TRPML1
TRPML

Defective pain sensitivity to cold
[139-141]
Neurodegeneration, elevated

Neurodegeneration with

plasma gastrin and retinal

ophthalmologic

degeneration [142]

abnormalities [143, 144]

TRPML2
TRPML3
TRPP1
(PKD2)
TRPP

Embryonic lethal [145]

TRPP2
(PKD2L1)
TRPP3
(PKD2L2)
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Renal cysts leading to
renal failure [146]

Table 2.1. Mammalian TRP channels (continued)
TRPP

TRPP3
(PKD2L2)
Defective pain sensitivity to heat
TRPV1

[147], and enhanced insulin
sensitivity [148]

TRPV2

Impaired innate immunity [149]
Impaired behavioral responses to

TRPV3

Severe skin

heat [150], and abnormalities in

abnormalities [152]

fur and whiskers [151]

Skeletal dysplasia [159Impaired antidiuretic hormone
regulation [153, 154], defective

TRPV
TRPV4

pain sensitivity to mechanical
stimuli [155], impaired bladder
function [156, 157], and hearing
loss [158].

161]; osteoarthritis [162,
163]; muscle paresis,
paralysis, atrophy or
congenital absence
[164-167] and dwarfism
[160, 168]. Coding SNP
associated with
hyponatremia [168]

Hypercalciuria, polyuria and
TRPV5

reduced bone thickness
[169, 170]

TRPV6

Possible role in intestinal Ca2+
absorption [171, 172]

* Other common names for each member are listed within parenthesis.
†

Clinical features caused by mutations in human TRP genes. For details about

the exact syndromes and inheritance patterns see Appendix A.
‡

TRPC2 is a pseudogene in humans [173].
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2.2.3 The human TRPA1 gene
In humans, the TRPA1 gene is located in chromosome 8, it contains 27 exons, it
encodes a protein of 1,119 amino acid residues (UCSC ID: uc003xza.3) and no splice
variants have been identified [100]. The human TRPA1 protein shares about 80% identity
with both the mouse and rat TRPA1 proteins (see Appendix B for the protein sequence
alignment), making mice and rats interest models for the study of TRPA1 function.
2.2.4 Tissue expression of TRPA1
TRPA1 mRNA has been detected in a wide variety of tissues and cell types. In
addition, the generation of Trpa1 knockout (Trpa1–/–) mice has allowed to confirm
TRPA1 expression at the protein level in some of these tissues. Immunolabeling of the
TRPA1 protein has also been described in a wide variety of tissues, but only the reports
showing strict controls for the antibodies used have been included in this review.
In the mouse, TRPA1 mRNA is highly expressed in dorsal root (DRG), trigeminal and
nodose ganglia [174-176] and in the cochlear epithelium [99, 177]. In addition, lower
transcription levels have been detected in the tongue [178], stomach, small intestine and
colon [179]. The presence of an active Trpa1 promoter and functional TRPA1 channels
in DRG neurons (including C and Aδ fibers) innervating the skin has been confirmed
using tissue from wild type and TRPA1-deficient mice [180]. Immunoreactivity against
the TRPA1 protein in bronchial epithelium and smooth muscle has also been detected in
tissue from wild type but not Trpa1–/– mice [181].
In the rat, high expression of TRPA1 mRNA is detected in dorsal root ganglia [174],
small intestine and colon [179, 182]. Lower mRNA expression levels are also detected in
brain, stomach [179], bladder [183], cerebral arteries [184] and pancreatic beta cells
[185].
In human tissues, TRPA1 mRNA has been detected in fibroblasts [181, 186], small
intestine, colon, skeletal muscle, heart, pancreas, lymph nodes, spleen [187], skin [188,
189] and stomach [179]. TRPA1 immunolabeling has also been reported in primary lung
epithelium, lung smooth muscle cells [181], urethral cells [190] and several cell lines of
human origin. However, cautious consideration needs to be given to some of these
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immunolabeling reports given the limitations in tests about antigen specificity of the
antibodies used.
For more details about TRPA1 tissue expression in the mouse, rat and human, see
reference [191].
2.2.5 Channel assembly from TRPA1 subunits
Four TRPA1 subunits assemble to form a functional channel. In mice, the two TRPA1
splice variants can interact (presumably forming heteromeric channels) and lead to
increased TRPA1 expression in the plasma membrane and larger agonist-induced
currents [100]. There is also evidence that TRPA1 and TRPV1 subunits can form
heteromeric channels [192, 193]. Moreover, TRPA1-TRPV1 heteromeric channels seem
to have slightly different gating and inactivation kinetics, and sensitivity to both TRPA1
and TRPV1 agonists. Some decreases in agonist sensitivity can be simply explained by
the decrease in binding sites (e.g., an agonist specific for TRPV1 could potentially have 4
binding sites in a homomeric TRPV1 channel, but only 2 binding sites in a TRPA1TRPV1 heteromeric channel with 2 subunits of each type [192]). However, some agonists
seem to prefer specific channel configurations and may involve interactions between
neighboring subunits.
2.2.6 Ankyrin repeats in the intracellular N-terminus of TRPA1
TRPA1 subunits exhibit six transmembrane domains (see Appendix C for the
prediction of transmembrane segments in mouse, rat and human TRPA1 subunits), which
are a hallmark in the TRP family. TRPA1 also contains a unique intracellular N-terminus
with a large number (~14 to 18) of ankyrin repeats [186] (Figure 2.1). TRPN channels
have even larger numbers of ankyrin repeats (~29) but, as mentioned earlier, they are not
expressed in mammals.
Ankyrin repeat domains are found in a broad variety of proteins, including
transcription factors, scaffold proteins, enzymes, regulatory subunits an even other
members of the TRP family (i.e. TRPC and TRPV channels, with a rather small number
of repeats: 4 to 6). The amino acid sequence of an ankyrin motif varies significantly
between proteins but, on average, it consists of 30 to 34 residues arranged into a helix26

turn-helix domain coupled to a β-hairpin loop. The structure of several ankyrin repeats
has been resolved and, amusingly, a tandem of five repeats resembles a hand, where the
helix-turn-helix domains form the palm and each β-hairpin loop forms a finger.

Figure 2.1. Diagram of a TRPA1 channel subunit
The diagram illustrates a TRPA1 subunit with its six transmembrane segments
(for clarity, only S1 and S6 are labeled), both intracellular N- and C-termini
and several ankyrin repeats (ANK) in the N-terminus. The pore-forming region
is located between S5 and S6. The cyan circle indicates a methionine residue
required for caffeine activation. A highly hydrophobic ankyrin repeat that
might interact with the plasma membrane is shown in magenta (Appendix C).
The ankyrin repeat that is known to contain an EF-hand-like domain to bind
Ca2+ has been colored orange. The yellow starts indicate areas where several
cysteine residues are required for channel gating by reactive agonists. The
green circles designate cysteine (N) and histidine (C) residues required for
activation by Zn2+. The blue circle in S5 shows the position of a glycine residue
required for channel gating by cold temperature and inhibition by menthol.
Ankyrin repeats are known to allow protein-protein interactions (that sometimes
involve covalent bindings) and, in TRPA1 channels in particular, they are important for
agonist-induced gating (see section 2.3 for more details). In fact, one of the ankyrin
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repeats in TRPA1 is known bind Ca2+ ions [194] but, technically, it does not constitute a
classic EF-hand domain [195] (see section 2.3.4 for more details). In addition, it has been
proposed that ankyrin repeats might provide elastic properties to proteins that express
large numbers of them [196]. For more comprehensive reviews on ankyrin repeats, see
[195, 197].
2.2.7 The intracellular C-terminus and pore-forming regions of TRPA1
Based on its homology to the other channels in the TRP family, the pore-forming
region in a TRPA1 subunit is thought to be comprised of the loop between the
transmembrane segments S5 and S6 (Figure 2.1). TRPA1 channels are permeable to
monovalent and divalent cations. The selectivity between K+, N+, Cs+, Mg2+ and Ca2+
ions has not been extensively characterized for TRPA1 channels, however, results from
one study correlate with a non-selective cation channel: PCs/PNa = 1.42, PMg/PNa = 1.23,
PK/PNa = 1.19 and PNa/PCa = 1.19 [174]. Consistent with this, TRPA1 permeability to Cl–
is low: PCl/PNa = 0.28 [174]. Single-channel recordings have shown several conductance
levels for TRPA1 but, on average, the channel conductance is around 100 pS [175].
Interestingly, single channel conductance is greatly reduced by Ca2+ (~ 54% reduction)
[175]. Importantly, these changes in conductance can arise from agonist-induced dilation
of the TRPA1 pore [198].
Although most agonists bind to the N-terminus of TRPA1 (see section 2.3), there is
evidence suggesting that the intracellular C-terminus is involved in channel gating by a
few agonists (e.g. Zn2+) [199]. In addition, mutations to several C-terminal amino acid
residues show impaired TRPA1 sensitivity to voltage and to the potent agonist, mustard
oil [200]. The TRPA1 transmembrane segments S5 and S6 and the pore-forming region
are important for the binding and activation by other agonists as well.
2.3 TRPA1 agonists and the mechanisms of TRPA1 channel gating
There is a large inventory of compounds that activate TRPA1 channels; for a
comprehensive list see Table 2.2 and reference [191]. Two general mechanisms of
ligand-induced TRPA1 gating have been recognized: (i) ‘classical’ binding of
structurally-related agonists to –one, perhaps more– binding pockets within the TRPA1
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channel, and (ii) covalent modifications to the TRPA1 subunits mediated by ‘reactive’
agonists. These reactive chemical compounds and endogenous agonists typically lead to
channel gating by modifying amino-acid residues within the TRPA1 intracellular Nterminus (Figure 2.1) [201, 202]. These covalent modifications can remain in the TRPA1
proteins from minutes to hours, and can sometimes lead to long-lasting TRPA1 channel
activation [201-203].
Table 2.2. List of TRPA1 agonists
Species

Mechanism and/or

Other TRP

*

site of action

channels†

Δ12-PGJ2

H

Covalent modifications

1-butanol

H

[205]

1-heptanol

H

[205]

1-hexanol

H

1-octanol

H

1-pentanol

H

[205]

1-propanol

H

[205]

Agonist

15dPGJ2

Interaction with N-terminal

[205, 206]

Cys and C-terminal His

2-APB

H

‘Classical’ binding

4-HHE

H, M

Covalent modifications

4-HNE

H, M, R

4-ONE

H, M

Covalent modifications

H

Covalent modifications

[204, 207]
TRPV1,
TRPV3

[202, 208]
[207, 209]

N-terminal Cys and Lys

[210, 211]

covalent modifications

AA
Acetaldehyde

[205, 206]

Cys and C-terminal His

Covalent modifications

8-iso PGA2

[204]

Interaction with N-terminal

H, M

Ref.

TRPV1

[207, 209]
[204]
[212]

H, M

[213]
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Table 2.2 List of TRPA1 agonists (continued)
N-terminal Cys covalent

[101, 202,

modifications

214]

Acrolein

H, M, R

AITC

H, M, R

Allicin

H, M, R

BITC

H

Butenal

M

[211]

Ca2+

H

[194, 217]

Caffeine

M

Cannabinol
Carvacrol

N-terminal Cys and Lys

[201, 215]

covalent modifications

[216]
Covalent modifications

[202]

Binding to intracellular Met

[178]

H, R
R

[215]
‘Classical’ binding

TRPV3

[218]

N-terminal Cys covalent

[201, 202,

modifications

212]

CA

H, M

Cd2+

H, M

[219]

Crotonaldehyde

M, R

[214]

Cu2+

H, M

[219]

DADS

H, R

Desflurane

M, R

Diclofenac

H, R

N-terminal Cys covalent

[202, 216]

modifications

[206, 220]
‘Classical’ binding

[208]

DPDS
Ethanol
Etomidate
Eugenol

[221]
H

[205]

M, R

[206]
TRPV1,

M

TRPM8

[212]

FFA

H, R

‘Classical’ binding

[208]

Flurbiprofen

H, R

‘Classical’ binding

[208]

Formaldehyde

M

TRPV1

[211]

Gingerol

M

TRPV1

[212]
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Table 2.2 List of TRPA1 agonists (continued)
H+
H2O2

H
M, R

Interaction with S5 and S6,
and N-terminal cys
N-terminal Cys and Lys
covalent modifications

TRPV1
TRPM2

[222, 223]
[207, 224]
[225]

Hexenal

M

[211]

Heptenal

M

[211]

Hypochlorite

H, M

N-terminal Cys and Lys

[225]

covalent modifications

IA

M

Cys covalent modifications

[201, 211]

IAA

M

Cys covalent modifications

[201]

Icilin

M

‘Classical’ binding

Indomethacin

H, R

‘Classical’ binding

Isoflurane

M, R

Ketoprofen

H, R

‘Classical’ binding

[208]

Lidocaine

H, M, R

Binding to intracellular Cys

[226]

Menthol

H, M

Interaction with S5

Methanol

H

Methyl salicylate

M

TRPM8

[201]
[208]
[206, 220]

TRPM8

[227, 228]
[205]

TRPV1

[212]

MFA

H, R

‘Classical’ binding

[208]

MOA

M

Cys covalent modifications

[201]

MpBZ

M

MTSEA

M

[229]
N-terminal Cys covalent
modifications

[201, 202]

NFA

H, R

‘Classical’ binding

[208]

Nicotine

H, M

‘Classical’ binding

[230]

H

‘Classical’ binding

[208]

Nifedipine
Nitrooleic acid
NMM

H, M
H

[231]
N-terminal Cys covalent
modifications
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[202]

Table 2.2 List of TRPA1 agonists (continued)
Octenal

M

[211]

Pentenal

H, M

[101, 211]

PGA2

H

Propofol

Covalent modifications

[204]

M, R

[206]

SC

M

Cys covalent modifications

[201]

SCA

M

Cys covalent modifications

[201]

TDI

H, M

Cys covalent modifications

[232]

THC

H, R

‘Classical’ binding

[202, 215]

Theobromine

M

Binding to intracellular Met

[178]

Theophylline

M

Binding to intracellular Met

[178]

H, M

Interaction with S5

H, M, R

Covalent modifications

Thymol
Umbellulone
Zn2+

H, M

TRPM8,
TRPV3

[227, 228]
[233]

Interaction with N-terminal

[199, 219]

Cys and C-terminal His

* Species where TRPA1 activation has been reported by the agonist: human (H),
mouse (M) or rat (R).
†

Ligand promiscuity with other mammalian TRP channels.

Abbreviations: 2-APB, 2-amino-phenyl borane; 4-HHE, 4-hydroxyhexenal; 4HNE, 4-hydroxynonenal ; 4-ONE, 4-oxononenal; AA, arachidonic acid; AITC,
allyl

isothiocyanate

(mustard

oil);

BITC,

benzyl

isothiocyanate;

CA,

cinnamaldehyde; Cys, cysteine; DADS, diallyl disulfide; DPDS, dipropyl
disulfide; FFA, flufenamic acid; IA, iodoacetamide; IAA, iodoacetamide alkyne;
MFA, mefenamic acid; MOA, mustard oil alkyne (propargyl isothiocyanate);
MpBZ,

methyl

p-hydroxybenzoate;

MTSEA,

(2-aminoethyl)

methanethiosulphonate; NFA, niflumic acid; NMM, N-methyl maleimide; Ref.,
References; SC, super cinnamaldehyde; SCA, super cinnamaldehyde alkyne; TDI,
toluene diisocyanate; THC, Δ9-tetrahydrocannabinol.
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Channel inactivation following covalent modifications could be achieved through
several mechanisms. For instance, while some covalent modifications appear to be
completely irreversible (e.g., by the reactive agonist N-methyl maleimide –NMM) others
appear to be temporary [201, 202]. TRPA1 channels are also susceptible to voltageinduced inactivation (after cell depolarizations) [234] and to blockage by intracellular
Ca2+ [175, 235]. In addition, TRPA1 protein turnover and endocytosis rates would also
affect the amount of covalently-modified TRPA1 channels present in the plasma
membrane.
2.3.1 Pungent compounds
The pungent perception after the ingestion of certain foods is mediated by the
activation of TRPA1 channels in nerve terminals in the mouth. These, sometimes painful,
sensations are induced by specific compounds, such as: allyl isothiocyanate –AITC– (also
known as ‘mustard oil’, found in wasabi, mustard and horseradish) [215],
cinnamaldehyde –CA– (cinnamon) [212], carvacrol and thymol (oregano and thyme)
[218, 227], gingerol (ginger) [212], eugenol (clove) [212], allicin and diallyl disulfide –
DADS– (garlic and onion) [216].
Some of these pungent compounds are electrophiles and, as such, can potentially react
with neuclophilic amino acid residues like cysteine, lysine and histidine. In fact, the
mechanism of TRPA1 gating by some of these reactive agonists (i.e. AITC, CA and
DADS) has been shown to specifically involve covalent modifications of cysteine and/or
lysine residues in the TRPA1 N-terminus (Figure 2.1) [201, 202]. These covalent
modifications might even involve to the formation of disulfide bonds between cysteine
residues [236]. Several key N-terminal cysteine residues have been reported to be
necessary for channel gating by these reactive agonists [201, 202]. Moreover, agonist
sensitivity depended on the amount of cysteine residues present (in targeted mutation
studies). However, when three of the cysteine residues were mutated in the same
construct, TRPA1 sensitivity to non-reactive agonists was also decreased, suggesting a
general defect in TRPA1 gating [199]. Similarly, TRPA1 sensitivity to AITC was
impaired when several C-terminal lysine, arginine and alanine residues were mutated
[200]. The sensitivity of these C-terminal TRPA1 mutants to non-reactive agonists was
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not tested and, therefore, it is plausible that these mutations cause structural changes that
affect TRPA1 gating.
Because some of these pungent compounds are non-reactive agonists, their mechanism
of action seems to involve the ‘classical’ binding between an agonist and a receptor (i.e.
TRPA1 channel). In particular, TRPA1 activation by thymol requires amino acid residues
located within the transmembrane segment S5 [228].
The noxious effects caused by topical application or subcutaneous injection of these
pungent compounds are described in section 2.4.1.
2.3.2 Airborne irritants
Several aldehydes in cigarette smoke, air pollution or tear gas (e.g., acrolein –2propenal–, crotonaldehyde and acetaldehyde [237]), as well as some volatile
environmental (i.e. umbellulone) and industrial chemicals (i.e. toluene diisocyanate –
TDI–, hypochlorite and formaldehyde) are known to gate TRPA1 channels [211, 213,
214, 225, 232, 233]. These reactive agonists seem to activate TRPA1 channels in a
manner similar to the reactive pungent agonists described above, which involves covalent
modifications to cysteine and lysine residues in the N terminus of TRPA1 subunits
(Figure 2.1) [202, 225]. In the airways, they can activate TRPA1 channels present in
bronchial epithelial and smooth muscle cells, as well as in neurons innervating the nasal
cavity and the bronchi. Inhalation of these volatile TRPA1 agonists causes noxious
responses in the meninges and in the respiratory airways, which are described in more
detail in section 2.4.1.
2.3.3 Byproducts of reactive oxygen and nitrogen tissue damage
The generation of reactive oxygen and nitrogen species (ROS and RNS, respectively)
increases during instances of cellular stress (e.g., inflammation, hypoxia or mechanical
trauma). These reactive molecules can cause damage to lipids, proteins and nucleic acids,
and can eventually lead to cellular apoptosis.
Some ROS, such as hydrogen peroxide (H2O2), act as TRPA1 agonists themselves
[207]. Moreover, ROS-induced lipid peroxidation leads to the generation of byproducts
such as 4-hydroxynonenal (4-HNE), 4-hydroxyhexenal (4-HHE) and 4-oxononenal (434

ONE) that can directly bind and trigger TRPA1 channel gating [207, 209-211]. On the
other hand, RNS can add highly reactive NO2 groups to fatty acids. These nitrated
phospholipids (e.g., nitrooleic acid –OA-NO2) can bind and activate TRPA1 channels as
well [231]. In general, nitrated phospholipids seem to be more potent than peroxidation
byproducts in the activation of TRPA1 channels.
Notably, the mechanism of TRPA1 channel activation by 4-HNE seems to involve
covalent modifications to the same cysteine and lysine residues required for activation by
reactive pungent compounds and airborne chemicals (Figure 2.1) [210].
2.3.4 Divalent cations
As described in section 2.2.6, TRPA1 channels have an ankyrin domain that resembles
an EF hand and is able to bind Ca2+ (Figure 2.1). Intracellular Ca2+ can directly trigger
TRPA1 channel gating through its interaction with the EF hand-like domain [194, 217].
Because TRPA1 channels are permeable to Ca2+, channel activation by other agonists can
be potentiated after the initial influx of Ca2+.
In a similar manner, TRPA1 channels are permeable to Zn2+, a heavy metal that can
directly bind to TRPA1 (on intracellular domains) and trigger channel gating [199]. Some
anti-fungal and anti-parasitic drugs that act as Zn2+ ionophores can indirectly induce
TRPA1 gating by increasing intracellular levels of Zn2+ [219]. Specifically, two cysteine
and one histidine residues are important for the TRPA1 sensitivity to Zn2+ [199]. One of
the cysteine residues, located in the N-terminus of TRPA1, is involved in channel gating
by reactive agonists as well. The other cysteine residue and the histidine residue are
located in the C-terminus of TRPA1 (Figure 2.1).
Other divalent cations that can directly bind and gate TRPA1 channels are Cd2+ and
Cu2+ [219]. Fe2+ can modulate TRPA1 activation by other agonists, but Fe2+ does not
directly gate TRPA1 channels [207, 219].
2.3.5 Noxious cold
Initial reports showed that TRPA1 channels were gated by cold temperatures (< 17°C)
[174]. However, even after a decade of studies, researchers do not agree on whether
TRPA1 channels can directly sense noxious cold. Several groups have supported the
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initial findings and have shown cold sensitivity in TRPA1 channels expressed in
heterologous systems [217, 238]. Correlations between the percentages of TRPA1expressing and cold-sensitive DRG neurons were reported [212, 239]. Meanwhile, other
groups failed to find correlations between AITC-sensitive and cold-sensitive DRG
neurons [215, 238, 240]. In addition, cold seems to induce a small Ca2+ influx in
heterologous systems that is independent of TRPA1 channels [217]. This result could
indicate that noxious cold indirectly gates TRPA1 channels via a small increase in
intracellular Ca2+ levels. Another level of complexity was added with the generation of
Trpa1–/– mice by two independent groups that showed opposite behavioral results. While
one group reported impaired sensitivity to noxious cold in TRPA1-deficient mice [102],
the second group found no difference in cold sensation between TRPA1 knockout and
wild type mice [101]. Further studies in mice indicated that cold exposure does not
directly gate TRPA1 channels but instead potentiates TRPA1 activation when the channel
has been primed by a different agonist [241]. Moreover, direct channel gating by cold, if
present at all, is a property of mouse and rat but not human TRPA1 channels [242, 243].
A glycine residue in the TRPA1 transmembrane segment S5 is required for cold
sensation (Figure 2.1), but other unknown amino acid residues might also be involved.
For comprehensive reviews on cold sensitivity by TRPA1 channels see [244, 245].
2.3.6 Pro- and anti-inflammatory agents
Prostaglandins (PGs) are pro-inflammatory agents produced downstream of the
hydrolysis of membrane phospholipids via the activity of cyclooxygenases (COXs).
Several prostaglandins and their metabolites can trigger TRPA1 gating (i.e., 15dPGJ2,
PGA2, 8-iso PGA2 and Δ12-PGJ2) and cause pain [246]. Because only ‘reactive’ PG
metabolites seem to lead to TRPA1 activation [204], the mechanism of channel gating
seems to involve covalent modifications, perhaps, of the same amino acid residues
targeted by other reactive agonists (Figure 2.1). The inflammatory pain induced by PGs is
commonly treated with non-steroidal anti-inflammatory drugs (NSAIDs) that act as COX
inhibitors. Interestingly, several of these NSAIDs are TRPA1 agonists as well (e.g.,
flufenamic acid –FFA–, mefenamic acid, niflumic acid, flurbiprofen, indomethacin,
ketoprofen and diclofenac) [208], making them the most puzzling TRPA1 agonists.
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While TRPA1 activation has been frequently linked to pain-like behaviors (as described
in section 2.4), NSAIDs are extensively known for their analgesic effects. In addition,
because these NSAIDs are non-reactive agonist, their mechanism of action probably
involves ‘clasical’ binding or interaction between the agonist and the TRPA1 channel.
2.3.7 Local and general anesthetics
Several anesthetics can activate TRPA1 channels as well. Lidocaine, a membranepermeable local anesthetic, can activate TRPA1 channels when applied at high
concentrations (> 3 mM) [226]. Interestingly, at even higher concentrations (> 100 mM),
lidocaine acts as a channel blocker. In addition, the mechanism of TRPA1 activation by
lidocaine seems to involve some of the cysteine residues typically targeted by reactive
agonists. Some inhalation (e.g., isoflurane and desflurane) and intravenous (e.g., propofol
and etomidate) general anesthetics can trigger TRPA1 gating [206]. General anesthetics
of the inhalation class seem to activate TRPA1 channels via a mechanism similar to the
one used by Zn2+ (Figure 2.1). In contrast, intravenous general anesthetics appear to
involve a different, yet unknown, mechanism. Because some drugs indirectly activate
TRPA1 channels (via an increase in intracellular Zn2+) [219], more studies are required to
clarify whether inhalation-type anesthetics can directly bind and gate TRPA1 channels.
2.3.8 Other TRPA1 agonists
Some alcohols, xanthine derivatives and antibacterials are other compounds that can
behave as TRPA1 agonists. In addition, menthol and weak acids can induce TRPA1
gating as well.
Primary alcohols (from methanol to 1-octanol) have been shown to activate TRPA1
channels at high concentrations (> 1 mM), with greater potencies exhibited by those with
larger carbon chains [205, 206]. However, there is a limit in the length of the alcohol
carbon chain that can activate TRPA1 channels since decanol fails to trigger channel
gating [206]. In addition, the mechanism of action of these alcohols seems to involve the
same cysteine and histidine residues required for TRPA1 gating by Zn2+ and inhalationtype anesthetics. Because agonist potency directly correlates with molecule size, the
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presence of a binding pocket in TRPA1 subunits has been proposed [206], in manner
analogous to other ligand-gated ion channels (e.g., GABAA and glycine receptors) [247].
Xanthine derivates, such as caffeine, can activate TRPA1 channels as well, and
TRPA1 gating by these compounds does not require intracellular Ca2+ [178]. This favors
the idea of a direct mechanism of channel gating rather than indirect activation via the
effect of caffeine on intracellular stores. Moreover, a methionine residue in the
intracellular N terminus of mouse TRPA1 is required for caffeine activation (Figure 2.1)
[248].
Methyl p-hydroxybenzoate (MpBZ), an inert compound with antibacterial properties,
can activate TRPA1 channels [229]. The TRPA1 reactive agonists AITC, CA and allicin
as well as the non-reactive agonists carvacrol and thymol (described in section 2.3.1) are
pungent compounds that exhibit antibacterial properties as well. However, because
MpBZ is a non-reactive TRPA1 agonist, the mechanism by which it can trigger channel
gating might resemble that of the non-reactive antibacterial/pungent compounds.
TRPA1 channels can directly sense both cytosolic and intracellular weak acidification
[222, 223, 249]. Activation after extracellular acidification seems to be a property of
human, but not mouse TRPA1 channels. In contrast, channel gating by intracellular
protons is a feature conserved between mammals. TRPA1 activation by protons does not
require the intracellular N-terminal cysteine residues that are involved in channel gating
by reactive agonists. Instead, the transmembrane domains S5 and S6 are involved in
TRPA1 sensing of extracellular acidosis. However, it is unknown whether intracellular
protons activate TRPA1 channels through the same mechanism or protein region.
Menthol is a non-reactive compound that can activate mammalian TRPA1 channels
[227]. Menthol is structurally similar to thymol and carvacrol, which are two non-reactive
isomeric pungent compounds known to activate TRPA1 channels (described in section
2.3.1). Similar to thymol, menthol requires residues within the TRPA1 transmembrane
segment S5 to induce channel activation [228], which seems to indicate the presence of a
binding pocket near the pore region of TRPA1.
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2.3.9 Agonists able to inhibit TRPA1 channels
Ca2+ has a bimodal effect on the activation of TRPA1 channels by other agonists.
While micromolar concentrations of intracellular Ca2+ can potentiate TRPA1 activation
by reactive and non-reactive agonists (section 2.3.4), higher Ca2+ concentrations can lead
to channel blockage or inactivation [175, 194, 235].
While a low dosage of menthol acts as a mouse TRPA1 agonist (section 2.3.8), higher
concentrations (> 100 µM) are known to inhibit TRPA1 currents [227]. Interestingly,
menthol is not able to inhibit human TRPA1 channels, even at high concentrations (3
mM). In addition, the structurally similar compound thymol exhibits mouse TRPA1
inhibition at higher concentrations as well (>250 µM) [227]. This species-dependent
inhibition by menthol seems to involve the same TRPA1 region required for its activation
(i.e. transmembrane segment S5) [228]. Specifically, the same glycine residue that is
involved in TRPA1 activation by noxious cold (section 2.3.5) is required for TRPA1
inhibition by menthol [243]. Like menthol, other TRPA1 agonists have shown different
responses between species as well. For example, caffeine can trigger mouse and rat
TRPA1 gating (section 2.3.8), but it behaves as an inhibitor for human TRPA1 channels
[178].
Stimulation with PG metabolites, such as 15d-PGJ2, leads to TRPA1 activation
initially (section 2.3.6) but it is subsequently followed by a long-lasting channel
inactivation [250].
2.4 TRPA1 in nociceptive neurons
TRPA1 is expressed in about 30 to 50% of the TRPV1-expressing neurons in dorsal
root, trigeminal and nodose ganglia [174, 175]. Activation of TRPA1 channels (and
TRPV1 channels as well) leads to the depolarization of these neurons and the
development of action potentials that typically ‘encode’ pain-like sensations.
2.4.1 TRPA1 activation in nociceptive neurons
Subcutaneous injections of AITC, CA, MpBZ, H2O2, PGs, acetaldehyde, RNS-donors
or 4-HNE activate TRPA1 channels in nociceptive neurons innervating the skin. TRPA1
activation in these neurons produces pain, neurogenic inflammation (e.g., through the
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release of substance P and calcitonin gene related peptide –CGRP), itch and hyperalgesia
to mechanical and thermal stimuli [101, 102, 207, 210, 212, 213, 229, 251].
Inhalation-type general anesthetics induce bronchoconstriction and neurogenic pain
[252]. Similarly, the inhalation of TRPA1 volatile agonists like acrolein, formaldehyde or
Zn2+ induce cough, bronchoconstriction, mucous secretion and a decrease in respiratory
rate, among other symptoms [253]. These nociceptive effects presumably occur after the
activation of TRPA1 channels in C- and Aδ-fibers innervating the respiratory tract, as
well as activation of TRPA1 channels in bronchial epithelial and smooth muscle cells
[101]. In mouse models of allergen-induced asthma the airway hyperreactivity was
significantly reduced in TRPA1-deficient mice [254]. Inhalation of umbellulone (a
reactive compound produced by the ‘headache tree’) or hypochorite (an oxidative agent
in chlorine gas) activates TRPA1 channels in trigeminal neurons innervating the nasal
cavity. TRPA1-induced activation of these nociceptive neurons leads to an increase in
blood flow in the meninges and the development of migraine headaches [225, 233].
In the gut, stimulation with TRPA1 agonists can increase the proportion of nociceptive
neurons that express functional TRPA1 channels [255]. TRPA1 activation in these
nociceptive neurons induces the release of pro-inflammatory neuropeptides and leads to
mechanical hypersensitivity [255-258]. Impaired regulation of the immune responses in
the gut typically underlies the development of inflammatory bowel diseases such as
colitis and Crohn’s disease [259, 260]. During these chronic inflammatory states, TRPA1
activation has been proposed to modulate, not only the pain responses, but the tissue
inflammation as well [261, 262]. However, whether TRPA1 plays a protective or harmful
role during inflammatory bowel diseases is still under debate.
Altogether, these findings support the increasing interest in the study of TRPA1
channels and their functional role in neuropathic pain, asthma, chronic obstructive
pulmonary disease (COPD) and inflammatory bowel diseases (reviewed in [263-266]).
Notably, PGs, H2O2, low pH and byproducts of ROS/RNS damage constitute
endogenous TRPA1 agonists that are commonly generated upon tissue stress or injury
(Figure 2.2). Because TRPA1 agonists employ several different mechanisms to achieve
channel gating or inactivation, the simultaneous exposure to multiple agonists leads to
complex responses. While some agonists counter-react the activity of others (perhaps by
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competing for the same binding sites), there are agonist combinations that lead to
synergistic and potent responses. Moreover, some TRPA1 agonists eventually induce
channel inactivation and therefore exert analgesic effects as well. For example, PG
metabolites have biphasic responses in nociceptive neurons. Initially they activate
TRPA1 channels and produce pain-like behaviors, but later they can provide analgesia
against other nociceptive signals through a TRPA1-depenent mechanism [250]. In
addition, TRPA1 activation by these endogenous agonists can be potentiated by cold
exposure [241].

Figure 2.2. Pathways for TRPA1 activation after tissue damage
TRPA1 channels can be directly activated by byproducts of reactive oxygen
(ROS) and nitrogen (RNS) species damage (e.g., 4-HNE and OA-NO2), weak
acidosis, intracellular Ca2+ and prostaglandins (PGs). Additionally, TRPA1
channels can be activated downstream of G-protein coupled receptors (such as
the bradykinin –BK– receptor –BR) via the activation of phospholipase C
(and perhaps the generation of diacyl-glycerol –DAG). Activation of TRPV1
channels by tissue acidosis can also modulate TRPA1 activity (e.g., secondary
to the influx of Ca2+).

41

2.4.2 Functional interplay between TRPA1 and TRPV1 channels
TRPV1 channels are gated by low pH (Figure 2.2), heat and capsaicin (the main
pungent compound of chili peppers) (reviewed in [97]). Several studies have shown that
TRPA1 and TRPV1 channels can cross-modulate each others’ properties when coexpressed in the same cell (reviewed in [267]). This is of particular importance given the
fact that TRPA1 expression in nociceptive neurons seems to be limited to the cells that
express TRPV1 channels [174, 175].
TRPA1 and TRPV1 subunits can directly interact by forming heteromeric channels
(section 2.2.5). However, it is still possible that the properties of homomeric TRPA1 and
TRPV1 channels are regulated through close interaction of the channels in the plasma
membrane or via intracellular second messengers. However, most reports showing the
functional interplay between TRPA1 and TRPV1 cannot clearly distinguish between
these two scenarios (i.e. heteromeric channels vs. cross-regulation of homomeric
channels). Regardless of the exact mechanism of interaction, TRPA1-specific agonists
clearly desensitize (although sometimes increase) responses to TRPV1 agonists when
channels are co-expressed [268, 269]. The reverse interaction is also true since capsaicin
desensitizes TRPA1-agonist currents. The potency of some TRPA1 agonists can be either
lower or higher in cells co-expressing TRPA1 and TRPV1 [270]. Additionally, TRPA1
and TRPV1 single channel properties (conductance, open probability and current-voltage
relationships) are modified in cells expressing both proteins [193]. A single point
mutation affecting the permeability to Ca2+ in TRPV1 subunits is able to modify cell
currents in response to TRPA1 agonists [271]. Moreover, TRPA1 channels might get
internalized after stimulation with AITC via a mechanism that is inhibited by the
expression of TRPV1 [268].
2.5 Regulatory mechanisms of TRPA1 function
TRPA1 channels can be activated and/or regulated by several G-protein coupled
receptors (GPCRs) via the generation of second messengers. Some of the GPCRs known
to modulate TRPA1 channel gating are the bradykinin receptor [212], m1 muscarinic
acetylcholine receptor (m1AChR) [215], protease-activated receptor 2 (PAR2) [272, 273]
and P2Y receptors (manuscript in preparation, Vélez-Ortega AC, et al., see Appendix D
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for details). Notably, bradykinin is a potent pro-inflammatory peptide that induces
vasodilation.
Phospholipase C (PLC) signaling downstream of GPCR activation modulates TRPA1
channels (Figure 2.2) as well as other members of the TRP family [212, 274]. Activation
of PLC leads to the cleavage of phosphatidylinositol 4,5-biphosphate (PIP2) from the
plasma membrane and generates diacyl glycerol (DAG) and inositol 1,4,5-triphosphate
(IP3). Therefore, PLC stimulation could modulate TRPA1 activity via three mechanisms.
First, PIP2 seems to inhibit TRPA1 channels and, therefore, PLC-mediated cleavage of
PIP2 would remove such inhibition [273, 275]. Second, because IP3 leads to the release
of Ca2+ from intracellular stores, PLC activation could induce TRPA1 gating via the
increase in cytosolic Ca2+ [212, 215]. Third, DAG application was shown to activate
TRPA1 channels as well, but its mechanism of action remains unknown [212].
Interestingly, in the presence of phospholipase-A2 (PLA2) activity, DAG can be
converted into arachidonic acid (AA), a precursor in the generation of PGs. AA, PGs and
their metabolites could activate TRPA1 channels (see section 2.3.6). However, TRPA1
activation downstream of PLC does not seem to require the N-terminal cysteine residues
that are involved in channel gating by these reactive agonists [202].
PAR2 and bradykinin receptors can also stimulate protein kinase A (PKA) [272, 273].
Activation of PKA might increase the translocation of TRPA1 channels into the plasma
membrane which could explain the increase in TRPA1 currents after stimulation of PKA
[276].
The toll-like receptor-7 (TLR7) is involved in innate immune responses. TLR7
recognizes single stranded RNA (e.g., from viruses) and it is typically localized in the
endosomes of immune cells (reviewed in [277]). However, TLR7 is also expressed in a
subset of DRG neurons [278] and it can be activated by microRNAs (miRNAs).
Moreover, miRNA-dependent activation of TLR7 in DRG neurons induces TRPA1
gating and nociceptive behavior in mice [279]. The mechanism of TLR7-mediated
TRPA1 activation remains unknown but it does not seem to require the TLR7
intracellular signaling cascade.
Annexin A2 (AnxA2) is involved in the trafficking of proteins to and from the plasma
membrane (reviewed in [280]). Recently, AnxA2 was shown to directly interact with
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TRPA1 subunits and to be able to control the amount of TRPA1 expression in the plasma
membrane (without altering Trpa1 mRNA levels) [281]. Whether AnxA2-dependent
expression of TRPA1 in the plasma membrane is regulated by PKA activity remains to be
elucidated.
2.5 TRPA1 as a hair cell MET channel candidate
The inner ear sensory cells (i.e. hair cells) have particular cellular specializations (i.e.
stereocilia bundles) in charge of detecting mechanical stimulation (sound in the cochlea
and movement/acceleration in the vestibular system) (section 1.4.1). However, the
molecular identity of the mechano-electrical transducer (MET) channel involved in this
process is still unknown. Several candidate genes have been proposed in past years. In
fact, the TRPA1 channel was proposed as a MET channel candidate in 2004 [177].
TRPA1 expression and channel properties strongly supported this hypothesis.
Trpa1 mRNA was detected in the mouse cochlear epithelium through in situ
hybridization. Although Trpa1 mRNA was in fact present in the sensory hair cells,
mRNA levels appeared to be significantly higher in the surrounding supporting cells
(specifically, in Hensen’s cells) [177]. Notably, TRPA1 channel properties seemed to
perfectly mirror those of the hair cell MET channel: non-selective cation selectivity,
average single channel conductance (~98 vs. ~100 pS) and current reduction by Ca2+ (53
vs. 54% reduction) [175]. Moreover, the MET channel blockers gentamicin, ruthenium
red, Gd3+ and amiloride were also able to block TRPA1 channels. However, the half
maximal inhibitory concentrations (IC50) differed greatly between TRPA1 and MET
channels for Gd3+ (0.1 vs. 10 µM) and amiloride (511 vs. 50 µM) [175, 282, 283].
In 2006, knockout mice generated by two independent groups ruled out TRPA1 as the
MET channel. [101, 102]. In both groups, the pore-forming region of TRPA1 was
deleted, which renders the subunits nonfunctional. The Trpa1–/– mice had defects in the
nociception of mechanical, chemical and thermal noxious stimuli, yet they exhibited
normal hearing and vestibular functions.
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2.6 Research hypothesis and scope of the dissertation
Trpa1 mRNA is highly expressed in the inner ear [177], but this tissue is not
considered to have prominent nociceptive innervation. Given that Trpa1–/– mice exhibit
normal hearing and hair cell mechanotransduction [101, 102], the function of TRPA1
channels in the cochlear epithelium remains elusive.
Acoustic overstimulation leads to an increase in reactive oxygen species (ROS) in the
cochlear epithelium (reviewed in [284]). The oxidative stress following a single event of
noise exposure can last for several days or even weeks and lead to the accumulation of,
among others, the lipid peroxidation byproduct 4-HNE [285]. Because 4-HNE could
behave as an endogenous agonist for TRPA1 channels in the cochlea, we hypothesized
that cochlear TRPA1 channels act as sensors for oxidative damage after noise exposure.
First, we sought to identify the specific cell types within the cochlear epithelium that
expressed the TRPA1 gene and that contained functional TRPA1 channels (sections 4.1
and 4.2). Next, we evaluated the responses of the cochlear epithelium to direct
application of TRPA1 agonists, such as 4-HNE (sections 4.3 to 4.8). Lastly, we attempted
to unveil the physiological significance of the TRPA1-induced responses observed by
using in vitro and in vivo approaches (sections 4.9 to 4.11).
Chapter 3 presents the experimental approaches used and Chapter 4 the results of the
experiments and their analyses. In addition, Chapter 5 includes the discussion of the
results of this project, taking into account the limitations of the study and possible future
directions.

Copyright © A. Catalina Vélez-Ortega 2014
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CHAPTER 3
Materials and methods
3.1 Mice
TRPA1-deficient mice (Trpa1–/–) and control littermates (Trpa1+/+) were a kind gift
from Dr. David Corey and Dr. Kelvin Kwan (Harvard University) to the Frolenkov
laboratory in 2006. These mice were then backcrossed with C57BL/6 mice. The Trpa1–/–
mice, the pore-forming region (exons 22 to 24) was replaced with a vector containing an
endoplasmic reticulum (ER) retention signal (KDEL), a stop codon, an internal ribosome
entry site (IRES) and the human placental alkaline phosphatase (PLAP) gene as a
reporter [102]. Genotyping of these mice was performed as previously published by our
laboratory [286].
Given that Trpa1+/– mice have exhibited an intermediate phenotype in several tests
[101], all experiments in these study were performed with either Trpa1+/+ or Trpa1–/–
mice. Therefore, two separate colonies of wild type (Trpa1+/+ x Trpa1+/+) and TRPA1deficient (Trpa1–/– x Trpa1–/–) breeding pairs were established and maintained. In some
cases, to corroborate results obtained with the Trpa1+/+ and Trpa1–/– mice from the two
separate colonies, Trpa1+/+ and Trpa1–/– mice were crossed, breeding pairs between F1
heterozygous (Trpa1+/–) siblings were established and F2 Trpa1+/+ and Trpa1–/–
littermates were used for comparisons within experiments.
All animal procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) of the University of Kentucky (protocol 00903M2005).
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3.2 Cochlear explants
3.2.1 Tissue dissection
Cochlear explants were isolated during the first postnatal week because cochlear hair
cells die rapidly when tissue dissections are performed on or after the second postnatal
week. Pups were placed in a cold chamber for 5 to 8 minutes and then decapitated. The
skin around the skull and the facial bones were removed. Next, the skull and brain were
cut into two hemispheres and placed in a plastic Petri dish with cold (~4-10°C)
Leibovitz’s L-15 medium (Gibco) were the tissue dissection was continued. The brain
and the meninges were removed to expose the inner surface of the skull. The tympanic
bullae were dissected out of the temporal bones and placed into a new Petri dish with
fresh L-15 medium. The otic capsule was carefully removed and the cochlear epithelium
was pulled away from the cochlear modiolus. At this stage, the cochlear epithelium has a
tubular conformation thus, in order to flatten out the tissue, the Reissner’s membrane was
cut. This approach allowed the organ of Corti to remain attached to the outer supporting
cells (i.e. Claudius’ and spiral prominence cells) and the stria vascularis (Figure 3.1A). In
contrast, for experiments where the outer supporting cells were not needed, the tissue was
held by the spiral limbus while the stria vascularis was pulled away. This maneuver
caused the tissue to tear at the level of the Claudius’ cells but left the organ of Corti and
inner supporting cells intact (Figure 3.1B).
Explants were either allowed to attach to glass-bottom Petri dishes (in experiments
with cultured explants) or held by two glass fibers glued onto a coverslip (in experiments
on freshly-isolated tissue).
3.2.2 Tissue culture of cochlear explants
For direct attachment of the cochlear explants onto glass-bottom Petri dishes (MatTek
Corporation), each explant was placed on a dish with a small amount of culture medium
(~ 200 µL), which consisted of Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco)
supplemented with 7% fetal bovine serum (FBS) (Atlanta Biologicals) and 10 µg/mL
ampicillin (Calbiochem). The small amount of medium was dispersed throughout the
glass bottom making the liquid surface tension keep the cochlear explant in place. Dishes
were temporarily sealed with Parafilm® M (Bemis Company, Inc.) to minimize liquid
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evaporation and then placed in an incubator at 37°C and 5% CO2 for 12-16 h. After this
time, the explants had completely attached to the glass (Figure 3.1) so the Parafilm was
removed and 2 mL of fresh culture medium were added to each dish. Explants were
placed back in the incubator for 1-2 more days before imaging was performed.

Figure 3.1. Cochlear epithelium attached to a glass-bottom dish
A, B, Several overlapping pictures were taken with a 10X objective to cover
the entire length (from base to apex) of a cochlear epithelium with (A) or
without (B) outer supporting cells and stria vascularis (OSC), attached to a
glass-bottom Petri dish. C, As a reference, a diagram is provided to illustrate
the tissue configuration at the cross sections indicated by the two dashed lines.
Often, changes in the morphology of the hair cell stereocilia bundles were observed in
cultured cochlear explants that contained outer supporting cells and the stria vascularis
(Figure 3.2). In some cases, the rows of OHCs were completely absent (data not shown),
an indication that these cells had undergone apoptosis. In fact, a closer examination of the
tissue revealed a large quantity of apoptotic cells within the stria vascularis after only 1
day in culture (Figure 3.3). Because cochlear explants that did not contain the outer
supporting cells or stria vascularis appeared healthy, we believe the dying cells in the
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stria vascularis had a noxious effect on the rest of the tissue. Therefore, as described in
the following section, we designed a strategy that would allow us to study cochlear
explants immediately after dissection.

Figure 3.2. Cochlear explants cultured with outer supporting cells and stria
vascularis exhibited morphological abnormalities
A, B, Bright field imaging of wild type cochlear explants dissected on
postnatal day 4 (P4) and cultured without (top) or with (bottom) outer
supporting cells for 1 (A) or 3 days (B). Three focal planes of each area are
shown to highlight the stereocilia bundles of IHC (left) and OHC (middle and
right). Arrow to some of the stereocilia bundles that did not exhibit normal
morphology. IHC, inner hair cell; OHC, outer hair cell; OSC, outer supporting
cells and stria vascularis.
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Figure 3.3. Apoptotic cells are observed in the stria vascularis during culture
A, B, Scanning electron micrographs of the organ of Corti (top) and stria
vascularis (bottom) regions from wild type cochlear explants cultured for 1
(A) or 2 days (B). After 1 day in culture most stereocilia bundles appear
normal while several abnormally swollen cells are observed in the stria
vascularis (arrows). After 2 days in culture, the swelling in the stria was less
noticeable but the hair bundle morphology was disorganized. Several ‘holes’
were observed in the stria (arrow heads), and they probably represent areas
were apoptotic cells had been recently removed. IHC, inner hair cell; OHC,
outer hair cell; SV, stria vascularis.
3.2.3 Freshly-isolated cochlear explants
To perform experiments in freshly isolated cochlear explants, it was necessary to keep
the tissue from moving freely. To do so, thin glass fibers were pulled from glass
capillaries (World Precission Instruments) using a P-2000 laser puller (Sutter
Instrument). The pulled fibers measured ~1-2 cm in length and were fairly flexible. Two
fibers were glued onto a glass coverslip (~2 cm in diameter) (Fisherbrand) using the
silicone elastomer Sylgard® (World Precission Instruments). The coverslips were placed
on a hot plate to quickly cure the elastomer (~3-5 min). Next, the coverslips were
mounted on plastic or glass-bottom dishes using a small amount (~1-3 µL) of Sylgard®
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and allowed to cure overnight (Figure 3.4A). The cochlear epithelium was placed under
the two glass capillaries to keep it in place during imaging and patch clamp recordings
(Figure 3.4B).

Figure 3.4. Freshly-isolated cochlear tissue held in place by glass capillaries
A, Dish configuration used to hold the cochlear tissue in place for experiments
performed in freshly-isolated tissue. B, Cochlear tissue placed under the glass
capillaries imaged with a 4X objective. Four overlapping images were taken
to cover the area shown in the picture.
3.2.4 Identification of cochlear cell types
The highly organized architecture of the cochlear epithelium allows for the
identification of its different cell types. Here, the steps to differentiate Hensen’s from
Claudius’ cells will be used as an example.
i) First, the supporting cells types were identified by their location relative to the
sensory hair cells in the x and y axes. The stereocilia bundles of the inner (IHC) and outer
(OHC) hair cells are easily identified on the apical surface of cochlear explants (Figures
3.5A and 3.5B) and they provide the first reference about the position of all supporting
cells. For instance, the Hensen’s and Claudius’ cells located toward the lateral side of the
OHC (i.e., the bottom of Figures 3.5A and 3.5C).
ii) Because different cell types are observed at different focal planes (Figure 3.5D), at
the beginning of every experiment a stack of bright field images spanning the entire
thickness of the explant was obtained, with images taken every 1 µm. This image stack
51

was used as reference during the data analysis. Hensen’s cells are columnar cells
organized in two (sometimes three) intercalated rows. The first row of Hensen’s cells is
the closest to the OHCs and is located at a higher z plane than the second row of
Hensen’s cells. In contrast, Claudius’ cells are short cuboidal cells arranged in a flat
configuration (one-cell thick).

Figure 3.5. Representative bright field images of a cochlear explant taken at
two different focal planes
A, Focal plane at the level of the hair cell stereocilia. One row of IHCs, three
rows of OHCs and the cells of the Kolliker’s organ (KoC) are visible. B,
Higher magnification of a region from A highlighting the IHC and OHC
stereocilia bundles. C, Focal plane below the hair cell bodies, where pillar
(PC), Deiters’ (DC), Hensen’s (HeC) and Claudius’ cells (CC) are visible. D,
Diagram of a cross-section of the organ of Corti indicating the two focal
planes shown in A and C.
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iii) Lastly, the differences in cell morphology also allowed for the identification of
boundaries between cell types. While a cross-section of a Hensen’s cell exhibits a
hexagonal yet almost ovoidal shape, a cross-section of a Claudius’ cell looks like a
hexagon with sides of similar length (Figure 3.5C).
3.3 Immunohistochemistry
3.3.1 PLAP immunolabeling
Cochlear explants were fixed in a 4% paraformaldehyde (PFA) (Electron Microscopy
Sciences) solution in 1X phosphate-buffered saline (PBS) (Gibco) for 1-4 hours. Explants
were washed with PBS containing 0.01% Triton-X (Electron Microscopy Sciences).
Next, the tissue was placed in a blocking solution that consisted of 10% normal goat
serum (NGS) (Invitrogen) in wash buffer for 1h at room temperature (RT). Explants were
incubated overnight with a mouse anti-hPLAP clone 8B6 antibody (1:100) (SigmaAldrich) in blocking solution at 4°C in a humid chamber. Incubation with a goat antimouse Alexa Fluor 488 secondary antibody (1:1000) in blocking solution was performed
at room temperature for 2h. Tissue was counterstained in 300 nM 4’,6-diamidino-2phenylindole (DAPI) (Invitrogen) in PBS for 5 min and mounted with ProLong® Gold
antifade medium (Invitrogen). The imaging set up used is described in section 3.3.3.
One of the figures in Chapter 4 contains an image obtained by our collaborator K.
Kwan (Rutger’s University) (manuscript in preparation, Vélez-Ortega, et al.). He
followed a similar protocol of PLAP immunolabeling. The only differences were in the
secondary antibody used (goat anti-mouse Alexa Fluor 568), staining with 500 ng/ml
Hoechst 33235 instead of DAPI, and adding phalloidin (1:400) counterstaining as well.
His image was obtained with an Olympus FluoView 1000 scanning confocal microscope
equipped with at 63X PlanSApo objective (1.42 NA), at 1024x1024 resolution with a
pixel dwell time of 2-8 µs.
3.3.2 Immunolabeling of 4-HNE-modified proteins
Tympanic bullae (from noise-exposed and control mice) were perfused with a solution
of 4% PFA in 1X PBS and kept for 1 to 4 h at 4°C before further dissection. Perfusion
was performed through the oval window after making a hole in the apical end of the otic
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capsule. Tissue dissection was performed in distilled water. Samples were washed with
PBS and permeabilized for 10 min in a 1% Triton-X solution. Tissue was blocked for 45
min in 10% NGS in PBS and incubated with rabbit polyclonal anti-HNE (1:50) (Abcam)
in blocking solution over night at 4°C. Incubation with the secondary mouse anti-rabbit
Dylight 488 antibody (1:200) (Jackson Immunoresearch) was performed for 2 h at RT.
Samples were counterstained with DAPI (600 nM) for 10 min and mounted in antifade
medium. The anti-4-HNE antibody recognizes proteins that have been covalently
modified by 4-HNE after oxidative stress. To test the performance of this antibody, we
exposed cochlear explants to varying concentrations of hydrogen peroxide (H2O2)
(Molecular Probes) over night (Figure 3.6).
3.3.3 Imaging set up
An upright Olympus BX51WI spinning disc confocal microscope was used. The
microscope was equipped with a 100X LUMPlan FL objective (1.0 numerical aperture –
NA) (Olympus), an Olympus U-RFL-T mercury arc lamp, a nanopositioning system for
focal plane control (Mad City Labs) and the Evolve 512 EMCCD camera (Photometrics).
The camera was used at its full chip resolution (512x512) and digitization (16-bit). The
filter cubes used allowed for excitation and emission bandwidths for Alexa Fluor 488,
Dylight 488 (488/20 nm and 525/50 nm) and DAPI (350/50 and 460/50 nm) (Olympus).
The MetaMorph for Olympus Imaging Series v.7.7 (Molecular Devices) was used for
imaging acquisition. All imaging settings (e.g., exposure, gain, readout speed) were kept
identical between different samples.
3.4 Drug delivery
3.4.1 Stock and working solutions of the drugs used
ATP and several TRPA1 agonists (4-HNE, CA and AITC) were used for tissue
stimulation during different experiments.
4-HNE (Cayman Chemical) was purchased at a 64 mM concentration in ethanol, and 1
µL of this solution was mixed with 320 µL of bath medium to achieve a 200 µM working
solution. The 4-HNE stock was stored at -80°C and working solutions were made fresh
each time.
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Figure 3.6. Performance test of the 4-HNE antibody
A, B, Immunolabeling with the anti- 4-HNE antibody was performed in
cochlear explants exposed to 20 (A) or 200 µM H2O2 (B) for ~12 h. Bright
field images (left) and maximum intensity projections of 4-HNE
immunofluorescence (right) are shown. Notice that the levels of 4-HNE
immunolabeling are higher in the cells exposed to the higher H2O2
concentration. In particular, supporting cells surrounding the IHCs show the
brightest labeling. IHC, inner hair cells; OHC, outer hair cells.
CA (Sigma-Aldrich) was dissolved in 60% ethanol to make a 100 mM stock solution
(6.3 µL of a 1.05 g/mL CA solution were mixed with 1 mL of 60% ethanol). This stock
solution was kept at 4°C and used for up to a week. Working solutions (100 µM) were
made by mixing 1 µL of the stock solution with 1 mL of bath medium and made fresh
each time.
A 95% AITC solution (Sigma-Aldrich) was dissolved in 60% ethanol to make a 200
mM stock solution (4.9 µL of AITC with 250 µL of 60% ethanol). 1 µL of the stock
solution was mixed with 2 mL of bath medium to achieve a working solution at 200 µM.
AITC stock solutions were stored at -80°C.
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ATP-Na2 (Sigma-Aldrich) was diluted in distilled water (Gibco) to a 1 mM
concentration (stock solution) and stored at -80°C in small aliquots to avoid thawingfreezing cycles. To achieve their final concentration (2 to 250 µM), ATP aliquots were
diluted with bath medium immediately before use.
3.4.2 Glass micro-pipettes
Micro pipettes were pulled from glass capillaries (World Precission Instruments) using
a P-2000 laser puller. Capillaries were made of borosilicate glass, 10 cm long, fire
polished, contained an internal filament (to facilitate filling with liquid) and outer/inner
diameters of 1/0.58 mm. Small diameter (~ 2-3 µm) pipettes were used during the Ca2+
imaging experiments while pipettes with larger diameters (~ 6-8 µm) were used during
the patch clamping experiments.
3.4.3 Puff stimulation
Glass micro-pipettes were used to stimulate small tissue areas on the cochlear explants
with ATP (2 to 250 µM, Sigma-Aldrich) or with the TRPA1 agonists 4-HNE (200 to 400
µM, Cayman Chemical), CA (100 to 200 µM, Sigma-Aldrich) and AITC (100 µM,
Sigma-Aldrich). These drugs were always dissolved in the same type of solution present
in the bath. The pipette tips were placed ~8 to 10 µm above the tissue surface using a
MP-285 micromanipulator (Sutter Instrument).
A pneumatic pico-pump (World Precision Instruments) was used to apply pressure at
the back of the pipette and, for fine pressure control, a TraceableTM manometer gauge
(Fisher Scientific) was placed in the tubing line between the pico-pump and the pipette.
The pico-pump was triggered by a 5 V transistor-transistor logic (TTL) signal delivered
by a data acquisition (DAQ) board (National Instruments) controlled by the Clampex or
Metamorph software. The delay in the puff stimulation was estimated to be ~ 40 ms
(Figure 3.7).
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Figure 3.7. System delay during puff stimulation
A,B, The delay between the TTL trigger and the beginning of drug delivery
was measured by placing a puff pipette filled with a 2 M KCl solution ~10 µm
away from a patch clamping electrode (see section 3.7) connected to a patch
amplifier. Changes in the standing current through the electrode were induced
after the puff stimulation (A) and they typically started ~40 ms after the TTL
pulse was delivered (B).
The area to be stimulated was determined by the size of the pipette tip and the pressure
applied at the back of the pipette (Figure 3.8). Typically, the pressure applied ranged
between 2 to 4 kPa.
3.5 FM1-43 labeling
The use of the small cation dye FM1-43 to assess for the presence of functional
TRPA1 channels in cochlear hair cells was previously reported by our laboratory [286].
Briefly, cochlear explants from wild type and Trpa1–/– mice were pre-treated with 10mM
1,2-Bis[2-aminophenoxy]ethane-N,N,N′,N′-tetraacetic acid (BAPTA) (Sigma-Aldrich) in
Ca2+-free Hank’s balanced salt solution (HBSS) (Gibco) for 10 min. Next, cochlear
explants were incubated with 5 µM FM1-43 for 30 s in Ca2+-free HBSS and immediately
washed with standard HBSS.
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Figure 3.8. Puff stimulation area
A-D, Two pipettes were filled with fluorescent dye (Fura-2) to mimic drug
delivery. Notice how the area of puff stimulation changes between low (A)
and high (B) puff pressures. In addition, the increase and decrease in
fluorescence during the stimulation with low (C) and high (D) puff pressure is
shown. Notice the time correlation between the changes in fluorescence and
the TTL pulse (black line) in both conditions. a.u., arbitrary units.
Imaging was performed within 30 min after the incubation with the FM1-43 dye, and
it was performed in standard HBSS at RT. The same set up described in section 3.3.3 was
used, but the microscope was equipped with a 60X LUMPlan FL N objective (1.0 NA)
(Olympus) and with filter cubes for 488/20 nm emission and 525/50 nm excitation
(Olympus). Imaging acquisition settings were kept identical between different samples.
3.6 Ratiometric calcium imaging
3.6.1 Loading cells with the Ca2+ indicator
Cochlear explants were loaded with the membrane-permeable ratiometric Ca2+
indicator: fura-2-acetoxymethyl ester (AM) (Invitrogen). To help solubilize the dye, 50
µg of fura-2-AM were dissolved in 10 µL of a 20% Pluronic acid solution in DMSO
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(Invitrogen). This 5 mM stock solution of the dye was stored at < -15°C for up to a month
and limited to 3 thawing-freezing cycles. Before each experiment, the stock solution was
thawed in a 37°C bath (~20 min) and vigorously mixed (vortexed for ~5 min). The
cochlear explants were incubated in L-15 medium containing 2 µL of the stock solution
(i.e., 10 µM concentration of the fura-2 dye) for 50 min at RT. Explants were washed and
then incubated in fresh L-15 medium for 20 min to allow the complete de-esterification
of the dye. Imaging was performed immediately after, in L-15 medium at RT. For some
experiments, 50 µM pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) was
added to the bath solution before imaging.
3.6.2 Live cell imaging
Imaging was performed using the set up described in section 3.3.3. However, instead
of the mercury arc lamp, the Lambda DG-4 system (Sutter Instrument) was used to
control the fast switching between illumination at 340 and 380 nm. Therefore, because
the Lambda DG-4 illumination path bypassed the spinning disk unit of the microscope, it
was not possible to perform ratiometric Ca2+ imaging in a confocal mode. A filter cube in
the microscope allowed the emission at 510/80 to be captured by the camera. Three
different objectives were used: 40X 0.8 NA (LUMPLFLN40X/W), 60X 1.0 NA
(LUMPLFLN60X/W) and 100X 1.0NA (LUMPLFL100XW/IR) (Olympus). In addition,
sometimes a secondary custom-made 2X magnification lens was added in the infinitycorrected light path of the microscope. Alternating images between the 340 (F340, Ca2+bound dye) and 380 nm (F380, Ca2+-free dye) illuminations were obtained to assess
changes in intracellular Ca2+ levels. At the beginning of each experiment image stacks for
the F340 and F380 illuminations were take every 1 µm and covered the entire thickness
of the tissue. These stacks were used as references –for cell types and positions– during
the data analysis.
3.6.3 Image analysis
Image analysis was performed using the ImageJ software [287] and the Ratio Plus
plugin (http://rsb.info.nih.gov/ij/plugins/ratio-plus.html). Each ratio image (R) was
obtained by dividing corresponding pixels between the F340 and F380 images (F340/F380).
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Background subtraction for the independent signals was not performed given that the
background light was several orders of magnitude smaller than the fura-2 signal. The
error that this background light introduced in the ratio measurements was calculated to be
around 0.006%. To enhance the changes in intracellular Ca2+ with time, ratio images
were normalized to the first ratio obtained in the series (R/R0). A pixel value of 1 would
indicate no change in intracellular Ca2+ was evident. Instead, a pixel value of 2 would
correspond to an increase in intracellular Ca2+ but not necessarily a doubling in the
amount of Ca2+.
3.6.4 Calculating free Ca2+ concentrations from F340/F380 ratios
Within each experiment, exposure and gain settings were kept identical for the F340
and F380 images. However, different objectives and illumination intensities were used
between different experiments (Table 3.1), thus a different calibration curve was
generated for each situation.
Table 3.1. Imaging conditions used during ratiometric Ca2+ imaging
Objective
40X
60X
100X

Extra

F340

F380

R2 value of

magnification

intensity*

intensity*

calibration curve

50%

< 33% †

0.9979

100%

33%

0.9981

No

100%

33%

0.9989

2X

100%

33%

0.9872

No

50%

100%

0.9971

2X

* F340 and F380 intensities are controlled by changing the optical alignment of
two galvanometers in the Lambda DG-4 illumination system. Factory preset
values are provided to achieve 100%, 50% and 33% of the maximum output for
each channel.
† The alignment of the Lambda DG-4 galvanometers was modified. The F380
intensity was lower than 33% but the exact value was not determined.
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Briefly, a Ca2+ calibration buffer kit (Molecular Probes) containing eleven dilutions
with free Ca2+ ranging from 0 to 39 µM was used to generate calibration curves for all
imaging conditions used. Fura-2 pentapotasium salt (Invitrogen) was added to each
calibration dilution at a final concentration of 10 µM. To minimize errors, a small volume
of the fura-2 dye (6 µL) was added to a large volume of the calibration dilution (2 mL).
Next, 300 to 500 µL of each dilution were placed on a Petri dish and F340 and F380 images
were acquired. Special care was taken during imaging acquisition to keep the z position
constant between samples.
To determine the dissociation constant (Kd) of the fura-2 indicator, the
𝐿𝑜𝑔 �[𝐶𝑎2+ ]𝑓𝑟𝑒𝑒 � of the calibration dilutions were plotted (x axis) against
[𝑅− 𝑅𝑚𝑖𝑛 ]

𝐿𝑜𝑔 �[𝑅

𝑚𝑎𝑥 − 𝑅]

×

𝐹380 𝑚𝑎𝑥
𝐹380 𝑚𝑖𝑛

� (y axis), where R is the F340/F380 ratio for each dilution, Rmin

the F340/F380 ratio for the Ca2+-free dilution (0 µM), Rmax the F340/F380 ratio for the

saturating Ca2+ dilution (39 µM), F380 max the F380 value for 0 µM Ca2+ and F380 min the
F380 value for 39 µM Ca2+. All graphs resulted in straight lines (R2 values greater than
0.987) (Figure 3.9 and Table 3.1) where the x intercepts corresponded to 𝐿𝑜𝑔 (𝐾𝑑 ).
Lastly, free intracellular Ca2+ concentrations were estimated from experimental F340/F380
ratios (RExp) by using the Grynkiewicz equation [288]:

2+

[𝐶𝑎 ]𝑓𝑟𝑒𝑒 = 𝐾𝑑

𝐸𝐺𝑇𝐴

[𝑅𝐸𝑥𝑝 − 𝑅𝑚𝑖𝑛 ]
𝐹 380 𝑚𝑎𝑥
×
× 380
[𝑅𝑚𝑎𝑥 − 𝑅𝐸𝑥𝑝 ]
𝐹 𝑚𝑖𝑛

3.7 Patch clamping recordings
Glass micro-pipettes were pulled from glass capillaries using the P-1000 heating
filament puller (Sutter Instrument). Typically, pipettes exhibiting a resistance of 5 to 12
MΩ were used.
In some cases, to gain access to a particular cell within the tissue, it was necessary to
remove neighboring cells. For instance, OHCs and Deiters’ cells were removed to clear
the access to the lateral wall of the pillar cells. The intracellular solution used in the patch
pipettes contained (in mM): KCl (12.6), KGlu (131.4), MgCl2 (2), EGTA (0.5), K2HPO4
(8), KH2PO4 (2), Mg2-ATP (2) and Na4-GTP (0.2). The osmolarity and pH of the
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intracellular solution was adjusted to match that of the bath solution (typically, 310
mmol/kg and pH 7.4). After achieving a whole-cell configuration, the cell contents were
allowed to equilibrate with the patch pipette fluid for 5 min before any recordings were
performed. All recordings were performed at room temperature.

Figure 3.9. Calibration curves for the fura-2 dye
A, B, Calibration curves from 2 (out of 5) settings are shown: 40X objective
(with 2X extra magnification) with 50% F340 and < 33% F380 intensities (A), and
100X objective with 50% and 100% intensities (B). Values obtained for each
dilution were plotted (red diamonds) and data were fitted using a linear
regression.
Because all supporting cells are electro-chemically coupled (Figure 3.10), patch clamp
recordings had to be performed in the presence of a gap junction blocker. Some of the
blockers tested were carbenoxolone disodium salt (CBX) (Sigma-Aldrich) [289], octanol
(Sigma-Aldrich) [290] and flufenamic acid (FFA) (Fluka, Sigma-Aldrich) [291]. These
gap junction blockers were tested in the bath solution, the intracellular solution, or both.
CBX (100 – 500 µM) failed to block the propagation of a fluorescent dye from the
patched cell to its neighboring cells (indicating an incomplete block of gap junctions)
(Figure 3.11). Octanol seemed to completely block the gap junctions at high
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concentrations (1 mM) but impaired cell survival (data not shown), and thus limited the
duration of the recordings. However, 100 µM FFA provided a long-lasting blockage of
gap junctions without inducing the cell death observed with octanol. Therefore, 100 µM
FFA was added to the bath solution (i.e. L-15 medium) for all patch clamp experiments.
A stock solution of 100 mM FFA in DMSO was kept in small aliquots at -80°C for no
more than 4 weeks and freezing/thawing cycles were avoided.

Figure 3.10. Supporting cells are electrochemically coupled via gap junctions
To test the extent of the gap junctional conductance in the cochlear
epithelium, 265 µM fluorescein sodium salt (Sigma-Aldrich) was added to the
intracellular solution. The results obtained when patching an inner pillar cell
(IPC) are shown. A, B, Bright field images at the level of inner hair cell (IHC)
stereocilia (A) and IPC feet (B) show the tissue after the removal of the
neighboring outer hair cells and Deiter’s cells. C, The patch pipette in the bath
solution shows the leakage of the fluorescent dye. D, During the gigaohm
seal, no leakage of the fluorescent dye is observed. E-H, Whole-cell voltageclamp configuration of an IPC showing the fluorescent dye within the cell
immediately after breaking the membrane (E) and its diffusion to neighboring
cells 21 (F), 44 (G) and 63 min (H) later.
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The microscope described in section 3.3.3 was used, equipped with either a 60X or
100X objective (1.0 NA). A headstage preamplifier was mounted onto MP-285
micromanipulators. During the experiment, the tissue was observed with a Hitachi 1/2"
surveillance video camera.
The MultiClamp 700B amplifier together with the pClamp 10 software (Molecular
Devices) were used for the patch clamp recordings. The ‘membrane test’ feature in
pClamp was used to monitor (i) pipette resistance, (ii) patch resistance (i.e. gigaohm seal
formation) and (iii) cell parameters during the whole-cell configuration (e.g., cell
resistance, membrane capacitance, and access resistance). These parameters were
measured by delivering a 10 mV square pulse at 100 to 500 Hz.

Figure 3.11. CBX fails to block the diffusion of a fluorescent dye between
supporting cells
A, An inner pillar cell (IPC) was patch clamped and the fluorescein dye (265
µM) present in the intracellular solution diffused to neighboring cells even in the
presence of 500 µM CBX in the intracellular solution. Images at two focal
planes are shown: immediately below the inner hair cell (IHC) bundles (Left)
and near the IHC base (Right). B, Orthogonal view from the plane indicated with
a dashed line in A. The patch pipette on the lateral side of the IPC is visible, and
also the propagation of the fluorescent dye to cells located on the medial side of
the IHC. IBC, inner border cell; IPhC, inner phalangeal cell; IPC, inner pillar
cell.
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Preliminary experiments were performed to compare several cell parameters between
different types of cochlear supporting cells: inner pillar (IPC), outer pillar (OPC),
Deiters’ (DC), Hensen’s (HeC) and Claudius’ cells. After achieving a whole-cell
configuration, current-voltage (IV) relationships were evaluated using voltage steps from
-90 to +90 mV, with steps every 15 mV. These preliminary results indicated differences
in membrane capacitance and resting membrane potentials between the different
supporting cells (Figure 3.12). These results were used to decide the holding potentials
and voltage protocols applied to each cell type. The holding potentials (in mV) were
defined as: -40 to -50 (IPC), -20 to -30 (OPC), -10 to -20 (DC) and 0 to +10 (HeC).

Figure 3.12. Electrophysiological characteristics of cochlear supporting cells
A, B, Average values of membrane capacitance (A) and reversal potential (B) for
the different types of cochlear supporting cells. The numbers of cells averaged
are shown within parenthesis above each bar. IPC, inner pillar cells; OPC, outer
pillar cells; D3, Deiters’ cells from the third row; HeC, Hensen’s cells; CC,
Claudius’ cells.
Current responses to the puff stimulation with 100 CA were evaluated during a step
voltage to -90 mV. In addition, 300 ms ramps from -90 mV to +90 mV were delivered
before, during and ~5 min after puff stimulation. Data analysis was performed using the
Clampfit 10 software.
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3.8 Laser uncaging
3.8.1 Set-up configuration
The microscope described in section 3.3.3 was equipped with a 355 nm diode pumped
solid state laser (DPSL-355/30 system, Rapp OptoElectronic) and a 100X LUMPlan FL
N (1.0 NA). Using a fiber optic with a diameter of 50 µm, a laser spot size of ~10 µm
was achieved (Figure 3.13). Throughout the experiment, cell currents were measured
using the Clampex 10 software, and alternating bright field and Ca2+ imaging were
recorded using the Metamorph software. The Ca2+ indicator fluo-4 (Molecular Probes)
and a filter cube for 535/45 emission and 475/40 nm excitation were used for intracellular
Ca2+ imaging.

Figure 3.13. Laser spot size
A, Fluorescing grease mounted onto a glass microscope slide (Rapp
OptoElectronic) was used to measure the size of the laser spot. B, A short
laser pulse stimulation left a burned spot on the grease that was used to focus
the laser, until a final ~10 µm laser spot was achieved.
3.8.2 Ca2+ uncaging in pillar cells
A photolabile Ca2+ chelator, nitrophenyl EGTA (NP-EGTA) (Molecular Probes), was
delivered to cells via a patch pipette. The intracellular solution contained (in mM): KCl
(12.6), KGlu (131.4), CaCl2 (0.7), NP-EGTA (1), K2HPO4 (8), KH2PO4 (2), Na4-ATP
(2), Na4-GTP (0.2) and fluo-4 (0.05). L-15 medium supplemented with 100 M µFFA was
used as the bath solution. Outer pillar cells were patched at their basolateral membrane
66

near their feet. Cells were held at their resting potential ~-40 mV throughout the
experiment. In control experiments, NP-EGTA was replaced with EGTA.
Baseline recordings were performed for 100 to 300 s before the laser stimulation, and
continued for >500 s after that. Laser UV stimulation was performed with 15 to 25
pulses, 1 ms each, delivered at 166 Hz. Intracellular Ca2+ and cell diameter were
measured by monitoring fluo-4 fluorescence and bright field imaging, respectively,
during the experiment. For details about the cell diameter measurements, see section
3.9.3.
3.9 Measurement of tissue displacements and cell contractions
3.9.1 Imaging set-up and software
The microscope described in section 3.3.3 was equipped with a 100X objective (1.0
NA), a halogen bulb lamp (Olympus) and cubes for differential interference contrast
(DIC) imaging

(Olympus).

Time-lapse

bright

field

imaging

was

performed

simultaneously with the ratiometric Ca2+ imaging (section 3.6) and during the laser
uncaging experiments (section 3.8).
3.9.2 Tissue displacement measurements
TRPA1 activation caused tissue displacements evident during bright field imaging.
These tissue movements let to changes in the pattern of light scattering. Therefore,
images were analyzed using the ImageJ software [287]. Bright field frames that were
taken 10 s apart were subtracted to enhance any movement in the tissue. In the subtracted
images (32-bit), pixel values of 0 represented no movement between the two frames,
while positive and negative values indicated the presence of tissue displacements. The
standard deviation in the pixel values was measured within regions of interest and plotted
against time. Due to differences in light intensity, scattering patterns and contrast
between samples, results of different experiments were normalized and areas under the
curve (A.U.C.) were calculated. Within each experiment, comparisons were made
between frames taken before and after the TRPA1 agonist application.
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3.9.3 Measuring cell diameters
Bright field images were used to measure cell diameters using a method previously
published for OHC electromotility quantification [292]. In summary, pixel intensity
profiles were obtained from lines placed across the cells of interest (Figure 3.14A). These
measurements were performed for each time frame using the MetaMorph software and its
linescan feature (Figure 3.14B).

Figure 3.14. Cell diameter measurements
A, Bright field image showing the line used to measure the pixel value profile.
B, Pixel value profiles for the line shown in A at different time points (from
black to light grey). C, D, Cell edge movements were quantified by placing a
horizontal line (red line) and finding the first point where each pixel profile
was crossed. To do so, line profiles were aligned on the side to be measured
(left edge in C and right edge in D).
Cell edge movements were quantified using algorithms written in the Matlab software.
Pixel values along each line were interpolated to increase the number of points by 50
times. Movements at both edges of the cell were quantified after aligning the line profiles
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on the side to be measured (Figures 3.14C and 3.14D). The first point crossing a
horizontal line (placed by the user) was used to calculate the position of the cell edge.
Based on the movement of each edge and the original size of the line, the changes in cell
diameter were calculated.
3.10 Auditory brainstem responses (ABR)
3.10.1 Mouse anesthesia
Young adult mice (3 to 4 week old) were anesthetized with intraperitoneal injections
of 2,2,2-tribromoethanol (Avertin) (Sigma-Aldrich) at a dosage of 0.4 mg/g of body
weight. When required, a 0.1 mg/g boost was injected. Mice were kept on a heated plate
during the experiment.
3.10.2 ABR recordings
Subdermal needle electrodes were positioned at the base of each pinna (positive and
negative electrodes) and on the top of the head (ground electrode). A speaker (MF-1,
Tucker-Davis Technologies) was placed in front of the mouse, 1 inch away from the
center of the head.
An Auditory Workstation coupled with the BioSigRP software (Tucker-Davis
Technologies) was used to deliver 3 ms tones of a specific frequency (8, 16, 24 and 32
kHz) and sound pressure level decibel (SPL dB). Tones were presented at 200 Hz and
with alternating polarity. A threshold was established to reject signals that included
outlier signals (e.g., the QRS wave from the heart electrocardiogram). ABR signals were
averaged 512 to 1024 times for each frequency and SPL value. A half-interval search
algorithm was used to determine the hearing threshold value for each frequency, with a
final ~ 3 SPL dB resolution. For conditions where no hearing threshold was detected, the
highest SPL value evaluated was assigned (i.e. 112 SPL dB). Hearing thresholds were
measured before and several time points after noise exposure (Figure 3.15).
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Figure 3.15. Representative ABR traces before and after noise exposure
A-C, Example of ABR traces from the same mouse obtained before (A),
immediately after (B) and 2 weeks after (C) noise exposure. Notice that the
range of SPL dB values evaluated is different for each panel. For this mouse, the
hearing thresholds were assigned as: 30 (A), 91 (B) and 50 dB (C).
For the ABR recordings, two cohorts of mice were used. The first cohort compared
wild type and Trpa1–/– mice from the colonies that were maintained separately. In the
second cohort, wild type and Trpa1–/– littermates were compared. Since no differences
were observed between these two cohorts, the data were combined for plotting and
analysis purposes.
3.10.3 Noise exposure
Anesthetized mice were exposed to a broadband noise at 100 dB for 30 min. The noise
was delivered by a speaker placed in front of the mouse, 1 inch away from the center of
the mouse head.
3.11 Distortion product otoacoustic emissions (DPOAE)
These experiments were performed by the technician Stephanie Edelmann, MS, under
the supervision of A.C. Vélez-Ortega. Briefly, 3-4 week old mice were anesthetized (as
described in section 3.10.1) and a low-noise microphone probe (ER-10B+ model,
Etymotic Research Inc.) was placed in the mouse left ear canal. Two tones of f1 and f2
frequencies at a ratio of 1.2 (f1/f2) were generated by electrostatic speakers and presented
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with equal sound pressure levels (SPL). The microphone probe measured the intensity of
the 2f1-f2 frequency in the ear canal (i.e. DPOAE) together with the noise floor level (i.e.
intensity of the surrounding frequencies). Several stimuli frequencies (4 to 20 kHz) and
SPL values (40 to 70 dB) were evaluated. DPOAE values were measured before noise
exposure and at several time points of recovery.
3.12 Statistical analysis
The student’s t-test was used to compare the results from wild type and Trpa1–/– mice
in the following experiments: (i) intracellular Ca2+ baseline levels and peak responses
after TRPA1-agonist puff stimulation, (ii) tissue movement after TRPA1 stimulation and
(iii) changes in intracellular Ca2+ and cell diameter after laser stimulation. Changes in
intracellular Ca2+ levels in cells treated with FFA, were also analyzed using the student’s
t-test. Differences in peak whole-cell current responses after TRPA1 activation between
cells from from wild type and Trpa1–/– mice were evaluated using a t-test for samples
with unequal variances. Two-way ANOVAs were used to compare ABR and DPOAE
results between wild type and Trpa1–/– mice. Bonferroni corrections were performed for
the multiple comparisons made within the ABR and DPOAE results. The GraphPad
Prism software v.5 was used to perform the statistical analyses.
The numbers (n) of cells, regions and/or cochlear explants included in each analysis
are shown in the corresponding figures. Cells within a given explant were averaged and
the statistical analyses were performed using the mean values of each explant. Error bars
indicate the standard errors (SEM) around the mean values. Asterisks indicate statistical
significant differences with P values < 0.05 (*), < 0.01 (**) and < 0.001 (***).

Copyright © A. Catalina Vélez-Ortega 2014
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CHAPTER 4
Results
4.1 TRPA1 is widely expressed in the mammalian cochlea
The presence of Trpa1 mRNA in the cochlear epithelium has been previously
acknowledged [99, 177], however, those studies lacked the spatial resolution needed to
clearly identify the specific cell types that express the Trpa1 gene.
Because all commercially available antibodies against the TRPA1 protein tested so far
exhibit various degrees of non-specific binding in cochlear explants from Trpa1–/– mice
(personal communication from David Corey, Harvard University and Kelvin Kwan,
Rutgers University), the presence of an active Trpa1 promoter was evaluated using an
indirect method. In Trpa1–/– mice the human PLAP gene (i.e. the reporter gene used to
replace the Trpa1 pore-forming region in the knockout animals [102]) is driven by the
endogenous promoter of the Trpa1 gene. Therefore, we performed immunolabeling
against the human PLAP protein in cochlear explants from wild type and Trpa1–/– mice.
As expected, human PLAP expression was not detected in the cochlear epithelium
from wild type mice (Figure 4.1A top). Instead, human PLAP was expressed throughout
the entire cochlear epithelium from Trpa1–/– mice, including the sensory inner (IHCs) and
outer (OHCs) hair cells and also most types of supporting cells, in particular, Kolliker’s
organ, pillar, Hensen’s and Claudius’ cells (Figure 4.1A bottom). The staining against
human PLAP was particularly high in the row of pillar cells. Moreover, images at a
higher magnification confirmed the bright staining of human PLAP in the pillar cell
region and also in the Deiters’ cells (Figure 4.1B).
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Figure 4.1. TRPA1 is widely expressed in the cochlear epithelium.
A, PLAP immunolabeling (red) and phalloidin counterstaining of actin
filaments (green) in cochlear explants from wild type (top) and Trpa1–/– mice
(bottom). Images courtesy of David Corey and Kelvin Kwan (Harvard
University). B, PLAP immunolabeling (green) and DAPI counterstaining of a
cochlear explant from a Trpa1–/– mouse at a higher magnification than in A.
Left, DIC image at a focal plane by the OHC bundles shown as reference.
Middle, PLAP and DAPI fluorescent signals at a focal plane by the OHC
nuclei. Right, Z-axis maximum intensity projection of PLAP fluorescent
signal within the Deiters’ cell region.
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This approach allowed us to identify the presence of active TRPA1 promoters in most
cell types within the cochlear epithelium; however, it did not provide information about
whether these cells express functional TRPA1 channels or details about their subcellular
localization.
4.2 Sensory and supporting cells within the cochlear epithelium express functional
TRPA1 channels
To assess for the presence of functional TRPA1 channels, we evaluated the uptake of
the small fluorescent cation FM1-43 through open TRPA1 channels after stimulation
with the agonist cinnamaldehyde (CA) [286]. Explants were pre-treated with a BAPTAbuffered Ca2+-free solution to disrupt the tip links within hair cell stereocilia bundles,
thus eliminating the entry of the FM1-43 dye to IHCs and OHCs through the MET
channels that are partially open at rest due to the tip link resting tension. A short (30 s)
incubation with the FM1-43 dye led to small dye uptake in IHCs and all rows of OHCs in
explants from Trpa1–/– (Figure 4.2A) and wild type mice (Figure 4.2B). This small dye
uptake might occur via other non-selective cation channels expressed in hair cells (e.g.
P2X and TRPV1 channels). A similar degree of dye uptake was seen in explants from
Trpa1–/– mice when the incubation with FM1-43 was performed in the presence of 200
µM CA (Figure 4.2C). However, in the presence of CA, the dye uptake in wild type
explants was considerably increased in IHCs and OHCs, and it was also noticeable in
Hensen’s cells and the Kolliker’s organ (Figure 4.2D). These results indicate the presence
of functional TRPA1 channels in wild type IHCs, OHCs, Hensen’s and Kolliker’s organ
cells. Interestingly, no FM1-43 uptake was observed in wild type pillar and Deiters’ cells
in spite of the presence of PLAP labeling in these cells (Figure 4.2D). Since pillar and
Deiter’s cells are localized mostly underneath the hair cells and have limited access to the
apical surface of the organ of Corti, it is possible that their contact with either the FM143 dye or the TRPA1 agonist was limited as well. This could explain the lack of FM1-43
uptake in pillar and Deiters’ cells, even if they do express functional TRPA1 channels.
Alternatively, due to the complex nature of TRPA1 activation and regulation by several
types of agonists and second messengers (e.g., intracellular Ca2+ and downstream of
phospholipase C –PLC– activation) (reviewed in sections 2.3 and 2.5), it is possible that
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pillar and Deiter’s cells do express TRPA1 channels but different experimental
conditions might be required to trigger channel gating. Similarly, most Claudius’ cells
expressed PLAP but very few of them showed uptake of the FM1-43 dye (Figure 4.2D).
However, as stated earlier, the lack of FM1-43 uptake does not necessarily imply that
these cells do not express TRPA1 channels.

Figure 4.2. IHCs, OHCs, Hensen’s and Kolliker’s organ cells express
functional TRPA1 channels
A-D, FM1-43 uptake (green) in cochlear explants from Trpa1–/– (A, C) and
wild type mice (B, D) after a 30 s incubation with the FM1-43 dye alone (A,
B) or in the presence of 200 µM the TRPA1 agonist CA (C, D). Images shown
correspond to maximum intensity projections (z axis) from confocal stacks
taken for each field of view. KoC, Kolliker’s organ; IHC, inner hair cell;
OHC, outer hair cell; HeC, Hensen’s cells; CC, Claudius’ cells.
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Even though CA-induced FM1-43 uptake does reveal the presence of functional
TRPA1 channels, the degree of dye uptake does not necessarily correlate with the amount
of channels expressed. Because FM1-43 is a cation, its influx through open TRPA1
channels is greatly affected by the resting potential of a given cell. Moreover, differences
between cells types in the kinetics of TRPA1 channel gating and inactivation can also
influence the amount of FM1-43 uptake. For example, intracellular Ca2+ levels can
modify the conductance of TRPA1 at the single-channel level (section 2.2.7) [175].
We concluded that, among the supporting cells, functional TRPA1 channels are
present in at least the Hensen’s and Kolliker’s organ cells.
4.3 TRPA1 activation evokes robust and long-lasting Ca2+ responses in Hensen’s
cells
Next, we used cochlear explants loaded with the ratiometric Ca2+ indicator fura-2 to
study the responses of sensory and supporting cells to the puff application of TRPA1
agonists. In cochlear explants from wild type mice, puff application with 200 µM 4hydroxy-nonenal (4-HNE) induced robust Ca2+ responses in the Hensen’s cells (Figures
4.3A and 4.4A). Typically, we observed a ~ 40 s delay (mean = 38.1 ± 2.0 s, n = 184
cells from 7 explants) between the start of the 4-HNE puff application and the beginning
of the robust Ca2+ responses (Figure 4.5A). However, a small Ca2+ increase was often
evident at earlier time points. This somewhat biphasic response would be consistent with
the transition from low to high open probability in TRPA1 channels mediated by the
initial increase in intracellular Ca2+ [175]. The Ca2+ responses in Hensen’s cells induced
by 4-HNE exhibited a very slow decay as well (mean = 0.53 ± 0.05 % s-1, n = 161 cells
from 7 explants). This led to long-lasting Ca2+ responses even after the end of the 4-HNE
puff application (Figures 4.3A and 4.4A).
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Figure 4.3. TRPA1 agonists induce robust and long-lasting Ca2+ responses in
wild type Hensen’s cells
A, B, Time-lapse ratiometric Ca2+ imaging (R = F340/F380) normalized to baseline
(R0) of cochlear explants from wild type (top) and Trpa1–/– mice (bottom)
stimulated by puff application of 200 µM 4-HNE (A) or 100 µM CA (B). To the
left of each series of Ca2+ images, a bright field image is shown as reference to
indicate the types of sensory and supporting cells within the field of view.
Dashed lines indicate boundaries between different cell types. Arrows indicate
the position and direction of puff application. IHC, inner hair cells; OHC, outer
hair cells; HeC, Hensen’s cells; CC, Claudius’ cells.
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Figure 4.4. Intracellular Ca2+ levels from Figure 4.3 without normalization to
the baseline
A, B, Time-lapse ratiometric Ca2+ imaging (F340/F380) of cochlear explants
from wild type (top) and Trpa1–/– mice (bottom) stimulated by puff
application of 200 µM 4-HNE (A) or 100 µM CA (B). To the left of each
series of Ca2+ images, a bright field image is shown as reference to indicate
the types of sensory and supporting cells within the field of view. Dashed
lines indicate boundaries between different cell types. Arrows indicate the
position and direction of puff application. IHC, inner hair cells; OHC, outer
hair cells; HeC, Hensen’s cells; CC, Claudius’ cells.
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Figure 4.5. TRPA1 agonists induce robust Ca2+ responses in Hensen’s cells
from wild type but not Trpa1–/– mice
A, C, Changes in intracellular Ca2+ levels (in nM) in Hensen’s cells from wild
type (black) or Trpa1–/– mice (red) in response to puff application of 4-HNE
(A) or CA (C). The traces were obtained from the same experiments shown in
Figures 4.3 and 4.4, and the lines in the x-axis indicate the time points for each
of the panels shown in those figures. B, D, Peak Ca2+ responses (Rmax) relative
to baseline levels (R0) were evaluated in time windows (95 s) before
(baseline), during and immediately after (puff) and about 5 min after
(washout) agonist stimulation. Bars show mean ± SEM values. The number of
cells/explants included is shown above each bar. (*) indicates a P value < 0.05
determined by a Student’s t-test.
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Similar robust Ca2+ responses (i.e. delayed and long-lasting) were elicited by other
TRPA1 agonists such as CA (100 µM) (Figures 4.3B, 4.4B and 4.5C) and mustard oil
(allyl isothiocyanate –AITC–, 100 µM) (Figure 4.6) in wild type Hensen’s cells. As
expected, the same puff application with 4-HNE and CA failed to induce Ca2+ responses
in cochlear explants from Trpa1–/– mice (Figures 4.3, 4.4 and 4.5).
All three TRPA1 agonists tested also failed to induce Ca2+ responses in the supporting
Claudius’s cells (Figures 4.3, 4.4 and 4.6). These results are consistent with the lack of
FM1-43 uptake in Claudius’s cells after stimulation with CA (Figure 4.2).

Figure 4.6. Mustard oil induces Ca2+ responses in Hensen’s cells with similar
kinetics to 4-HNE and CA
A, Time-lapse Ca2+ imaging (R/R0) of a wild type cochlear epithelium showing
the response to 100 µM mustard oil (AITC) puff application. A bright field
image (left) is shown as reference and the yellow arrow indicates the position
and direction of puff application. Dashed lines indicate boundaries between
different cell types. IHC, inner hair cells; OHC, outer hair cells; HeC, Hensen’s
cells; CC, Claudius’ cells. B, Changes in intracellular Ca2+ (R/R0) in one of the
Hensen’s cells shown in A. Arrows below the x-axis indicate the time points
when the panels shown in A were taken.
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To our surprise, puff application with either 4-HNE, CA or AITC did not induce
prominent Ca2+ responses in the sensory IHCs and OHCs (Figures 4.3, 4.4 and 4.6).
These results did not correlate with our findings of FM1-43 uptake in IHCs and OHCs
after stimulation with CA (Figure 4.2). We wondered whether this discrepancy could
arise from the different CA concentrations and delivery methods used. The FM1-43
experiments were performed with a CA concentration (200 µM) that was double of that
used for the Ca2+ imaging (100 µM). However, puff application with a higher
concentration of 4-HNE (400 µM, double of what was used previously) also failed to
induce Ca2+ responses in IHCs and OHCs (Figure 4.7).

Figure 4.7. Sensory hair cells fail to show Ca2+ responses even after stimulation
with a high concentration of a TRPA1 agonist
A, B, Time-lapse Ca2+ imaging (R/R0) of cochlear epitheliums from wild type
(A) and Trpa1–/– mice (B) showing the response to 400 µM 4-HNE puff
application. A bright field image (left) is shown as reference and the arrows
indicate the position and direction of the puff application. Notice that the puff
was applied for a longer time on the Trpa1–/– explant. Dashed lines indicate
boundaries between different cell types. OHC, outer hair cells; HeC, Hensen’s
cells; CC, Claudius’ cells.
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For the FM1-43 experiments, cells were stimulated by CA present in the bath solution
while, during the Ca2+ imaging experiments, CA stimulation was performed using a puff
pipette. CA present in the bath solution certainly stimulates a larger number of cells
because it covers the entire tissue. However, the exposure to the CA-containing bath was
limited to 30 s, which is a much shorter stimulation duration than the one used with the
puff application (~ 60 s). We previously confirmed the presence of functional TRPA1
channels in sensory IHC and OHCs, and suggested that channel expression was limited to
the basolateral membrane in these cells [286]. Here, we believe the discrepancy between
the FM1-43 and Ca2+ imaging experiments mainly arises from the exposure to BAPTA in
the former. The exposure to a BAPTA-buffered Ca2+-free solution is likely to
compromise the tight junction barrier of the reticular lamina (i.e. the barrier formed by
the connection between all cells of the cochlear epithelium at their apical side) [293,
294]. A compromised tight junction barrier might allow CA to activate TRPA1 channels
in the basolateral membrane of IHCs and OHCs during the FM1-43 experiments. In
contrast, the tight junction barrier is intact during our Ca2+ imaging experiments, thus
limiting the access of CA to the basolateral membranes.
Because particularly long-lasting Ca2+ responses to TRPA1 activation were observed
in Hensen’s cells but not anywhere else within the cochlear epithelium, we believe
Hensen’s cells could be the major sensors for oxidative damage (i.e. 4-HNE) in the
cochlea. Therefore, we also wondered whether the absence of TRPA1 channels would
alter the resting intracellular Ca2+ levels in Trpa1–/– Hensen’s cells. However, we found
no differences in the baseline intracellular Ca2+ between Hensen’s cells from wild type
and Trpa1–/– mice (Figure 4.8).
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Figure 4.8. Hensen’s cells from wild type and TRPA1-deficient mice exhibit
similar resting intracellular Ca2+ levels
Intracellular Ca2+ levels (in nM) of Hensen’s cells from wild type (black) and
Trpa1–/– mice (red) were estimated from ratiometric Ca2+ imaging with the
fura-2 dye. Bars show mean ± SEM values. The number of cells/regions
included in the analysis is shown for each bar. A P value > 0.86 was
determined using a Student’s t-test.
4.4 Responses to TRPA1 agonists in the Hensen’s cells are modulated by the levels
of intracellular Ca2+ levels
The robust long-lasting responses to TRPA1 agonists in Hensen’s cells did not lead to
cell death. In fact, the intracellular Ca2+ levels in Hensen’s cells slowly decreased to
baseline-like levels (Figure 4.9A). Moreover, upon subsequent stimulations with the
same TRPA1 agonist, Hensen’s cells were able to once again exhibit similar long-lasting
Ca2+ responses. However, the peak responses were considerably different between
consecutive puff stimulations. We also noticed that, after TRPA1 agonist stimulation, the
intracellular Ca2+ in the Hensen’s cells recovered to a level that was slightly higher than
the pre-stimulation level.
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Figure 4.9. Intracellular Ca2+ modulates responses to TRPA1 agonists
A, Representative traces of the intracellular Ca2+ levels (R/R0) of three
Hensen’s cells subjected to two consecutive puff stimulations with 100 µM
CA. The breaks in the Ca2+ traces correspond to time points where imaging
was paused to minimize cytotoxicity due to UV overexposure. B, Histogram
showing the percentages of cells that responded to 400 M 4-HNE based on
their intracellular Ca2+ level (in nM) at the time of puff stimulation (baseline).
A responding cell was defined to have more than a 1.5 fold increase in
intracellular Ca2+ after 4-HNE stimulation. Inset, Representative traces of
changes in intracellular Ca2+ levels from some of the cells included in the
histogram. All traces shown in the inset are from cells analyzed within the
same field of view but over several puff applications.
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We hypothesized that the differences in magnitude of the responses to TRPA1 agonist
stimulation dependent on the levels of intracellular Ca2+ at the time of the puff
application. To test this, the number of Hensen’s cells that responded to the stimulation
with 400 µM 4-HNE was compared to their intracellular Ca2+ level at the moment of the
puff application. To determine the ‘responding’ cells, we chose an arbitrary threshold
level assuming that a cell was responding if we observed at least a 1.5 fold increase in
intracellular Ca2+ upon stimulation with 4-HNE. Our results showed that the majority of
responding cells exhibited intermediate levels of intracellular Ca2+ (~130 to 220 nM).
However, cells with low (~100 nM) or high (> 250 nM) intracellular Ca2+ levels often
failed to mount robust Ca2+ responses to the application of the TRPA1 agonist (Figure
4.9B). It is noteworthy to highlight that the lack of responses in cells that had high
intracellular Ca2+ baseline levels was not due to dye saturation (Figure 4.9B inset). These
results further support the notion that TRPA1 channel activity is modified by intracellular
Ca2+ [175, 194, 235]. While an increase in intracellular Ca2+ can initially potentiate the
responses of TRPA1 to other agonists, higher Ca2+ levels seem to inactivate the channel.
4.5 Cells of the Kolliker’s organ exhibit oscillating Ca2+ responses after TRPA1
agonist stimulation
In contrast to the delayed and long-lasting responses to TRPA1 agonists exhibited by
Hensen’s cells, 4-HNE puff stimulation led to fast and short-lived Ca2+ waves in the
Kolliker’s organ (Figure 4.10). These differences in the kinetics of TRPA1-induced Ca2+
responses might arise from the differences in Ca2+ handling properties between cell types.
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Figure 4.10. 4-HNE induces fast and short-lived Ca2+ responses in the cells of
the Kolliker’s organ
A, Time-lapse Ca2+ imaging (R/R0) of the Kolliker’s organ from a wild type
mouse during puff stimulation with 200 µM 4-HNE. A bright field image (left)
is shown as reference and the yellow arrow indicates the position and direction
of puff application. Dashed lines indicate boundaries between different cell
types. KoC, Kolliker’s organ cells; IHC, inner hair cells. B, Traces showing
the changes in intracellular Ca2+ in response to 4-HNE in 15 Kolliker’s organ
cells from the region shown in A.
We also observed striking differences between the Ca2+ responses in supporting cells
evoked by activation of TRPA1 channels and ATP receptors. In contrast to TRPA1
channels, puff application of low doses of ATP (e.g. 2 µM) induced oscillating and
relatively short-lived Ca2+ responses in Kolliker’s organ, Hensen’s and Claudius’ cells
(Figure 4.11A). The oscillating nature of these Ca2+ waves is presumed to involve the (i)
activation/inactivation cycles of the G protein-coupled P2Y receptors, (ii) IP3-induced
release of Ca2+ from intracellular stores and (iii) feedback inhibition of Ca2+ on IP3
receptors (Figure 4.11C) [295].
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Figure 4.11. Oscillating and sustained Ca2+ responses in cochlear supporting
cells might reflect different Ca2+ handling properties
A, Representative Ca2+ traces showing the changes in intracellular Ca2+ (R/R0)
in Kolliker’s organ (left), Hensen’s (middle) and Claudius’ cells (right) after
stimulation with increasing concentrations of ATP (2, 20 and 250 µM). B,
Intracellular Ca2+ traces (R/R0) of Hensen’s cells after stimulation with
increasing concentrations of 4-HNE (200 and 400 µM). C, Diagrams showing
the signaling pathways involved after activation of TRPA1, P2Y or P2X
receptors/channels.
On the other hand, stimulation with high doses of ATP (e.g. 250 µM) activates P2X
ionotropic channels as well (Figure 4.11C). The large influx of Ca2+ through P2X
channels might overwhelm Ca2+ buffers in the cell and lead to a sustained increase in
intracellular Ca2+ instead of the oscillating behavior. While puff stimulation with 250 µM
ATP led to sustained Ca2+ responses in Kolliker’s organ and Hensen’s cells, Claudius’
cells continued to exhibit oscillating Ca2+ responses (Figure 4.11A). Because all of these
cochlear supporting cells seem to express functional P2X channels (reviewed in [62]), the
different Ca2+ responses to the same concentration of ATP are likely to arise from unique
Ca2+ handling properties within each cell type. However, we cannot rule out the
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possibility that differences in the expression levels and subunits of P2X and P2Y
receptors underlie these results.
Interestingly, puff stimulation with a high concentration of ATP did not lead to longlasting Ca2+ responses in the Hensen’s cells like the ones observed after stimulation with
TRPA1 agonists (compare the middle panel in Figure 4.11A with 4.11B). This result
indicates that Hensen’s cells are able to clear a large increase in intracellular Ca2+
quickly. Therefore, the long-lasting Ca2+ responses elicited by the TRPA1 agonists might
indicate that the channel itself gets temporarily locked into an open configuration (Figure
4.11C). In fact, the three TRPA1 agonists tested (4-HNE, CA and AITC) are reactive
agonists that can covalently bind to TRPA1 subunits to trigger channel gating [201, 202,
210]. Differences in the redox state between Hensen’s and Kolliker’s organ cells (e.g.,
expression and availability of antioxidants) could also explain the different Ca2+
responses observed upon stimulation with TRPA1 agonists.
4.6 TRPA1-dependent Ca2+ responses in the Hensen’s cell can propagate to the
Kolliker’s organ
When applying multiple puff stimulations with TRPA1 agonists within a specific
Hensen’s cell region, we often observed the development of Ca2+ waves in the cells of the
Kolliker’s organ (Figure 4.12A). The Kolliker’s organ can spontaneously trigger Ca2+
waves during the early postnatal development (section 1.7.1), however, the Ca2+ waves
that we noticed in the Kolliker’s organ seemed to coincide with the time of puff
application in the Hensen’s cell region (Figure 4.12B).
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Figure 4.12. Puff stimulation with TRPA1 agonists at the Hensen’s cell region
also triggers Ca2+ waves in the Kolliker’s organ
A, Time lapse ratiometric Ca2+ imaging (R/R0) of a cochlear epithelium after
puff stimulation with 400 µM at the Hensen’s cell region. A bright field image
(top) is shown as reference and the yellow arrow indicates the position and
direction of puff application. Dashed lines indicate boundaries between different
cell types. KoC, Kolliker’s organ cells; IHC, inner hair cells; OHC, outer hair
cells; HeC, Hensen’s cells. B, Representative Ca2+ traces from two Hensen’s
(shades of green) and Kolliker’s organ cells (shades of red) from the experiment
shown in A. Breaks in the traces represent time point where imaging was paused
to minimize cytotoxicity due to UV overexposure. The numbers in the x axis
indicate the time points where the frames in panel A where taken.
89

To test whether these ‘secondary’ Ca2+ waves were the result of TRPA1 agonist
diffusion, we performed a similar experiment in cochlear explants dissected on very early
postnatal days (P1-P2). At this developmental age, the cells of the Kolliker’s organ did
not respond to direct puff stimulation with TRPA1 agonists (Figure 4.13A bottom and
data not shown). However, puff stimulation with 4-HNE at the Hensen’s cell region of
the same explant (and field of view) was indeed able to trigger Ca2+ waves in the
Kolliker’s organ (Figure 4.13A top).

Figure 4.13. TRPA1-dependent activation of Hensen’s cells propagates to the
Kolliker’s organ and triggers Ca2+ waves that require extracellular ATP
A, B, Time-lapse ratiometric Ca2+ imaging of cochlear explants dissected on
postnatal days 1 or 2. The imaging was performed in the absence (A) or presence
(B) of the P2X and P2Y antagonist PPADS (50 µM). Stimulation with 400 µM
4-HNE was delivered via puff pipettes (yellow arrows) at the Hensen’s cell
region (A top and B) or at the Kolliker’s organ (A bottom). Dashed lines indicate
boundaries between different cell types. KoC, Kolliker’s organ cells; IHC, inner
hair cells; OHC, outer hair cells; HeC, Hensen’s cells.
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The Ca2+ responses that propagated to the Kolliker’s organ –after puff stimulation
with TRPA1 agonists at the Hensen’s cell region– were able to travel from cell to cell at a
much faster speed (e.g., 0.3 µm/s in the Hensen’s cells vs. 8 µm/s in the Kolliker’s
organ). In addition, the Ca2+ waves in the Kolliker’s organ exhibited rising speeds and
clearance rates that were higher than for the Ca2+ responses in the Hensen’s cells (as an
example, compare the traces in Figure 4.12B). The kinetics of the ‘secondary’ Ca2+
waves observed in the Kolliker’s organ resembled those of the spontaneous Ca2+ waves
that these cells exhibit during early postnatal days (section 1.7.1). The mechanism of
propagation of the spontaneous Ca2+ waves has been previously elucidated and, among
other signaling molecules, it involves the release of ATP to the extracellular space and
the activation of P2Y receptors on neighboring cells (Figure 1.10) [34, 70]. Therefore, we
wondered whether extracellular ATP was also involved in these ‘secondary’ Ca2+ waves.
In the presence of 50 µM PPADS –a P2X and P2Y antagonist– the puff stimulation with
4-HNE in the Hensen’s cell region generated Ca2+ responses that were still able to
propagate toward the medial cochlear side. However, in the presence of the purinergic
receptor blocker, the Ca2+ waves were limited to the rows of supporting cells immediately
adjacent to the IHCs, presumably the inner border cells (Figure 4.13B). These results
suggest that activation of TRPA1 channels in the Hensen’s cells is able to trigger the
already known ATP-dependent and self-propagating Ca2+ waves.
Interestingly, the TRPA1-induced Ca2+ responses in the Hensen’s cells never
propagated toward the lateral side of the cochlea (i.e., toward the Claudius’ cells and the
spiral prominence). Moreover, the propagation of these Ca2+ responses toward the medial
side of the cochlea did not involve the sensory hair cells given that we never observed
changes in the intracellular Ca2+ of IHCs or OHCs. As previously described [65], we did
observe that, after these ATP-dependent Ca2+ waves were generated in the Kolliker’s
organ, some of them were able to induce an increase in intracellular Ca2+ in the IHCs
(e.g., compare panels 5 and 6 in Figure 4.12A). Because all supporting cells are
electrochemically coupled via gap junctions, it is possible that the TRPA1-induced Ca2+
responses in the Hensen’s cells propagate to the Kolliker’s organ via Deiters’ and pillar
cells. Sadly, we were not able to test this hypothesis using Ca2+ imaging because the fura2 dye failed to load such cells (Figure 4.14).
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Figure 4.14. The ratiometric fura-2 Ca2+ indicator fails to load pillar and
Deiters’ cells
A, Representative images of the fura-2 fluoresce with 340 (F340) and 380 nm
(F380) illuminations showing one row of IHCs, three rows of OHCs and one row
of Hensen’s cells. The corresponding bright field image at the same focal plane
is shown as reference (left). Dashed lines indicate the boundaries between cell
types. B, Orthogonal view of the same tissue shown in A from stacks of images
taken every 1 µm. Notice that the fluorescent images were not taken in a
confocal mode and, therefore, there is plenty of out-of-focus light above and
below the hair cells. IHC, inner hair cells; PC, pillar cells; OHC, outer hair cells;
HeC, Hensen’s cells.

92

4.7 In the presence of a gap junction blocker Claudius’ cells exhibit TRPA1mediated Ca2+ responses
Because TRPA1-dependent Ca2+ responses in the Hensen’s cells might be able to
propagate across the cochlear epithelium via the gap juntional conductance between
supporting cells, we decided to evaluate the responses to TRPA1 agonists in the presence
of a known gap junction blocker, FFA.
FFA behaves as an agonist of rat and human TRPA1 (see section 2.3.6) but it is
unknown whether it can activate mouse TRPA1 channels as well. First, we tested
whether the presence of FFA in the bath solution could alter the levels of intracellular
Ca2+ in the Hensen’s cells, but found no differences between FFA-treated and control
cells (Figure 4.15).

Figure 4.15. Presence of FFA in the bath solution does not change the resting
Ca2+ level in Hensen’s cells
Resting intracellular Ca2+ levels (in nM) of Hensen’s in the presence (grey) or
absence (black) of the gap junction blocker FFA (100 µM) in the bath
solution. Intracellular Ca2+ levels were determined from ratiometric Ca2+
images of cells loaded with the fura-2 dye. Ca2+ levels from cells that were
monitored for up to 50 min after adding FFA are included in the graph. Mean
± SEM values are shown. The number of cells/regions included in the analysis
is shown for each bar. A P value > 0.4 was determined using a Student’s ttest.
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Next, we evaluated the Ca2+ responses to the application of 200 µM 4-HNE before and
after the addition of the gap junction blocker FFA to the bath solution. As shown
previously, in the absence of FFA the stimulation with 4-HNE led to delayed, robust and
long-lasting Ca2+ responses in the Hensen’s cells but no responses were observed in the
Claudius’ cells (Figures 4.16A and 4.16B). To our surprise, in the presence of FFA
Claudius’ cells were now able to respond to the puff stimulation with the TRPA1 agonist
(Figures 4.16C to 4.16F). The 4-HNE-induced Ca2+ responses in Claudius’ cells were
more robust after a 30 min exposure to FFA than they were after only 10 min with the
blocker (compare Figures 4.16C and 4.16E). Moreover, in the presence of FFA, the delay
in the Ca2+ responses –relative to the beginning of the puff application– decreased with
time for both Hensen’s and Claudius’ cells (Figures 4.16B, 4.16D and 4.16F).
Two alternative scenarios could explain the TRPA1-mediated responses in Claudius’
cells that are only seen after the incubation with FFA. First, FFA might be acting as an
agonist for mouse TRPA1. In this case, a concentration of 100 µM FFA may have been
too low to elicit changes in intracellular Ca2+ (Figure 4.15) but, FFA together with 200
µM 4-HNE could have exerted a synergistic effect on the TRPA1 channels present in
Claudius’s cells. FFA and 4-HNE activate TRPA1 channels through different
mechanisms. While 4-HNE is a reactive agonist that binds intracellular cysteine residues
in TRPA1, FFA is a non-reactive agonist that might activate TRPA1 after interacting
with, perhaps, a pocket-like domain. Interestingly, FFA is known to have a synergistic
action when applied together with CA –another reactive agonist that activates TRPA1 in
a manner similar to 4-HNE [201]. Of note, high concentrations (400 µM) of 4-HNE alone
failed to induce Ca2+ responses in Claudius’ cells (Figure 4.13 and data not shown).
Therefore, a synergistic effect between FFA and 4-HNE seems a more likely explanation
than a simple additive effect of both agonists.
If FFA does not behave as an agonist for mouse TRPA1, an alternative explanation
would involve FFA-induced changes in the intracellular environment that could favor
TRPA1 gating. It is plausible that blocking the electrochemical connection between
different types of supporting cells might lead to changes in resting potentials and/or
intracellular redox states which can potentiallyalter TRPA1 channel activation kinetics.
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Because the presence of the gap junction blocker changed the responses of the cells to
TRPA1 activation, we were not able to test whether the gap junctional conductance is
require for the propagation of TRPA1-induced Ca2+ waves from the Hensen’s cells to the
Kolliker’s organ.

Figure 4.16. In the presence of FFA, 4-HNE induces Ca2+ responses in
Claudius’ cells
A, C, E, Time-lapse ratiometric Ca2+ imaging (R/R0) showing the responses to
4-HNE (200 µM) in cochlear explants before (A) and 10 min (B) and 30 min
(C) after adding the gap junction blocker FFA (100 µM) to the bath solution.
A bright field image (left) is shown as reference and the yellow arrow
indicates the position and direction of puff application. Dashed lines indicate
boundaries between different cell types. IHC, inner hair cells; OHC, outer hair
cells; HeC, Hensen’s cells; CC, Claudius’ cells. B, D, E, Traces indicating the
changes in intracellular Ca2+(R/R0) in two Hensen’s cells (shades of green)
and two Claudius’ cells (shades of purple) from the data shown in panels A, C
and E.
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4.8 Deiters’ cells express functional TRPA1 channels
Given that the membrane-permeable fura-2 dye failed to load pillar and Deiter’s cells
(Figure 4.14), we decided to perform patch clamp recordings to test whether these cells
express functional TRPA1 channels or not. Changes in whole-cell currents after the puff
application of 100 µM CA were monitored. However, in order to measure the currents in
individual cells, the gap junction blocker FFA was added to the bath solution. As shown
previously, the presence of FFA did not seem to change resting intracellular Ca2+ levels
or inhibit the responses to TRPA1 agonists in Hensen’s cells (Figures 4.15 and 4.16).
Therefore we were confident that, even if FFA behaves as an agonist for mouse TRPA1
channels, we should still be able to see TRPA1 currents after the stimulation with CA. In
fact, FFA and CA have a synergistic effect in rat TRPA1 channels [208].
As expected, puff stimulation with CA induced large inward currents in Hensen’s cells
from wild type but not from Trpa1–/– mice (Figures 4.17A and 4.17D). The currentvoltage (I-V) relationship of the CA-induced responses in Hensen’s cells exhibited
prominent rectification at negative potentials and, presumably, channel inactivation at
positive potentials. This I-V relationship differs from the typical behavior of TRPA1
channels in heterologous expression systems (see Appendix D for a typical I-V
relationship obtained in HEK-293 cells transfected with a mouse TRPA1 construct).
Although the behavior of TRPA1 can differ between transfected and native channels
[245, 267, 268, 296], we wondered whether FFA could be modifying the I-V relationship
of TRPA1 currents in Hensen’s cells. To test this, we evaluated the CA-mediated currents
in the presence of a different gap junction blocker. We performed whole-cell patch clamp
recordings of Hensen’s cells in the presence of 1 mM octanol in the bath solution.
Octanol was chosen because this gap junction blocker does not seem to be an agonist for
mouse TRPA1 channels [205]. However, the I-V relationships obtained in the presence of
octanol were indistinguishable from the ones obtained in the presence of FFA (compare
Figures 4.17A and 4.18).
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Figure 4.17. TRPA1-mediated inward currents in Hensen’s and Deiters’s cells
A-C, Representative current-voltage (I-V) relationships for CA-induced currents
(IPuff – IBaseline) in Hensen’s (A), Deiters’ (B) and pillar cells (C) from wild type
(black) and Trpa1–/– mice (red). Insets, Representative inward currents elicited
by the puff application of 100 µM CA. D, Average peak inward currents
triggered by the puff application of CA and measured at a holding potential of 86 mV. Bars show mean ± SEM values. The number of cell included in the
analysis is shown for each bar. (*) indicates a P value < 0.05 determined by a ttest for samples with unequal variance.
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Figure 4.18. Current-voltage relationship of TRPA1 activation in the presence
of a different gap junction blocker
Current-voltage relationship of a wild type Hensen’s cell during the puff
stimulation with CA (IPuff – IBaseline) (green) and 5 min after washout (IWashout –
IBaseline) (black). Recordings were performed in the presence of 1 mM octanol.
We also observed CA-mediated current responses in wild type Deiters’ cells and they
had I-V relationships similar to the ones seen in Hensen’s cells (Figure 4.17B). These
results indicate that Deiter’s cells express functional TRPA1 channels as well. However,
the magnitude of the TRPA1 responses (i.e. peak currents) appeared to be smaller in
Deiters’ than in Hensen’s cells (Figure 4.17D).
When similar recordings were performed in pillar cells, we were not able to observe
changes in whole-cell currents elicited by the puff application of CA (Figures 4.17C and
4.17D). These results were unexpected given the bright PLAP staining exhibited by pillar
cells (Figure 4.1). However, as it was the case for Claudius’ cells, it is possible that the
experimental conditions used here (e.g., Ca2+ levels in the intracellular solution, type and
concentration of the agonist used, whole-cell instead of perforated patch) were not ideal
to allow TRPA1 channel gating.
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4.9 TRPA1 stimulation induces tissue movement that seems to originate at pillar
and Deiter’s cells
Bright field imaging performed during puff stimulation with 200 µM 4-HNE indicated
the presence of slow, yet prominent, tissue movements within the cochlear epithelium
(Figure 4.19A). These 4-HNE-induced tissue displacements were often delayed relative
to the beginning of the puff stimulation (Figure 4.19B), a feature similar to the delay in
the TRPA1-induced Ca2+ responses seen in Hensen’s cells. Interestingly, puff stimulation
with 4-HNE induced prominent tissue movement in cochlear explants from wild type but
not from Trpa1–/– mice (Figures 4.19C and 4.19D).
The TRPA1-induced tissue displacements were large and caused changes in the field
of view and/or focal plane during imaging. However, when bright field imaging was
performed near the pillar cell feet, prominent cell contractions were observed specifically
in outer pillar cells (Figure 4.20B) and, sometimes, in Deiters’ cells as well (Figure
4.20C).
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Figure 4.19. TRPA1 activation induces prominent tissue movement
A, Changes in time-lapse bright field (top) and Ca2+ imaging (R/R0) (bottom) of
a wild type cochlear explant during puff stimulation with 200 µM 4-HNE. The
top panel shows subtracted frames from images taken 10 s apart to enhance the
areas were tissue movement was observed. A non-subtracted bright field image
(left) is shown as reference. The yellow arrow indicates the position and
direction of puff application. Dashed lines indicate the boundaries between
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different cell types. OHC, outer hair cells; HeC, Hensen’s cells; CC, Claudius’
cells. B, top, Trace showing the changes in the standard deviation (SD) of pixel
values from the subtracted bright field (BF) images shown in A. B, bottom,
Trace showing the intracellular Ca2+ levels (R/R0) of one of the Hensen’s cells
from panel A. Arrows indicate the time points where the panels in A were taken.
C, SD changes in subtracted BF images from wild type (top) and Trpa1–/–
explants (bottom) stimulated with 200 µM 4-HNE. Individual traces (grey) were
normalized to the same height. For drawing purposes, the average traces for
explants from wild type (black) and Trpa1–/– mice (red) were normalized to
comparable baseline levels (i.e. the region of each trace before the puff
application). D, Bar graph showing the fold changes in area-under-the-curve
(AUC) values obtained from the traces shown in C and comparing time points
before and during/after the puff stimulation with 4-HNE (AUCPuff/AUCBaseline).
A value of 1 (dashed line) indicates that the TRPA1 stimulation did not induce
tissue movement. Bars show mean ± SEM values. The number of
regions/explants included in the analysis is shown for each bar. (*) indicates a P
value < 0.05 determined by a Student’s t-test.
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Figure 4.20. Tissue displacements seem to originate by the contractions of
pillar and Deiters’ cells
A, Bright field image showing the axis (yellow double-headed arrows) used to
measure cell diameter changes in OHCs and OPCs. Hensen’s cells were
removed so the puff application could reach areas underneath the tight
junction barrier. Dashed lines show the boundaries between cell types. The
yellow single-headed arrow indicates the position and direction of puff
application. B, Changes in cell diameter after puff stimulation with 200 µM 4HNE in an OPC (black) and an OHC (grey) from the wild type explant shown
in A. For comparison, the diameter measurements of an OPC from a Trpa1–/–
explant (red) are shown as well. C, Changes in cell diameter after puff
stimulation with 200 µM 4-HNE in OPCs (black and red) and DCs (grey and
pink) from wild type (black and grey) and Trpa1–/– (red and pink) mice. Cell
diameters were measured using the same axis shown in A. KoC, Kolliker’s
organ cells; IPC, inner pillar cells; OPC, outer pillar cells; OHC, outer hair
cells.
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In section 4.6, we showed that TRPA1 activation in Hensen’s cells is able to trigger
Ca2+ waves that depend on the release of ATP to the extracellular space. Since ATP itself
can lead to changes in the shape of the Kolliker’s organ cells [65, 66], we wondered
whether ATP could trigger shape changes in pillar cells as well. In fact, puff stimulation
with 2 µM ATP induced changes in the cell diameter of pillar cells that were similar to
the ones observed after TRPA1 stimulation (Figure 4.21). Interestingly, ATP puff
stimulation was sometimes able to induce changes in the shape of OHCs (Figure 4.21).
These ATP-induced changes in OHCs were observed in cochlear explants at about
postnatal day 6, a developmental age when the functional expression of prestin –the OHC
motor– could be starting. Therefore, we believe that ATP stimulation is depolarizing
OHCs via the activation of P2X channels and triggering prestin-indued cell shape
changes. Therefore, the tissue movements observed after ATP puff stimulation were far
more complex that the TRPA1-induced tissue displacements.

Figure 4.21. ATP puff stimulation induces pillar cell contraction
A, Bright field image showing the OHC and PC (yellow arrows) used to
measure cell diameter changes. Hensen’s cells were removed so the puff
application could reach areas underneath the tight junction barrier. Dashed
lines show the boundaries between cell types. The puff pipette was located at
the edge of the field of view as indicated by the black arrow. PC, pillar cell;
OHC, outer hair cell. B, Changes in cell diameter after puff stimulation with 2
µM ATP in an outer PC (black) and OHC (grey) from the wild type explant
shown in A. KoC, Kolliker’s organ cells; PC, pillar cells; OHC, outer hair
cells.
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4.10 Cochlear pillar cells posses Ca2+-dependent contractile machinery
The phalangeal processes of Deiter’s cells are known to exhibit mechanical responses
after the stimulation with ATP or after Ca2+ uncaging [56, 57]. However, it is unknown
whether pillar cells can exhibit similar Ca2+-dependent active mechanical responses.
Activation of ATP receptors or TRPA1 channels can both lead to an increase in
intracellular Ca2+. Therefore, we decided to test whether an increase of the cytosolic Ca2+
concentration was sufficient to trigger changes in the shape of pillar cells. We used the
photo-labile Ca2+ chelator o-nitrophenyl ethylene glycol tetraacetic acid (NP-EGTA) to
deliver ‘caged Ca2+’ to outer pillar cells using a whole-cell patch clamp configuration
(Figure 4.22A). Stimulation with a UV laser produced an immediate increase of
intracellular Ca2+ (Figure 4.22B) that was followed by a slow cell contraction (Figure
4.22C). These changes in intracellular Ca2+ and cell diameter were not observed in
control outer pillar cells were the photo-labile Ca2+ chelator had been replaced with
regular EGTA (Figures 4.22D and 4.22E).
Cell currents were also monitored during the experiment and only cells that did not
exhibit changes in the holding current were considered for the quantification of cell
diameters. Changes in the holding currents after the UV stimulation were similar (P >
0.56) between cells containing caged Ca2+ (ΔIm = -4.29 ± 2.8 pA) and control cells (ΔIm
= -3.23 ± 0.9 pA). Therefore, the Ca2+-induced shape changes in pillar cells are unlikely
to be driven by the potential osmotic responses associated with Ca2+-dependent ion
conductances.
In addition to the mechanical responses driven by Deiters’ cells, here we show that
active changes in the shape of pillar cells could also underlie the tissue movements
observed in the cochlear epithelium after TRPA1 stimulation. We believe this is the first
report showing that cochlear pillar cells possess Ca2+-dependent contractile machinery.
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Figure 4.22. Outer pillar cells exhibit cell contractions after an increase in
intracellular Ca2+
A, Bright field image illustrating the experimental approach used to deliver the
caged Ca2+ to individual outer pillar cells via whole-cell patch clamping. The
caged compound (1 mM, NP-EGTA) was present in the intracellular solution
(which contained 0.7 mM CaCl2). PC, pillar cells; OHC, outer hair cells. B,
Representative change in intracellular Ca2+ evaluated through the fluorescent
dye fluo-4 present in the intracellular solution (50 µM). Images were obtained
before (1) and after (2) stimulation with the UV laser. a.u., arbitrary units. C,
Representative traces showing the changes in intracellular Ca2+ (top), wholecell currents (middle) and cell diameter (bottom) of a cell loaded with the caged
compound (black) or with regular EGTA (grey). The dashed line represents the
time where UV stimulation occurred. D, E, Average peak increase in
intracellular Ca2+ (Fmax/F0) (D) and decrease in cell diameter (E) of cells loaded
with caged Ca2+ (filled bars) or control EGTA (open bars). Bars show mean ±
SEM values. The number of cells included for both analyses are shown in panel
E. (*) indicates a P value < 0.05 determined by a Student’s t-test.
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4.11 TRPA1 contributes to a long-lasting inhibition of cochlear amplification after
noise exposure
We hypothesized that the activation of cochlear TRPA1 channels in vivo may occur
after the oxidative damage following acoustic trauma. This activation would induce
changes in the pillar cell shape and modify the geometry of the cochlear epithelium and
alter hearing sensitivity. Therefore, we decided to test hearing thresholds and cochlear
amplification after exposing young adult (3-4 weeks old) wild type and Trpa1–/– mice to
noise.
First, we confirmed that, in agreement with published literature [101, 102], Trpa1–/–
mice and their wild type littermates exhibit identical hearing thresholds before noise
exposure (Figure 4.23).

Figure 4.23. Trpa1–/– mice exhibit normal hearing thresholds
Hearing thresholds were determined in wild type (black) and Trpa1–/– mice (red)
by evaluating the auditory brainstem responses (ABR) to tone stimulations at 8,
16, 24 and 32 kHz. Mean ± SEM values are plotted. A P value > 0.6 was
determined using a two-way ANOVA.
Next, we exposed the mice to a broadband noise at 100 dB for 30 min. Immediately
after the noise exposure, hearing thresholds were significantly higher in Trpa1–/– mice
(Figure 4.24A). However, five days after the noise exposure, wild type mice were the
ones exhibiting significantly higher hearing thresholds (Figure 4.24A).
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Figure 4.24. TRPA1 channels mediate a long-lasting inhibition of hearing
thresholds after noise exposure
A, Hearing threshold shifts (i.e. relative to thresholds before noise exposure)
measured via auditory brainstem responses (ABR). B, OHC function
essesntial for cochlear amplification was measured with distortion product
otoacoustic emissions (DPOAE) at 16 kHz. Wild type (black) and Trpa1–/–
mice (red) were evaluated immediately after (dash-dot lines) and/or 5 days
after (dashed lines) noise exposure. Mean ± SEM values are plotted. (**)
indicates a P value < 0.01 determined using a two-way ANOVA, and (*) P <
0.05 determined after Bonferroni corrections.
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The changes in the hearing thresholds after noise exposure indicated that, in spite of
initially exhibiting a greater hearing loss, Trpa1–/– mice are able to recover hearing
thresholds a faster rate than wild type mice (Figure 4.25). The hearing thresholds in
mammals crucially depend on the cochlear amplification provided by the OHC
electromotility. Thus, we wondered whether the differences in the recovery of hearing
thresholds between wild type and Trpa1–/– mice resulted from the modulation of the
electromechanical feedback of OHCs that can be assessed by measuring distortion
product otoacoustic emissions (DPOAE). We found that 5 days after noise exposure the
DPOAE was significantly lower in wild type mice (Figure 4.24B). These results suggest
that, after noise exposure, TRPA1 channels maintain hearing thresholds elevated by
delaying the recovery of the cochlear amplifier.

Figure 4.25 Faster recovery of ABR hearing thresholds in Trpa1–/– mice
Degree of recovery of auditory brainstem responses (ABR) in 5 days for wild
type (black) and Trpa1–/– mice (red). Data were calculated as the difference
between hearing thresholds immediately after noise exposure minus the
hearing thresholds 5 days later. The same data shown in Figure 4.24A were
used for this analysis. Bars show mean ± SEM values. (*) indicates a P value
< 0.05 determined by Student’s t-tests.
Because the delayed recovery of hearing thresholds in wild type mice might represent
the effect of a TRPA1-mediated ‘protective’ mechanism, we exposed mice to a second
round of noise on day 5 of recovery. Two weeks after the second noise exposure, the
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hearing thresholds at 8 and 16 kHz had recovered to normal levels but were still elevated
for 24 and 32 kHz (Figure 4.26). Therefore, this protocol of noise exposure led to a
mixture of temporary (TTS) and permanent (PTS) threshold shifts in both wild type and
Trpa1–/– mice. We did not observe significant differences between the hearing thresholds
of wild type and Trpa1–/– mice after the two weeks of recovery (P > 0.6). Because we
observed PTS even in wild type animals, it is very plausible that the noise protocol used
was too damaging to reveal the potential protective effect of TRPA1 activation.

Figure 4.26. The noise exposure used leads to permanent threshold shifts in the
high frequency range
Hearing thresholds were determined in wild type (black) and Trpa1–/– mice (red)
before (Baseline, solid lines) and 2 weeks after a second noise exposure (dotted
lines) by evaluating the auditory brainstem responses (ABR) to tone stimulations
at 8, 16, 24 and 32 kHz. Mean ± SEM values are plotted. (***) indicates a P
value < 0.001 (after Bonferroni corrections) between hearing thresholds at
baseline and after 2 weeks of recovery for each mouse group.
Noise exposure leads to the generation of reactive oxygen and nitrogen species in the
cochlea. Moreover, these reactive species continue to be generated for days after the
initial acoustic trauma [285]. Therefore, we wondered whether our protocol of noise
exposure was able to lead to an increase in oxidative damage that could last for at least 5
days. We performed immunolabeling of 4-HNE-modified proteins in cochleae from wild
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type mice. In agreement with our hypothesis, we found increased amounts of 4-HNEmodified proteins 5 days after noise exposure (Figure 4.27). These results indicate that,
even 5 days after the noise exposure, TRPA1 channels could get activated due to
prominent presence of oxidative tissue damage. Moreover, the TRPA1-mediated changes
of the shape of pillar cells could maintain the geometry of the cochlear epithelium in a
modified shape that decreases the cochlear amplification.

Figure 4.27. 4-HNE-modified proteins are increased in the cochlear epithelium
5 days after noise exposure
A-C, Immunolabeling against 4-HNE-modified proteins in cochleae from wild
type mice not exposed to noise (A) or at 5 days (B) or 2 weeks (C) after noise
exposure. ISC, inner sulcus cells; IHC, inner hair cells; OHC, outer hair cells;
HeC, Hensen’s cells.
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CHAPTER 5
Discussion of results, study limitations and future directions
TRPA1 channels have gained the reputation of broad damage sensors in numerous
tissues and pathological conditions. They are highly expressed in a subset of nociceptive
neurons where they are involved in the detection of ‘harmful’ stimuli and the modulation
of mechanical –and perhaps thermal– hyperalgesia. TRPA1 channels are also expressed
in non-neuronal tissues where they might alter inflammatory and immune responses,
through poorly understood mechanisms. TRPA1 mRNA expression has also been
reported in the mammalian inner ear [177]. However, Trpa1–/– mice have normal hearing
and balance (i.e. cochlear and vestibular functions, respectively), as well as normal
mechano-electrical transduction in the inner ear sensory cells (hair cells) [101, 102]. We
hypothesized that, similar to its function in other tissues, TRPA1 channels in the inner ear
act as tissue damage sensors; for instance, during the oxidative damage induced by
acoustic trauma.
Our results show that, indeed, TRPA1 channels in the cochlear epithelium can be
activated by byproducts of oxidative tissue damage. However, in the inner ear, TRPA1
channels seem to be doing more than merely “sensing” the damage. Our results
uncovered a novel TRPA1-initated pathway of communication between different types of
non-sensory (supporting) cochlear cells. The Hensen’s cells seem to act as major
‘sensors’ for tissue damage, while other supporting cells (i.e. pillar and Deiters’ cells)
types are the main ‘effectors’ by changing the geometry of the organ of Corti thus
altering hearing sensitivity. This pathway represents a hitherto unknown mechanism of
cochlear regulation.
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5.1 Propagation of TRPA1-mediated signals across the cochlear epithelium
Our results indicate the presence of an active TRPA1 promoter throughout the entire
cochlear epithelium. We also demonstrated TRPA1 channel activity in most supporting
cell types either with FM1-43 uptake, Ca2+ imaging or whole-cell patch clamp
recordings. In some supporting cells, these different techniques produced different
results. We did find that the kinetics of the responses to TRPA1 activation were
somewhat unique for each type of supporting cell. For instance, Hensen’s cells exhibited
robust and long-lasting Ca2+ responses to all TRPA1 agonists tested, while Claudius’
cells only responded to TRPA1 agonists when the gap junction blocker FFA was present
in the bath solution.
The particularly long-lasting behavior of the TRPA1-mediated responses in Hensen’s
cells seems to indicate that in these cells the channel is locked in an open configuration.
This might arise from (i) the reactive nature of the TRPA1 agonists tested and/or (ii) a
positive feedback provided by the intracellular Ca2+ levels. To test whether the longlasting responses to TRPA1 stimulation are the result of long-lasting covalent
modifications in its intracellular N-terminus, additional experiments should be performed
using non-reactive agonists, such as icilin, since they seem to activate TRPA1 via a
‘classical’ lock-and-key mechanism.
Interestingly, the TRPA1-mediated Ca2+ responses in Hensen’s cells never propagated
to their immediate neighbors, the Claudius’ cells. Instead, TRPA1-mediated Ca2+
responses in the Hensen’s cells always propagated toward the medial side of the cochlea,
and elicited Ca2+ waves in the Kolliker’s organ. These ‘secondary’ Ca2+ waves in the
Kolliker’s organ required the release of ATP to the extracellular space for their cell-tocell propagation. Therefore, we believe the Ca2+ responses that we observed in the
Kolliker’s organ are secondary to the activation of TRPA1 channels in Hensen’s cells and
correspond to the Ca2+ waves that have been previously described by others (Figure 1.10)
[37, 70].
Extracellular ATP is thought to be an important signaling molecule during tissue
damage in the cochlea. Damage of a single sensory hair cell is able to trigger robust ATPdependent self-propagating Ca2+ waves in the cochlear epithelium; mice lacking P2X2
receptors are more susceptible to noise-induced permanent hearing loss [81]; and low
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levels of ATP have been detected in the cochlear fluids after acoustic overstimulation
[68]. It has been demonstrated that ATP-initiated Ca2+ waves in the cochlear epithelium
are sustained by and critically depend on the Ca2+-evoked release of ATP into the
extracellular fluid [295]. However, the exact mechanism initiating the very first release of
ATP into cochlear fluids remains unknown. Our results revealed a previously unknown
and never considered mechanism: the activation of TRPA1 channels in the Hensen’s cells
might initiate Ca2+ waves that trigger the release of ATP to the extracellular space. Once
the ATP is released outside the cell, it can maintain secondary Ca2+ waves through
previously described mechanisms (Figure 1.10) [37, 70] and/or activate TRPA1 channels
in other supporting cells downstream of metabotropic P2Y receptors (manuscript in
preparation, Vélez-Ortega AC, et al., see Appendix D for details). Therefore, the
activation of TRPA1 channels may represent a long-sought event that initiates protective
ATP signaling in the cochlea during noise exposure. Obviously, our results do not refute
other potential mechanisms of ATP release, such as the one hypothesized for cells within
the stria vascularis [68, 297]. However, ATP release associated with Ca2+ waves
propagating after TRPA1 activation in Hensen’s cells would result in the most effective
local rise of extracellular ATP right in the organ of Corti region.
The activation of TRPA1 channels downstream of P2Y receptors has been studied in
transfected HEK-293 cells but not in cochlear supporting cells (manuscript in
preparation, Vélez-Ortega AC, et al., see Appendix D for details). Therefore, patch clamp
recordings could be performed in cochlear supporting cells from wild type and Trpa1–/–
mice to evaluate for the presence of TRPA1-induced inward currents after puff
stimulation with a very low concentration of ATP –that may activate P2Y but not P2X
receptors–.
TRPA1 activation in the Hensen’s cells is unlikely to stimulate direct ATP release
from these cells to the extracellular fluid; otherwise, the Claudius’ cells –which express
P2Y receptors– would have exhibited Ca2+ responses secondary to the TRPA1
stimulation of Hensen’s cells. If Hensen’s cells do release ATP to the extracellular space
after TRPA1 activation, one plausible explanation for the absence of responses in the
Claudius’ cells would require the (i) release of ATP through the basolateral membrane of
Hensen’s cells and (ii) the expression of P2Y receptors in the apical surface of Claudius’
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cells. However, the exact subcellular localization of P2Y receptors in Claudius’ cells is
unknown.
The exact mechanism of propagation of TRPA1-dependent Ca2+ responses from the
Hensen’s cells toward the Kolliker’s organ has not been completely resolved. We did not
observe the involvement of inner (IHC) and outer (OHC) hair cells in this propagation
but, because the ratiometric Ca2+ dye used failed to load pillar and Deiters’ cells, we were
unable to see whether the Ca2+ responses propagated through these two types of
supporting cells. Several unsuccessful attempts to load pillar and Deiters’ cells with the
Ca2+ dye were performed as follows:
i) Nearby supporting and/or hair cells were removed to disrupt the tight junctional
barrier at the reticular lamina of the cochlear epithelium and thus allow uptake of the
Ca2+ dye through the basolateral membranes. Unfortunately, supporting cells can quickly
re-seal the reticular lamina. Therefore, we had to remove a substantial number of cells to
guarantee that the reticular lamina would not be resealed during the incubation with the
Ca2+ dye. This caused extensive damage to the tissue and considerable alterations of its
geometry and cell shapes.
ii) The approach described above resulted in the uptake of the Ca2+ dye only by pillar
and Deiters’ cells that were in close proximity to the site of tissue damage. Therefore, to
increase the amount of Ca2+ dye present underneath the reticular lamina, puff pipettes
were used to establish a perfusion system between the rows of pillar cells (i.e. the space
that constitutes the tunnel of Corti in the adult cochlea). This perfusion strategy often led
to pressure build up underneath the tissue when the “exit” pathway was resealed (i.e.
secondary area where cells had been removed to allow for the perfusion to occur). This
increase in fluid pressure underneath the reticular lamina disrupted connections between
the basolateral membranes of supporting cells, as evidenced during bright field imaging.
iii) To minimize the excretion of the intracellular Ca2+ dye, we also loaded the
cochlear explants in the presence of 250 µM of the organic anion-transport inhibitor
sulfinpyrazone (Invitrogen) [298, 299]. This strategy slightly improved the loading of
other cell types, but not of pillar and Deiters’ cells.
iv) Normally, the cochlear explants were incubated in the presence of the Ca2+ dye for
50 min at room temperature. In order to decrease incubation times in some of the
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approaches described above, the dye concentration was increased and/or the incubation
was performed at 37°C. Once again, this approach failed to improve the loading of pillar
and Deiters’ cells with the Ca2+ dye.
v) The loading of the ratiometric Ca2+ dye was also evaluated in rat cochlear explants
because they have slightly larger cells and, therefore, a greater surface area of pillar and
Deiters’ cells that would be exposed to the Ca2+ dye. However, rat pillar and Deiters’
cells also failed to uptake the Ca2+ dye.
vi) The goal of the five strategies described above was to improve the loading of pillar
and Deiters’ cells in freshly-dissected cochlear explants. The loading with the Ca2+ dye
greatly improved in Deiters’ cells from explants that had been cultured for 2-3 days.
However, after this time in culture, the Deiters’ cells were no longer located underneath
the OHCs; instead, the OHCs had slid between the rows of Deiters’ cells. In addition to
the alterations in tissue organization after 2-3 days in culture, the OHCs were more
susceptible to undergo apoptosis after the stimulation with the TRPA1 agonists.
Therefore, we were not able to use cultured cochlear explants to evaluate the propagation
of TRPA1-induced Ca2+ waves from the Hensen’s cells toward the Kolliker’s organ.
To overcome the difficulties in loading pillar and Deiters’ cells with the membranepermeable ratiometric Ca2+ dye (fura-2, AM), other types of Ca2+ indicators could be
employed such as the genetically encoded G-CaMP3 [300] or D3cpv [301] Ca2+
reporters. Vectors encoding these Ca2+ indicators are commercially available (Addgene
plasmids #22692 and #36323, respectively) and could be used to transfect cells from
cochlear explants via electroporation [302, 303] or gene gun [304]. Alternatively,
transgenic mice with conditional expression of G-CaMP3 limited to cells expressing the
Cre recombinase are also commercially available (Jackson laboratories, stock number
014538). They could be bred with mice that express Cre under a ubiquitous promoter or
under promoters specific for cochlear supporting cells (e.g., Cre expression under the
Prox1 promoter would be limited to outer pillar and Deiters’ cells [305]).
It is possible that TRPA1-initiated Ca2+ responses at the Hensen’s cells propagate
through the gap junctional conductance to the Kolliker’s organ via Deiters’ and pillar
cells. Interestingly, the permeability of gap junctions connecting Hensen’s to pillar cells
is very different from the permeability between Hensen’s and Claudius’ cells [33, 34].
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Our whole-cell recordings showed that Deiters’ cells express functional TRPA1
channels too but we were unable to detect TRPA1-mediated currents in pillar cells.
However, if pillar cells do express TRPA1 channels, it is possible that they were simply
not gated due to the conditions of our experimental approach. In fact, Claudius’ cells
failed to exhibit TRPA1-mediated Ca2+ responses during our initial experimental
conditions, but we eventually revealed the presence of functional TRPA1 channels in
these cells as well.
Regardless of the exact mechanism of cell-to-cell propagation, the TRPA1-induced
Ca2+ responses in the Hensen’s cells consistently traveled in a unidirectional way. This
behavior differed from other types of Ca2+ waves elicited after hair cell damage. ATPdependent self-propagating Ca2+ waves triggered after the death of a single hair cell can
propagate in all directions around the damaged site, even to Claudius’ cells [37, 38].
TRPA1-initiated Ca2+ responses in Hensen’s cells are likely to require the propagation of
a second messenger that may be specific for some unique gap junctions between these
cell types [33, 34], which would account for the inability of the signal to propagate
toward the Claudius’ cells. The physiological significance of this special mechanism of
propagation of TRPA1-initiated Ca2+ responses from the Hensen’s cells toward the
Kolliker’s organ may be to simply ensure the activation of supporting cells that have poor
access to the apical surface of the cochlear epithelium (e.g. pillar and Deiters’ cells). This
could be the case when, for instance, byproducts of oxidative stress are mainly present in
the endolymph.
Altogether, our results indicate that (i) Hensen’s cells mount robust Ca2+ responses in
the presence of oxidative damage via the activation of TRPA1 channels; and (ii) this
responses are able to propagate to the Kolliker’s organ and trigger Ca2+ waves that
release ATP to the extracellular space (Figure 5.1).
The ATP-induced Ca2+ waves after hair cell death are known to activate intracellular
signaling cascades that may promote cell survival [37, 69]. Because TRPA1 activation
can trigger ATP-dependent Ca2+ waves, it is possible that similar –if not the same–
signaling pathways are activated. Of note, Hensen’s cells might exert anti-inflammatory
actions by releasing into the extracellular space the contents of their lipid droplets, which
are rich in the anti-inflammatory protein annexin A1 [61]. Perhaps, the long-lasting
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increase in intracellular Ca2+ induced after TRPA1 activation of Hensen’s cells can
activate the signaling pathways involved in the release of the lipid contents.

Figure 5.1. Diagram of Ca2+ responses and their propagation after TRPA1
stimulation in the cochlear epithelium
Hensen’s cells seem to be the major sensors of oxidative damage in the
cochlea. The TRPA1-mediated Ca2+ responses in Hensen’s cells can
propagate toward the Kolliker’s organ (presumably involving the gap
junctional conductance through Deiters’ and pillar cells) but do not
propagate toward the Claudius’s cells. After making their way to the
Kolliker’s organ, ATP-dependent self-propagating Ca2+ responses are
elicited. Because extracellular ATP can activate TRPA1 channels
downstream of P2Y receptor signaling, the release of ATP in the Kolliker’s
organ could initiate secondary activation of TRPA1 channels. Deiters’ cells
express TRPA1 channels and can respond to direct agonist stimulation.
Pillar cells may also express TRPA1 channels despite our inability to evoke
TRPA1 responses in these cells during whole-cell patch clamp experiments.
The activation of TRPA1 channels in the cochlear epithelium after the stimulation
with 4-HNE, a byproduct of oxidative tissue damage, indicates that TRPA1 channels
behave as tissue damage sensors in the cochlea, similarly to their role in nociceptive
neurons. TRPA1 channel activation in nociceptive neurons leads to membrane
depolarization and triggers action potentials that result in the sensation of pain. ‘Ear pain’
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is generated by the activation of nociceptive neurons innervating the outer and middle ear
since the inner ear is not considered to have nociceptive innervation. Cochlear supporting
cells do not trigger action potentials; instead, TRPA1 activation leads to an increase in
cytosolic Ca2+ that might activate several signaling cascades. The signaling cascades
activated after TRPA1 gating in cochlear supporting cells might be similar to those
observed in TRPA1-expressing non-neuronal cells (e.g., epithelial and smooth muscle
cells in the lung). In particular, the A549 cell line derived from human lung epithelial
cells shows a robust increase in the phosphorylation of ERK1/2 and Akt2 after TRPA1
stimulation with mustard oil [306]. Similar, results were obtained in HEK-293 cells
transfected with human or mouse TRPA1 [306]. Therefore, activation of TRPA1
channels in the inner ear might trigger pro cell-survival signaling cascades similar to
those activated by extracellular ATP (i.e. involving ERK1/2 phosphorylation).
In this study, however, we did not pursue the changes in cell signaling cascades after
TRPA1 activation. Instead, we decided to study the effect of TRPA1 activation in the
mechanical properties of the cochlear epithelium. This approach was considered after
noticing that TRPA1 activation induced prominent tissue displacements observed during
bright field imaging.
5.2 TRPA1 activation induces changes in the geometry of the cochlear epithelium
The TRPA1-mediated Ca2+ responses described above led to a slow but prominent
movement within the cochlear epithelium. Because the tissue displacements involved
changes in a three-dimensional (3D) fashion, they were hard to study through imaging
obtained from a 2D plane. Luckily, when the direction of the tissue movement was
aligned with the focal plane that was being imaged, we noticed prominent cell
contractions in the pillar cells and Deiters’ cells.
Flash photolysis of caged Ca2+ led to long-lasting contractions in outer pillar cells,
indicating that these cells possess Ca2+-dependent contractile machinery. The phalangeal
processes of Deiters’ cells have been reported to exhibit mechanical responses after an
increase in intracellular Ca2+ [56, 57]. Therefore, outer pillar cells together with Deiters’
cells might contribute to the TRPA1-dependent tissue movements observed. However,
we believe we are the first to show that pillar cells in the organ of Corti possess Ca2+118

dependent contractile machinery. Notably the phalangeal processes of Deiter’s cells and
the stalks of pillar cells possess a cytoskeleton rich in microtubules and actin filaments
(reviewed in [32]). To understand the machinery driving the Ca2+-dependent changes in
cell shape, future studies could evaluate TRPA1-dependent tissue displacements in the
presence of pharmacological treatments that modify the cytoskeleton dynamics. In
particular, several drugs that enhance or inhibit the polymerization of actin filaments o
microtubules have been shown to modify the stiffness of cochlear pillar cells [307].
Moreover, an inhibitor of myosin II was able to both increase and decrease –depending
on the developmental age– the stiffness of pillar cells [307].
In an attempt to ‘quantify’ the magnitude of the TRPA1-induced tissue displacements,
we tried to perform an optical flow analysis of the bright field time-lapse image
sequences. This type of analysis measures the relative motion of specific pixels within a
sequence of images, and it is often used to track the movement of edges and objects. The
analysis was performed with the collaboration of Dr. Brandon K. Fornwalt and Dr.
Jonathan Suever from the Department of Physiology at the University of Kentucky.
Unfortunately, we were unable to track the changes in cell shape with this technique. The
major problem arises from the assumption that the pixels to be tracked will not exhibit
significant changes in grayscale values over time. However, changes in the shape of cells
alter the light scattering pattern in the image, which results in prominent changes in pixel
value intensity (Figure 5.2). To overcome the problem of pixel value changes for optical
flow analysis, we would need to perform significant modifications to existing algorithms.
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Figure 5.2. Tissue movement during bright field imaging leads to changes in
pixel intensity values
A, Bright field image showing an example of a region within the cochlear
epithelium where tissue displacements were evaluated after puff stimulation
with TRPA1 agonists. The white arrow indicates the position and direction
of puff application. B-C, Sub-region from the image in A (indicated by the
dashed window) is shown at a higher magnification and from three different
time points (B-C) during the time lapse imaging. Yellow arrows indicate
areas where cell contractions led to changes in pixel intensity values
between frames (compare arrows in panel C, with the corresponding pair in
either B or D).
A simpler approach we used to detect the presence of tissue movements by subtracting
frames taken 10 s apart. This analysis is sensitive to both pixel movement as well as
changes in pixel value. It revealed two distinct peaks in the average trace for 4-HNEinduced movement from the wild type explants (Figure 4.19C, top). Due to the type of
analysis used, a second peak could simply represent the time point when the tissue is
recovering toward its original shape. However, the study of the individual bright field
recordings showed that, in some explants, the 4-HNE-induced movements occurred
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several minutes after the puff stimulation (i.e. near the end of the recording) (data not
shown). Therefore, the second peak observed in Figure 4.19C (top) indicates the average
time point where the movement occurred in the explants that exhibited a delay.
To fully understand which cell types are involved and what type of changes (e.g.,
elongation vs. contraction) orchestrate the tissue displacements triggered after TRPA1
stimulation, we believe that the imaging technique used needs to provide information in
4D (x, y, z and time). Using a cell-membrane dye (CellMaskTM, Molecular Probes) we
successfully labeled the plasma membrane of hair cells and supporting cells within the
cochlear epithelium (Figure 5.3).

Figure 5.3. Labeling of cell membranes in the cochlear epithelium for 3D
imaging reconstruction
A, Representative 3D view of a cochlear explant labeled with the plasma
membrane dye CellMaskTM. B, An orthogonal view from the tissue shown in A.
C, Diagram illustrating the cell types observed in the image from B.
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Using a spinning disc confocal microscope (section 3.3.3) for the time-lapse imaging,
we were able to obtain 3D stacks every ~ 3-5 s. The stacks consisted of 5 to 10 confocal
images acquired every 3 µm. Because the TRPA1-induced tissue displacements are slow,
we believe this imaging speed is sufficient for the study of this type of movements.
However, this type of labeling seemed to compromise the integrity of the plasma
membrane and caused cell death in some sensory and supporting cells during the puff
application of 4-HNE. As an alternative, 4D imaging could be performed using tissue
from the mT/mG mouse, a reporter mouse that exhibits ubiquitous expression of a
membrane-targeted fluorescent marker. In fact, this mouse was recently used to study the
architecture of live cochlear epithelium via 3D image stacks [308]. In a future study, we
consider collaborating with Dr. Anthony Ricci (Stanford School of Medicine) to cross the
mT/mG transgenic mice with our TRPA1-deficient mice, in order to study the TRPA1mediated shape changes in the organ of Corti of older mice.
In the adult cochlear epithelium, the heads of inner and outer pillar cells are in close
contact while their feet are separated at the basilar membrane. This ‘triangular’
orientation of the pillar cells forms the tunnel of Corti, a fluid-filled space between the
rows of inner and outer hair cells. Regardless of the type of movement induced by
TRPA1 stimulation, it is clear that any changes in the shape of pillar cells can potentially
modify the entire geometry of the organ of Corti (Figure 5.4).
As a consequence, the resting angle between the OHC stereocilia and the tectorial
membrane (Figure 1.4) might change, and this would have an impact on hearing
sensitivity.
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Figure 5.4. Changes in pillar cell shape can alter the geometry of the organ of
Corti
Diagram illustrating how the changes in the shape of pillar cells can alter the
angle between the reticular lamina and the tectorial membrane. This change in
the tissue geometry would modify the angles between the OHC stereocilia and
the tectorial membrane during sound stimulation. Consequently, changes in
pillar cell shape would alter the hearing sensitivity.
5.3 TRPA1-mediated inhibition of cochlear amplification
After acoustic trauma, ATP is released into the cochlear fluids [68] and reactive
oxygen and nitrogen species are generated in the cochlear epithelium [284, 285].
Therefore, noise exposure could lead to the activation of cochlear TRPA1 channels either
through endogenous agonists or downstream of P2Y receptor activation (manuscript in
preparation, Vélez-Ortega AC, et al., see Appendix D for details).
We showed the contraction of pillar cells in response to puff application of TRPA1
agonists or ATP. The release of ATP into cochlear fluids may mediate changes in pillar
and Deiters’ cell shape during and immediately after the noise exposure. In contrast, the
byproducts of oxidative stress could continue to activate TRPA1 channels and lead to the
changes in pillar cell shape for several days after the acoustic trauma.
As reviewed in section 1.9, noise exposure is known to cause changes in the
architecture of the organ of Corti. However, whether these changes were simply the result
of mechanical damage or were driven by active changes in the shape of some cells was
unknown. Here we propose that acoustic overstimulation leads to TRPA1-mediated Ca2+dependent changes in the shape of pillar and Deiters’ cells that can potentially alter the
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entire geometry of the cochlear epithelium. Interestingly, a reduction in cochlear
microphonics (i.e. an alternative method to test the cochlear sensitivity) has been shown
to correlate with changes in the shape of cochlear supporting cells after acoustic
overstimulation [85]. We found that wild type mice have a delayed recovery of hearing
sensitivity after noise exposure when compared to Trpa1–/– mice. And we believe this
reduction in hearing sensitivity results from the TRPA1-initiated changes in the geometry
of the organ of Corti. Therefore, TRPA1 activation in cochlear supporting cells could be
one of the mechanisms driving the development of TTS via the changes in the geometry
of the organ of Corti.
We propose a model where noise exposure leads to the activation of the cochlear
TRPA1 channels through two different pathways (Figure 5.5). During noise exposure, the
ATP that is acutely released into the cochlear fluids could activate TRPA1 channels
downstream of the P2Y receptors. TRPA1 activation may result in changes in the
geometry of the organ of Corti that would decrease hearing sensitivity and provide some
degree of protection to the cochlear sensory epithelium. For instance, a reduction in
glutamatergic excitotoxicity would result in a lesser degree of postsynaptic afferent
terminal retraction from the IHC. The loss of this TRPA1-mediated protection could
explain why immediately after noise exposure Trpa1–/– mice exhibited higher hearing
thresholds than wild type mice.
OHC electromotility via the piezoelectric behavior of prestin in the plasma membrane
constitutes the cochlear amplifier. Given that TRPA1 channels are expressed in OHC
[286], TRPA1 activation during noise exposure could also modulate hearing sensitivity
by exerting a direct effect on prestin function. However, we did not observe Ca2+
responses in OHCs after puff application with any of the TRPA1 agonists tested.
Nevertheless, it is necessary to study the impact of TRPA1 activation on OHC
electromotility to fully understand its contribution in the differences that we observed
between wild type and Trpa1–/– mice during and immediately after noise exposure.
While the release of ATP into cochlear fluids might be an acute phenomenon after
noise exposure, the generation of reactive oxygen species after acoustic overstimulation
can last for several days or weeks [285]. During this period of time, TRPA1 channels
would continue to be activated, for example, by lipid peroxidation byproducts like 4124

HNE. This long-lasting activation of TRPA1 channels might maintain a modified
geometry of the organ of Corti and explain the longer-lasting TTS that we observed in
wild type mice.

Figure 5.5. TRPA1 activation after ATP release or 4-HNE production in the
cochlea modulates hearing thresholds
Diagram illustrating representative changes in hearing thresholds for wild type
(black) and Trpa1–/– mice, and the two pathways that could activate TRPA1
channels after noise exposure. The acute release of ATP into the cochlear
fluids could initiate the changes in tissue geometry during the noise exposure
and limit the damage-induced increase in hearing threshold. Later, the chronic
exposure to byproducts of oxidative tissue damage, like 4-HNE, might
maintain the tissue with the modified geometry for days after the acoustic
trauma. This long-lasting inhibition of cochlear amplification might protect
from damaging loud sounds while the organ of Corti structures are repaired.
Further studies could be designed, using multiple noise exposure protocols, to test
whether TRPA1-mediated changes in hearing sensitivity in fact protect against noiseinduced hearing loss. We tried a couple of protocols with noise exposure at 2 or 3
different time points. However, 2 weeks after the last episode of noise exposure, all mice
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exhibited high levels of PTS across most frequencies tested. We believe that, for multiple
noise exposures, it will be necessary to decrease the magnitude of the noise used.
Moreover, we evaluated hearing thresholds 2 weeks after the noise exposure to assess for
the development of permanent threshold shifts (PTS) after noise exposure. We now
believe that it would appropriate to continue measuring the recovery of hearing
thresholds for longer time points (e.g., 4 to 6 weeks after noise exposure) to better
estimate the development of PTS. Additionally, it would be interesting to test whether
exposure to low noise makes Trpa1–/– mice more susceptible to develop age-related
hearing loss. Similarly, it has not been reported whether patients suffering from the
familial episodic pain syndrome due to a gain-of-function mutation in TRPA1 channels
exhibit elevated hearing thresholds or perhaps age-related hearing loss [103]. To this
date, there is only one human pedigree reported to carry mutations in the TRPA1 gene.
Interestingly, these individuals are from a small region near my hometown in Colombia
and I am quite familiar with one of the groups involved in the original report of the
mutation: the Molecular Genetics group from the University of Antioquia (Colombia) led
by Dr. Grabiel Bedoya. I performed the research for my Master’s degree in the same
institution –and the exact same building– where this group is located which might
facilitate future collaborations. Initially we could perform hearing tests in all members of
this pedigree and establish whether carriers of the mutation exhibit higher hearing
thresholds than age-matched non-carriers within the same family.
5.4 Closing remarks
In summary, in this study I have demonstrated that:
i) TRPA1 agonists, including the endogenous byproducts of oxidative stress, evoke
robust and long-lasting Ca2+ responses in Hensens’ cells;
ii) these responses are able to propagate to the Kolliker’s organ and trigger Ca2+ waves
that release ATP to the extracellular space;
iii) the propagation of Ca2+ waves is accompanied by prominent tissue displacements
originated at pillar and perhaps Deiters’ cells;
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iv) pillar cells possess active Ca2+-dependent contractile machinery that could change
the geometry of the organ of Corti and regulate hearing sensitivity during and long after
noise exposure; and
v) the hearing thresholds of TRPA1-deficient mice are indeed more susceptible to
acoustic trauma during noise exposure and show a decrease in the long-lasting temporal
shift of hearing thresholds due to, we believe, the loss of the protective component in this
threshold shift.
To the best of our knowledge, all of these results are novel and represent a hitherto
unknown mechanism of cochlear regulation after noise exposure.

Copyright © A. Catalina Vélez-Ortega 2014
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APPENDIX A

List of syndromes associated to mutations in human TRP genes with their respective
entry numbers in the Online Mendelian Inheritance in Man (OMIM) catalog (i.e. MIM
numbers). The OMIM catalog can be accessed at http://www.omim.org.
AD

Autosomal dominant

AR

Autosomal recesive

Ref.

References
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TRP
gene
TRPA1
TRPC6
TRPM1
TRPM2
TRPM4
TRPM6

MIM

Syndrome

Inheritance

Familial episodic pain syndrome

AD

615040

[103]

AD

603965

[112, 113]

AR

613216

[118-121]

609633

[123]

AD

604559

[128-130]

AR

602014

[135, 136]

105500

[138]

AR

252650

[143, 144]

AD

613095

Olmsted syndrome

AD

614594

[152]

Brachyolmia type 3

AD

113500

[159]

Digital arthropathy-brachydactyly

AD

606835

[162, 163]

Metatropic dysplasia

AD

156530

AD

606071

[164-167]

AD

600175

[164]

AD

181405

[164, 165]

Focal segmental glomerulosclerosis
2
Congenital stationary night
blindness type 1C
Coding SNP associated with
bipolar disorder
Progressive familial heart block
type 1B
Hypomagnesemia with secondary
hypocalcemia

number

Ref.

Susceptibility to amyotrophic
TRPM7

lateral sclerosis- Parkinsonism/
dementia complex

TRPML1
TRPP1
TRPV3

TRPV4

Mucolipidosis IV
Polycystic
kidney disease

Charcot-Marie-Tooth neurophathy
type 2C
Congenital nonprogressive distal
spinal muscular atrophy
Scapuloperoneal spinal muscular
atrophy
129

Reviewed
in [146]

[161, 309,
310]

Parastremmatic dwarfism
Maroteaux spondyloepiphyseal
dysplasia
TRPV4

Kozlowski spondylometaphyseal
dysplasia
Coding SNP associated with
hyponatremia

130

AD

168400

[160]

AD

184095

[160]

AD

184252

[161]

613508

[168]

APPENDIX B

Protein BLAST: Sequence alignment between the human (top, UCSC ID: uc003xza.3)
mouse (bottom, UCSC ID: uc007ajc.1) and rat (UCSC ID: RGD_1303284) TRPA1
proteins. There percentage of identity between ortholog pairs and the percentage of
coverage for each alignment are shown below:
% identity (including gaps)
Human
Mouse
Rat

% coverage (of both)

Human

Mouse

Rat

---

80.2

80.1

Human

---

96.7

Mouse

---

Rat

|

Identical amino acid residues

+

Similarly charged amino acid residues

–

Gap inserted in the amino acid sequence

131

Human

Mouse

Rat

---

99.5

99.5

---

99.9
---

132

133

134

APPENDIX C

Prediction of transmembrane domains in human (UCSC ID: uc003xza.3), mouse
(UCSC ID: uc007ajc.1), and rat (UCSC ID: RGD_1303284) TRAP1 protens using the
TMpred

software

(http://www.ch.embnet.org/software/TMPRED_form.html)

[311]

release 25 (which is based on the SwissProt database release 25). Windows of 14 to 33
amino acid residues were used for the predictions. TMpred scores higher than 500 are
considered significant (red dashed lines).
TMpred compares an amino-acid sequence of interest to a database of naturally
occurring transmembrane proteins. Sequence, hydrophobicity score, flanking regions,
domain orientation, among others, are used for the comparisons and score calculations.
Notice that, in addition to the six channel forming transmembrane segments (S1 to
S6), a highly hydrophobic domain was predicted in the N-terminal region of human,
mouse and rat TRPA1 proteins (roughly from amino acid residues 350 to 360). In
addition, a hydrophobic domain was predicted in the C-terminal region of the human
TRPA1 protein (around the amino acid residue 1020). These intracellular hydrophobic
regions might constitute domains that closely interact with the plasma membrane.
i-o

Inside (cytoplasmic) to outside (luminal) orientation

o-i

Outside to inside orientation
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136

APPENDIX D

TRPA1 channels are activated downstream of ATP metabotropic P2Y receptors.
These set of experiments were performed by Ruben Stepanyan, PhD, during his
postdoctoral training in the Frolenkov laboratory.
Current-voltage responses to 20 μM AITC (A) and 10 μM ATP (B) puff stimulation of
HEK-293 cells transfected with a Trpa1-IRES-GFP construct (blue squares), a GFP-only
construct (“mock”, black circles) or not transfected (black triangles). Insets show
representative current traces to the puff stimulation with AITC or ATP.
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